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1 Introduction 
1.1 RNase P 
Ribonuclease P (RNase P) is a ribonucleoprotein that is responsible for the 5’-maturation of 
precursor RNAs (ptRNAs), one of several post-transcriptional modifications necessary for the 
functional synthesis of tRNA. RNase P cleaves the 5’-leader of ptRNAs by hydrolysing the 
phosphodiester bond immediately 5’ of the first nucleotide of mature tRNA; it produces 5’-
OH and 3’-phosphate groups. tRNA processing is the most widely studied activity of RNase 
P, but RNase P also cleaves other substrates, such as some viral RNAs (Mans et al., 1990; 
Hartmann et al., 1995), p4.5S RNA (Peck-Miller and Altman, 1991), ptmRNA (Komine et 
al., 1994), a few mRNAs (Li and Altman, 2003; Alifano et al., 1994) and some riboswitches 
(Altman et al., 2005). 
RNase P is present in all domains of life (bacteria, archaea and eukarya). So far, all known 
RNase P enzymes consist of one RNA subunit and at least one protein subunit (Fig. 1.1). 
Some chloroplast RNase P enzymes (Wang et al., 1988, Thomas et al., 1995) and 
mitochondrial RNase of Trypanosoma brucei (Salavati et al., 2001) are proposed to be 
exceptions, being putative protein enzymes. 
 
Fig. 1.1: Schematic representation of bacterial, archaeal and eukaryotic RNase P. Secondary structure of the 
respective exemplary RNA subunits are shown in dark blue. The green oval indicates the bacterial RNase P 
protein subunit. Homologous protein subunits in archaea and eukarya are drawn in red, while blue ovals 
represent proteins only associated with eukaryotic RNase P. Grey ovals indicate an additional protein in archaea 
or eukarya, which cannot be found in all representatives of the respective domain of life. 
The first RNase P to be characterised was isolated from Escherichia coli (Altman and Smith, 
1971). In general, bacterial RNase P enzymes consist of one RNA (~400 nt; ~130 kDa) and 
one protein subunit (~120 aa; 13-14 kDa), encoded by the rnpB and rnpA genes, respectively. 
2  Introduction 
The RNA subunit is responsible for the catalytic activity (Guerrier-Takada et al., 1983). 
Composition of RNase P from archaea and eukarya reveals increased complexity (reviewed in 
Walker and Engelke, 2006): 
Beside one RNA subunit, archaeal RNase P enzymes have been described to consist of at 
least four protein subunits (Andrews et al., 2001; Hartmann and Hartmann, 2003; Fukuhara et 
al., 2006). Whereas the RNA subunit is structurally similar to bacterial RNase P RNA, the 
archaeal protein subunits have been identified as homologues of yeast and human RNase P 
proteins (Frank et al., 2000; Hall und Brown, 2002). 
Nuclear RNase P from yeast or human consists of one RNA subunit and nine (Chamberlain et 
al., 1998) or ten (Jarrous und Altman, 2001; Van Eenennaam et al., 1999 & 2001) associated 
proteins, respectively. Eukaryal RNase P proteins were shown to be essential under all 
conditions tested. 
In bacteria (Schedl and Primakoff, 1973; Gößringer et al., 2006), yeast nuclei (Lee et al., 
1991), human (Jarrous and Altman, 2001) and mitochondria (Morales et al., 1992; 1989) 
RNase P has been shown to be essential. 
1.2 Bacterial RNA subunit 
The RNase P RNA subunit in bacteria consists of about 350-450 nucleotides. The RNA 
subunit has been shown to be catalytically active in the absence of the protein subunit under 
high salt conditions in vitro (Guerrier-Takada et al., 1983), thus being a typical ribozyme. 
RNase P RNA is basically composed of two domains which can fold independent of each 
other (Pan, 1995; Loria and Pan, 1996): The specificity domain (S-domain) comprises helices 
P7-P17 and is involved in substrate binding by contacting the T-arm of ptRNA as 
demonstrated by biochemical experiments (Pan et al., 1995; Loria and Pan, 1998) and 
photocrosslinking studies (Nolan et al., 1993; Chen et al., 1998; for details see Chapter 1.3). 
The catalytic domain (C-domain) is composed of helices P1–6 and P15–18. This domain 
contains universally conserved residues, recognizes the acceptor-stem of tRNAs and the 
tRNA 3’-CCA. It includes all structural elements required for catalysis, including catalytically 
important metal ion binding sites. RNA subunits of different bacteria share a common core; 
these conserved core sequences and structures, when combined in a synthetic minimal RNase 
P RNA, were shown to be sufficient for catalytic activity (Siegel et al., 1996; Waugh et al., 
1989; see also bacterial minimal consensus Fig. 1.2). Only about 40 nts in bacterial RNase P 
RNAs are absolutely conserved based on the sequences known until now. These conserved 
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residues are concentrated in the vicinity of the ptRNA binding interface (Haas and Brown 
1998). 
Most RNase P RNAs belong to the structural type A (A for ancestral) represented e.g. by E. 
coli RNase P RNA. Furthermore, in low G+C Gram-positive bacteria, such as B. subtilis, type 
B RNAs are found (Haas et al., 1996). An intermediate structure (type C) is found in green 
non-sulfur bacteria (Haas and Brown, 1998). 
 
 
Fig. 1.2: Consensus type A and type B RNase P RNAs. Invariant nucleotides are indicated by capital letters (A, 
G, C or U), variable nucleotides are marked as dots (●). Only nucleotide positions that are present in all 
members of each type of RNA are shown. Grey lines indicate elements of the E. coli (type A) or B. subtilis (type 
B) RNAs that are absent in some of the RNAs of each type (adapted from Haas et al., 1996). The catalytic 
domain is highlighted in green, the specificity domain in yellow. 
The structural differences between type A and type B RNAs are mainly caused by the absence 
and presence of helical elements. In addition, there is variation in the form of small 
differences in the lengths of helices, loops and joining regions (Fig. 1.2; Haas and Brown, 
1998).  
The main differences in secondary structure between type A and B RNAs concern helical 
regions which are only present in one or the other, respectively. P6, J15/16 and helix P18 are 
e. g. only part of E. coli RNase P RNA. Helix P6 of E. coli RNase P RNA, a pseudoknot 
formed by peripheral distal nucleotides, and helix P17 are thought to be replaced with helix 
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P5.1 in B. subtilis (Haas et al., 1991). Helix P15 is reduced from 4 to 3 bp in type B RNA, 
and P16/17 are missing. Helix P18 is shortened in length in B. subtilis. However the helices 
P15.1 and P19 as additional elements in B. subtilis are possible to take over structural 
functionality. 
Despite the differences in secondary structure, the overall structural arrangement of the 
different RNAs is very similar. This could be shown in the X-ray crystal structures of type A 
and type B RNase P RNA, originally only solved for the specificity domains of Bacillus 
subtilis (Krasilnikov et al., 2003) and Thermus thermophilus (Krasilnikov et al., 2004) and 
more recently for entire RNA subunits of Bacillus stearothermophilus (Kazantsev et al., 
2005) and Thermotoga maritima (Torres-Larios et al., 2005). A more detailed insight into the 
structural features of RNase P will be given in Chapter 1.5. 
1.3 General substrate recognition 
RNase P cleaves various substrates (see Chapter 1.1) for which no obvious sequence 
similarity exists between their 5’-flanks. Therefore it is of special interest, how correct 
recognition and positioning of substrates is obtained. 
In early studies it has been shown that introduction of mutations within the ptRNA which 
caused structural perturbations affected cleavage efficiency by RNase P (Altman et al., 1974). 
This finding indicated that in general three dimensional structural features of tRNAs are 
recognised by RNase P (Altman et al., 1993). 
T-stem and T-loop (conferred to as T-arm in Fig. 1.3) form non-Watson-Crick contacts with 
the S-domain of the RNA subunit, which was shown by modification-interference and 
crosslinking studies (Kirsebom and Vioque, 1996; and references therein). Most native tRNA 
molecules have a 7 base pair long acceptor-stem (while tRNAHis and tRNASeCys are 
exceptions having an 8-bp stem). Biochemical experiments showed that the acceptor-stem is 
in close contact with the RNase P RNA (Harris et al., 1994; Kahle et al., 1990; Thurlow et al., 
1991) and that the length and its primary structure is a major determinant for cleavage site 
selection (Holm and Krupp, 1992; Kirsebom and Svärd, 1992). The coaxially stacked T-arm 
and acceptor-stem normally defines a distance of 12 base pairs from the T-loop to the 
cleavage site. This distance-ruler has been suggested to be involved in localization of the 
cleavage site (Kahle et al., 1990; Thurlow et al., 1991). The variable loop and the D-arm only 
play an indirect role in substrate recognition, as they are responsible for fixing the T-arm in its 
genuine conformation and position (Hardt et al., 1993; Gaur et al., 1996). The contacts with 
the acceptor-stem are mainly mediated by the C-domain of the RNA subunit. 
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Fig. 1.3: Scheme of the secondary structure of a ptRNA. The black arrow indicates the site of cleavage by 
RNase P. The green oval highlights the Watson-Crick base pairs formed between tRNA 3’-CCA and nucleotides 
G292 and G293 in loop 15 of RNase P RNA from E. coli (A). In panel B the tertiary structure of tRNAPhe from 
yeast is shown; the structural domains are coloured according to the scheme in panel A. The region recognised 
and directly interacting with RNase P RNA is marked by the grey oval. 
In 4.5S RNA, a non-tRNA substrate of E. coli RNase P, the terminal stem structure seems to 
mimic the coaxially stacked acceptor-stem and T-stem (Forster and Altman 1990; Peck-Miller 
and Altman, 1991). 
Aside from the secondary structural features, also the base identity of positions close to the 
RNase P cleavage site seems to be of importance (Kirsebom and Vioque 1996 and references 
therein). In more than 80% of all characterised tRNAs the nucleotide at position +1 is a 
guanosine (Sprinzl et al., 1998). Especially the identity of the G1-C72 base pair was shown to 
be important in the RNA-alone reaction (without the protein subunit), and the +1 nucleotide 
was suggested to serve as guiding nucleotide (Svärd and Kirsebom 1992). However, the 
presence of the protein subunit seems to reduce the importance of the G1-C72 base pair, as the 
holoenzyme, in contrast to the RNA alone, was shown to cleave substrates with other 
canonical and non-canonical base pairs at position 1-72 with the same efficiency as substrates 
containing the G1-C72 base pair (Harris et al., unpublished data). 
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1.3.1 CCA interaction 
The interaction of tRNA 3’-CCA with RNase P RNA is of special interest in this study. A 
first hint to the involvement of the 3’-terminus in RNase P catalysis was provided in an early 
study demonstrating that puromycin, an analogue of the 3’-termini of aminoacyl-tRNAs, 
inhibits the RNase P reaction (Vioque 1989). Further experiments showed that in E. coli the 
two cytosines (position C74 and C75) of 3’-CCA of tRNAs interact with the two conserved G 
residues G292 and G293 in loop 15 (E. coli numbering), by Watson-Crick base pairing (Fig. 
1.3; Kirsebom and Svärd, 1994). The importance is underlined by the fact that in E. coli all 
tRNA genes already encode 3’-CCA. This interaction provides a substantial contribution of 
the free energy of (p)tRNA binding in vitro (Hardt et al., 1995; Oh et al., 1998; Busch et al., 
2000), supports selection of the correct cleavage site (Kirsebom and Svärd, 1994) and is 
suggested to play a role in the binding of catalytic Mg2+ (Oh et al., 1998; Busch et al., 2000). 
Also non-tRNA substrates encode 3’-CCA, or in the case of 4.5S RNA 3’-CCC, and therefore 
allow base-pairing with the mentioned residues in loop 15. 
The interactions with the T-arm, acceptor-stem and the CCA-terminus occur to the RNA 
subunit of RNase P. An additional contact occurs to the 5’-leader of ptRNAs, however, a 
function of the protein subunit of bacterial RNase P. 
1.4 Role of the protein subunit 
In bacteria the protein component contributes only one-tenth to the mass of the holoenzyme. 
However, the protein component facilitates cleavage by RNase P under physiological salt 
concentrations and is required for efficient tRNA processing in vivo (Guerrier-Takada et al., 
1983; Reich et al., 1988; Kurz et al., 1998; Kole et al., 1980). 
The three-dimensional structures of RNase P proteins from three different bacteria have been 
determined by X-ray crystallography (Bacillus subtilis: Stams et al., 1998; Thermotoga 
maritima: Kazantsev et al., 2003) or NMR (Staphylococcus aureus: Spitzfaden et al., 2000). 
Based on these structures and phylogenetic conservation, three potential RNA binding motifs 
have been identified: an RNR-motif which consists of an ~11 aa conserved consensus 
sequence (Altman, 1989; Pace and Brown, 1995), a metal ion binding loop and a conserved 
cleft formed by an alpha helix and a four-stranded β-sheet as depicted in Fig. 1.4. The first 
two RNA binding motifs are thought to interact with RNase P RNA and the third with ptRNA 
(Niranjanakumari et al., 1998; Sharkady and Nolan, 2001; Biswas et al., 2000).  
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Fig. 1.4: Three-dimensional structure of the B. subtilis RNase P protein. α-helices (red) and the β-sheet (yellow) 
are numbered sequentially from the N- to the C-terminus. The RNR-motif, the metal ion binding loop and the 
central cleft formed by α1 and the β-sheet are potential RNA-binding sites. 
For the B. subtilis and E. coli RNase P proteins, both of which play a central role in this study, 
a similar fold is suggested (Fig. 1.5). 
 
Fig. 1.5: Sequence alignment of E. coli and B. subtilis RNase P proteins done with AlignX (Invitrogen). Below 
the secondary structural elements found in B. subtilis RNase P protein are aligned. Similarity describes the 
degree of conservation between the two proteins (identical or similar based on physico-chemical properties). 
By phosphorothioate-iodine protection assays it has been shown that the protein protects 
residues located in helices P2, P3 and at the periphery of P4 (Buck et al., 2005b; see also Fig. 
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1.10). Several residues within these structural elements of the C-domain are known to be 
important for catalytic function, but the protein itself does not play a direct role in catalysis 
(Christian et al., 2002 and references therein). Furthermore, binding of the protein appears to 
induce local conformational changes in both type A (P5-P8,L15/16) and type B (P15.1-P5.1, 
L15) RNA (Buck et al., 2005b). Recent data also suggest a stabilization of the RNase P 
protein upon binding to the RNA subunit (Guo et al., 2006). 
The precise role of the protein subunit is still not fully clear. In some studies with the E. coli 
holoenzyme, the protein has been shown to stabilize the active tertiary structure of the RNA 
subunit (Guerrier-Takada et al., 1983; Kim et al., 1997, Westhof et al., 1996). Additional 
experiments pointed out a role in dimer formation of the B. subtilis holoenzyme (Fang et al., 
2001) and in broadening of substrate specificity (Gopalan et al., 1997; Liu and Altman, 1994). 
In vitro studies showed that the protein has profound effects on reactivity of the RNA subunit 
by increasing the affinity for substrate over product (Reich et al., 1988; Kurz et al., 1998). 
This effect is mainly caused by a direct protein contact to the 5’-leader (Niranjanakumari et 
al., 1998) and may prevent inhibition of the B. subtilis holoenzyme by mature tRNA which in 
vivo is present in excess over ptRNA. 
More recent data suggest that the protein contributes to all these effects, including enhanced 
specificity for ptRNA versus mature tRNA. Inconsistencies derived from various observations 
may be explained by structural and functional differences between type A and type B RNase 
P; such differences seem to reside mainly in the respective RNA subunits. For example, the P 
protein was shown to stabilize its RNA subunit in the E. coli system, while such an effect was 
not evident for B. subtilis RNase P (Buck et al., 2005a).  
1.5 Tertiary structure of bacterial RNase P 
The recently solved crystal structures of two RNase P S-domains gave first insights into the 
details of RNase P RNA architecture. These S-domains of RNase P RNA from T. 
thermophilus (type A) and B. subtilis (type B), despite their different composition of 
structural elements, share a common arrangement of regions involved in ptRNA recognition, 
namely stems P9, P10 and P11 and the joining regions J11/12-J12/11. This creates a similar 
ptRNA binding interface in type A and B RNase P RNA (Fig. 1.6; Krasilnikov et, al. 2004), 
although the stabilisation of the similar core is achieved by different overall folds. 
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Fig. 1.6: Structural conservation of the putative ptRNA recognition interface in the S-domains of T. 
thermophilus (type A) and B. subtilis (type B) RNase P RNA. Region J11/12-J12/11 (green) and stems P9, P10 
and P11 (blue) contain nucleotides involved in ptRNA recognition (red). ptRNA recognition regions adopt a 
very similar geometry but are stabilized differently (Krasilnikov et al., 2004). 
X-ray structures of the complete RNA subunits of T. maritima RNase P (Torres-Larios et al., 
2005) and B. stearothermophilus (Kazantsev et al., 2005) have provided further insights into 
RNase P RNA architecture. Here, the structure of T. maritima P RNA (a representative of 
type A RNase P RNA) will be discussed in more detail. 
The molecule is generally very flat and is built up of two layers. The larger layer consists of 
P1-P12 and P15-P17, including the junctions J5/15, J11/12-J12/11 and the loop L15 region. 
The second layer comprises P13, P14 and P18 (Fig. 1.7). S- and C-domains interact via three 
main tertiary interactions, P8/L18, P4/L8 and P1/L9. Most of the universally conserved 
regions, including the putative ptRNA binding interface, are positioned within the larger 
layer. The S-domain structure is essentially identical to the one from T. thermophilus and 
underscores the structural stability of the domain. The C-domain comprises several coaxially 
arranged helices; one helical stack is formed by P1/P4/P5 another one by P2/P3. P18 
protrudes almost perpendicularly from the two afore mentioned two helical stacks, linking 
P2/P3 to P15/P17 stems and folding back onto the large layer by means of the L18/P8 
interaction. A pseudoknot is performed between P15/P17 and P6, however, this part is not 
defined in the electron density map of this structure. No canonical tertiary interactions are 
seen between the helices forming the C-domain; however the major structural elements 
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(P1/P4/P5, P2/P3, P15/P16 and P18) are held together by short single-stranded joining 
segments, which include several highly conserved residues involved in complex interactions 
not resolved in this X-ray structure. P1 seems to be essential for folding, since it interacts with 
P9. The central organizer of the structure is the P8/P9 helical stack, while the overall structure 
is mainly stabilised by tetraloop-helix and A-minor interactions. The region P15/P16/P17 
seems to be very dynamic in structure, because electron density could not be detected for 
these residues. It is suggested that this region is able to undergo slight conformational changes 
e.g. during holoenzyme assembly or substrate binding. The fact that the molecule crystallised 
as a dimer by formation of an intermolecular pseudoknot P6 raises the question about the 
functional significance of the structure. Packing effects can influence the arrangement of 
biomolecules within a crystal and may therefore distort the biologically active conformation 
of the observed biopolymer (Eyal et al., 2005). However, the observed overall structure 
agrees well with the predictions based on various biochemical approaches. 
 
Fig. 1.7: Three-dimensional structure of T. maritima RNase P RNA (PDB code 2a2e) in two orthogonal views. 
Unconnected grey spheres indicate nucleotides, for which electron density map was insufficient to map their 
exact positions, likely due to increased flexibility of these residues. 
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The structure of B. stearothermophilus type B RNase P RNA has a very similar flat structure 
as well, consisting of mainly coaxially stacked helices held together by three long-range 
interactions (Kazantsev et al., 2005), including a characteristic interaction between L5.1 and 
L15.1, a hallmark of type B RNase P RNAs. There are several structural features unique to 
type A or type B RNase P, as it was expected from the basic differences proposed in the 
secondary structure models and the already existing crystal structures of the S-domain of each 
type. However, particularly interesting are the similarities between the two types of RNase P. 
Comparison of the type A and B full-length RNA structures revealed that different structural 
scaffolds support similar substrate recognition surfaces in the C-domain. The highly 
conserved structural core element of the S- and C-domain, consisting of coaxially stacks 
P1/P4/P5, P2/P3, P8/P9 and P15, the J11/12-J12/11 module and a connector module between 
stem P3 and P4, are similar in structure and in relative orientation (Fig. 1.8 ;Torres-Larios et 
al., 2006). According to what has been observed already in the crystal structure of the 
separate S-domains, a similar core seems to be stabilised by different structural features. The 
function of stabilization is taken over by different helical and structural elements typical 
either for type A or type B RNase P.  
 
Fig. 1.8: Stereo image of the superimposition of the structural cores. The type A structure is shown using the 
same colours as in Fig. 1.7, whereas the type B structure is shown in red (adapted from Torres-Larios et al., 
2006). 
Therefore, the modelling of the substrate into the RNA structure of the two types of RNase P 
gave very similar results. The tRNA could be positioned in such a way that the acceptor-stem 
lies roughly parallel to the P4 helix, while the T-arm interacts with conserved nucleotides in 
the S-domain as depicted in Fig. 1.9. The 5’-end of the tRNA, which corresponds to the 
cleavage site, lies near the universally conserved region within the C-domain, while the 3’-
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end is in proximity to the L15 region which remained unresolved in both X-ray structures of 
RNase P RNA. The proposed models fully agree with the biochemical observations that have 
focussed on the RNase P RNA-substrate interaction (Christian et al., 2002).  
 
Fig. 1.9: Models of type A and B RNase P RNA-tRNA complexes. The phosphate backbone of the core of the 
molecules is according to those represented in Fig. 1.8. The solvent-accessible surface of the C-domain is shown 
in cyan and of the S-domain in grey, respectively. The acceptor-stem of the tRNA is shown in red, while the 
nucleotides in vicinity of the cleavage site are marked in yellow. The nucleotides marked in magenta in the type 
A model indicate nucleotides proposed to interact with the T-arm of the tRNA. (from Torres-Larios et al., 2006) 
1.6 Holoenzyme Model 
Finally, the structures in combination with new protein-RNA protection data allowed to 
derive an updated model of the holoenyzme in complex with tRNA (Buck et al., 2005b). The 
model is based on the B. subtilis RNase P protein crystal structure and the structure of B. 
stearothermophilus RNase P RNA. Residues protected by the protein occupy a region 
approximately the size of the protein (Fig. 1.10 A). The model places the conserved RNR-
motif near helix P2 and P4 of RNase P RNA according to previous hydroxyl-radical mapping 
data and previous low-resolution models of the E. coli holoenzyme (Biswas et al., 2000; Tsai 
et al., 2003). According to a previously reported model (Kazantsev et al., 2005) the tRNA has 
been positioned as depicted in Fig. 1.10 B. Here, the T-stem lies in the S-domain ptRNA 
binding interface and the 5’-end of the tRNA lies near region P4/P5. The acceptor-stem sits 
on the flat groove formed by the concave C-domain. 
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Fig. 1.10: Structure of RNase P RNA from B. stearothermophilus (A). Residues protected by the protein are 
marked in magenta. The B. subtilis P protein is shown in green with important features indicated; blue patches 
indicate amino acids that were crosslinked to the 5’-leader of ptRNA. (B) A ternary complex model in the same 
orientation as in panel A (left) or in orthogonal orientation (right). tRNA is shown in red. (Model from Buck et 
al., 2005b). 
According to this model, the protein recognises the 5’-leader directly, as suggested earlier, or 
indirectly by influencing the conformation near the cleavage site. However, further structural 
and biochemical analyses are necessary to get more detailed information about interactions 
occurring in the ternary complex of RNA-protein-ptRNA, including the mapping of 
catalytically important magnesium ion binding sites in order to understand the cleavage 
mechanism of this ribozyme. 
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2 Goal of the Project 
The Ribonuclease P (RNase P) is a ribonucleoprotein enzyme, which catalyses the 5’-
maturation of precursor tRNAs (ptRNAs). Bacterial RNase P consists of one RNA subunit (P 
RNA; encoded by rnpB; ~400 nt), and a protein subunit (P protein, encoded by rnpA; ~120 
aa). In vitro, under elevated salt concentrations, the RNA subunit is catalytically active. 
However, under physiological conditions the protein subunit is essential for activity.  
 
Type A and B RNase P RNAs are interchangeable in vivo despite substantial biophysical 
differences 
Regarding the RNA subunits of bacterial RNase P, two major structural types are known, type 
A (ancestral; present in E. coli) and type B (Bacillus; represented in B. subtilis).  
One focus of this study was to examine to which extent type A and type B RNase P RNAs can 
take over each others function in vivo. For in vivo investigations in B.subtilis, the B. subtilis 
rnpB mutant strain SSB318 was characterized and employed for in vivo complementation 
analyses. In vivo studies in E. coli were initially performed in the E. coli rnpB mutant strain 
DW2, later in the newly  constructed strain BW. These in vivo analyses are of special interest, 
as for E. coli and B. subtilis RNase P many differences in their biogenesis, in 
biochemical/biophysical properties and enzyme function in vitro have been reported. 
 
The precursor tRNA 3’-CCA interaction with Escherichia coli RNase P RNA is essential 
for catalysis by RNase P in vivo 
One well characterised P RNA-substrate contact is the Watson-Crick base pairing interaction 
formed between the two cytosines (position C74 and C75) of 3’-CCA of tRNAs with the G 
residues G292 and G293 in loop 15 (E. coli numbering), two residues well-conserved among 
bacterial P RNAs. This interaction had been mainly characterized for the RNA-alone reaction 
in E. coli, but less for the RNase P holoenzymes and not at all in vivo. 
The in vivo role of the CCA interaction ought to be examined in the E. coli rnpB mutant strain 
DW2. Toward this goal, complementation efficiencies of various P RNAs carrying point 
mutations that interrupt the interaction with tRNA 3’-CCA had to be analysed. However, 
strain DW2 has the drawback, that complementation studies are performed under conditions, 
activating the cellular heat shock response mechanism. In addition, temperature-sensitive 
regulation is not reliably tight under certain circumstances. It was therefore desirable to 
construct a new tightly regulated E. coli rnpB mutant strain for our in vivo analyses. To be 
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able to interpret the in vivo phenotypes of the mutant P RNAs, kinetic experiments with in 
vitro reconstituted holoenzymes were performed in parallel. 
 
In vivo role of bacterial type B RNase P interaction with tRNA 3’-CCA 
For type B RNase P holoenzymes it was unclear if a similar CCA contact occurs and is 
relevant to the catalytic cycle. This is of special interest, as in comparison to E. coli, an 
organism which encodes all tRNAs with the 3’-CCA motif, B. subtilis only encodes two-third 
of its tRNAs with 3’-CCA, while for the other tRNAs 3’-CCA is attached 
posttranscriptionally after 3’-end processing. The importance of the CCA interaction in B. 
subtilis was therefore central part on the experimental agenda.  
For in vivo complementation analyses the B. subtilis rnpB mutant strain SSB318 was used. 
The in vivo growth phenotype associated with the expression of B. subtilis, S. aureus (type B 
P RNAs) and E. coli (type A P RNA) rnpB genes carrying point mutations that interrupt the 
interaction with tRNA 3’-CCA ought to be analysed. For better understanding of the in vivo 
results, the activity of in vitro reconstituted holoenzymes was characterised in parallel by 
kinetic experiments. 
In the context of the importance of the CCA-interaction in B. subtilis, the question arose 
whether there is an obligatory order of processing events for precursor tRNAs in B. subtilis. 
The central issue was to find out, if ptRNAs not encoding 3’-CCA have first to undergo 3’-
end processing by RNase Z in order to be efficiently cleaved by RNase P. 
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3 Methods 
3.1 Bacterial cell cuture 
All media, buffers, glass pipettes and flasks used for bacterial cell culture were autoclaved for 
20 min at 121°C and 1 bar. Alternatively, heat labile solutions were sterile filtrated and 
glassware was sterilised by heating for at least 3 hours at 180°C. 
3.1.1 Bacterial cell culture in liquid medium 
LB (Luria Bertani) Medium 
Peptone 10 g/l 
Yeast extract 5 g/l 
NaCl 10 g/l 
adjust pH to 7.5 (with NaOH) 
 
E. coli and B. subtilis cells were grown in LB medium at 37°C if not stated otherwise. For 
inducible promoter systems the media were supplemented for effective expression or 
repression with IPTG (1 mM), L(+)-arabinose (10 mM), xylose (2 % (w/v)) or glucose (2 or 
0.5 % (w/v)), respectively. To select for the presence of antibiotic resistance genes, growth 
media were adjusted to the appropriate antibiotic concentration (see Table 3.1). 
Table 3.1: Antibiotic concentrations applied for selection within this study. 
Antibiotic Bacteria Concentration 
[µg/ml] 
used for strain/plasmid  
ampicillin E. coli 100 pACYC177, pSP64, pTrc99a, 
pSBpt3’HH, pBR322, pHY300
tetracycline E. coli 10 pBR322 
 B. subtilis 30 pHY300 
chloramphenicol E. coli 25 BW 
 E. coli 30 DW2 
 B. subtilis 10 pDG364 
kanamycin E. coli 50 pDW160 
 B. subtilis 5 pMAP65 
erythromycin B. subtilis 0.5 SSB318, SSB320 
lincomycin B. subtilis 12.5 SSB318, SSB320 
For overnight cultures 3 ml LB medium were inoculated either directly from a glycerol stock 
or with a single colony from an agar plate, and incubated while shaking (180-220 rpm, GFL 
3033 shaking incubator) at 37°C. Strains carrying plasmids temperature-sensitive for 
replication or temperature-sensitive mutant strains were grown at 30°C (DW2/pDW160; 
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pKD46) or under non-permissive conditions at 43°C (DW2/pDW160). These overnight 
cultures were either used directly for plasmid preparation (Mini-preps, 3.3.2.2) or transferred 
to a larger volume (100 ml for Midi-prep and 500 ml for Maxi-prep, 3.3.2.1) of LB medium. 
For long-term storage glycerol stocks were prepared by mixing 500 µl Glycerol (99 %) and 
500 µl fresh bacterial culture. Glycerol stocks were frozen in liquid nitrogen and then stored 
at –80°C. 
3.1.2 Growth curves - Determination of cell doubling time 
E. coli DW2 cells harbouring complementation plasmids encoding B. subtilis rnpBwt or E. 
coli rnpBwt were tested for the loss of kanamycin resistance (loss of pDW160). Kanamycin-
sensitive and ampicillin- chloramphenicol-resistant clones were grown overnight at 37°C and 
then diluted to a starting OD578 of 0.05-0.1 and grown at 37°C under aeration (180 rpm in a 
GFL 3033 shaking incubator). In the case of complementation with B. subtilis rnpB, 
kanamycin-sensitive clones were analysed by PCR for lack of pDW160-encoded E. coli rnpB. 
B. subtilis SSB318 cells were grown overnight at 37°C in the presence of the appropriate 
antibiotics (Table 3.1) and 1 mM IPTG. IPTG was then removed by centrifugation (90 s, 9000 
rpm, Eppendorf Minispin) and resuspension of the cell pellet in 1 ml LB without IPTG; after 
a second washing step the final cell pellet was then resuspended in 2 ml LB, adjusted to a 
starting OD578 of 0.05 - 0.1 in 50 ml LB and grown in the presence or absence of IPTG, 
without antibiotics at 37°C and 180 rpm as above. After growth curve monitoring, samples 
were withdrawn from the cultures, diluted and plated in parallel on plates with and without 
antibiotics to exclude the loss of plasmids/resistance gene markers, both types of plates 
containing 1 mM IPTG. Cell doubling times were derived from early exponential phases by 
fitting the data points to an exponential equation (y=c·e b·x; c and b are constants, e is the base 
of the natural logarithm; function “Add a trendline” in Excel, Microsoft office). Cell doubling 
times were reproduced in at least 3 independent experiments. 
E. coli BW cells were grown overnight at 37°C in the presence of the appropriate antibiotics 
and 10 mM arabinose. Arabinose was washed out as described for B. subtilis SSB318 in the 
case of IPTG removal. 50 ml of prewarmed LB medium supplemented with the appropriate 
antibiotics and arabinose or glucose was adjusted to OD578 of 0.05 - 0.1 and grown at 37°C at 
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3.1.3 Cell growth on agar plates 
To grow bacteria on agar plates, the LB medium was supplemented with 12 g/l Agar-Agar 
before autoclaving. Antibiotics were added after the medium was cooled down to 50°C to 
prevent inactivation of thermolabile antibiotics.  
3.1.4 Preparation of competent cells 
To transform foreign DNA into bacterial cells, we applied different methods:  
For preparation of competent E. coli cells we used either treatment with special buffers or 
electroporation. B. subtilis cells were transformed either by utilising their natural competence 
or by electroporation. 
3.1.4.1 Preparation of chemically competent E. coli cells, RbCl method 
 
TFB1-Solution  
MOPS 10 mM 
RbCl 10 mM 
pH 7.0 with NaOH 
sterile filter, as MOPS precipitates during autoclaving 
 
TFB3-Solution  
MOPS 100 mM 
CaCl2 50 mM 
KCl 10 mM 
Glycerol 15 % (w/v) 
pH 6.5 with NaOH 
sterile filter, as MOPS precipitates during autoclaving 
 
100 ml LB medium were inoculated with 3 ml overnight culture and incubated at 37°C and 
180 rpm until OD578 reached 0.5-0.6. Cells were kept on ice for 5-10 min and then 
centrifuged for 5 min at 4°C and 6000 rpm (Eppendorf 5810R). Cell pellets were resuspended 
in 30 ml TFB1 solution, incubated for 5 min on ice and centrifuged again. The supernatant 
was discarded and the cell pellet was resuspended in 4 ml TFB3 solution. Aliquots of 200 µl 
cell suspension were frozen in liquid nitrogen and stored at –80°C. 
3.1.4.2 Preparation of electrocompetent E. coli cells 
Preparation was done according to the protocol provided in the manual of the electroporator 
GenePulser, Fa. Biorad. 
500 ml LB medium were inoculated with 3 ml overnight culture and incubated at 37°C and 
180 rpm. For temperature-sensitive strains temperature was adjusted to the permissive 
temperature of the respective strain. Cells were grown to an OD578 of 0.5-0.7, incubated on 
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ice for 20 min and then centrifuged for 15 min at 4°C, 4000 rpm (Eppendorf 5810R). The 
supernatant was discarded and the cell pellet was resuspended in 500 ml ice-cold 10 % (v/v) 
glycerol. After centrifugation cells were washed a second time with 250 ml and a third time 
with 50 ml 10 % (v/v) glycerol. Finally the cell pellet was resuspended in 2 ml 10 % (v/v) 
glycerol, and 200 µl aliquots were frozen in liquid nitrogen and stored at –80°C. 
3.1.4.3 Preparation of electrocompetent B. subtilis cells 
Growth Medium (electrocompetent cells B. subtilis) 
LB Medium with  
Sorbitol 0.5 M 
 
Washing solution (electrocompetent cells B. subtilis) 
Glycerol 10 % (w/v) 
Sorbitol 0.5 M 
Mannitol 0.5 M 
Use double-distilled water! 
 
Preparation was done according to the protocol provided in the manual of the Multiporator, 
Fa. Eppendorf. 
500 ml LB medium (containing 0.5 M sorbitol) were inoculated with 30 ml preculture and 
grown at 37°C and 180 rpm until OD578 reached 0.85-0.95. Cells were cooled for 10 min on 
ice and then centrifuged for 10 min at 4°C and 4000 rpm. Cells were washed four times with 
washing solution and finally resuspended in 8 ml washing solution. Aliquots of 200 µl were 
frozen in liquid nitrogen and stored at –80°C. 
3.1.4.4 Natural competence - B. subtilis 
3.1.4.4.1 HS/LS medium method 
HS Medium 
ddH2O 59.6 ml 
10 x S-base 8 ml 
Arg/His-Mix 8 ml 
10 % Yeast extract (w/v) 800 µl 
1 % L-Tryptophane (w/v) 400 µl 
1 % L-Phenylalanine (w/v) 400 µl 
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LS Medium 
ddH2O 17.2 ml 
10 x S-base 2 ml 
50 % Glucose (w/v) 200 µl 
10 % Yeast extract (w/v) 200 µl 
50 mM Spermine 200 µl 
1 M MgCl2 50 µl 
1 % L-Tryptophane (w/v) 10 µl 
1 % L-Phenylalanine (w/v) 10 µl 
20 % Peptone (w/v) 10 µl 
 
Arg/His-Mix 
L-Arginine 8 g 
L-Histidine 0.4 g 
adjust pH to 7.0 with H3PO4 
ddH2O ad 100 ml 
 
10 x S-Base 
(NH4)2SO4 2 g 
K2HPO4 14 g 
KH2PO4 6 g 
Na3Citrat·2H2O 1 g 
ddH2O ad 100 ml, then autoclave 
add 100 µl 1M MgSO4 and readjust the total volume to 100 ml 
 
An extremely efficient method, although more time consuming as cells cannot be stored and 
have to be freshly grown each time, is growing B. subtilis cells in HS and LS medium to make 
them competent. 
B. subtilis cells were grown overnight at 37°C in HS medium (according to Spizizen, 1958; 
modified) in the presence of appropriate antibiotics if required (0.5 µg/ml erythromycin, 12.5 
µg/ml lincomycin and 1 mM IPTG for SSB318, see also Table 3.1). The cell culture was then 
diluted into 20 ml of LS medium (modified Spizizen minimal salts; Spizizen, 1958) to a 
starting OD578 of 0.05 - 0.1. Cells were then grown to an OD578 of 0.5 - 0.7 at 30°C while 
shaking at 100 rpm (GFL 3033 shaking incubator). For transformation approximately 0.5- 1 
µg DNA was added to 1 ml of this culture which was grown for another 1 to 2 h at 37°C 
under shaking at 900 rpm (Eppendorf Thermoshaker). Cells were plated on agar plates with 
antibiotics and inductor if required.  
For direct complementation tests after transformation, cells were washed once by 
centrifugation (1 min, 6000 rpm, Eppendorf Minispin) and resuspension in 1 ml LB medium 
to remove the inductor IPTG. 
28  Methods 
To monitor complementation efficiency in SSB318, cells were plated in parallel on LB agar 
plates with or without 1 mM IPTG and supplemented with the respective antibiotics (Table 
3.1). In cases of low transformation efficiency, cells were first plated only in the presence of 
IPTG and afterwards single colonies were resuspended in 600 µl LB medium and plated in 
appropriate (e.g. 1:50) dilution in parallel on LB agar plates with or without 1 mM IPTG as 
described above. 
For transformation of pDG364 derivatives, cells were plated on media containing 0.5 µg/ml 
erythromycin, 12.5 µg/ml lincomycin, 10 µg/ml chloramphenicol (resistance encoded by 
pDG364) and 1 mM IPTG. 
3.1.4.4.2 SpC/SpII medium method 
SpC Medium 
T-Base 20 ml 
50 % Glucose (w/v) 0.2 ml 
1.2 % MgSO4·7 H2O (w/v) 0.3 ml 
1 % Peptone (w/v) 0.5 ml 
10 % Yeast extract (w/v) 0.4 ml 
 
SpII Medium 
T-Base 200 ml 
50 % Glucose (w/v) 2 ml 
1.2 % MgSO4·7 H2O (w/v) 14 ml 
1 % Peptone (w/v) 2 ml 
10 % Yeast extract (w/v) 2 ml 
0.1 M CaCl2 1 ml 
 
T-Base 
(NH4)2SO4 2 g 
K2HPO4·H2O 18.3 g 
KH2PO4 6 g 
Na3Citrat·2H2O 1 g 
ddH2O ad 1000 ml 
autoclave and readjust volume 
 
This protocol is suited for the preparation of competent B. subtilis cells for long-term storage 
(up to several months). 
A single colony was inoculated in 3 ml SpC medium supplemented with the respective 
antibiotics and inductors and grown overnight at 37°C and 180 rpm (GFL 3033 shaking 
incubator). In the morning the preculture was transferred into 20 ml prewarmed SpC medium 
and grown at 37°C and 180 rpm until an OD578 of 1.0 was reached. 5 ml of this culture were 
Methods   29 
then transferred into 45 ml of SpII medium and incubated for 90 min at 37°C under shaking at 
180 rpm. Cells were centrifuged for 5 min at 20°C and 6000 rpm, and finally resuspended in 
4.5 ml of their supernatant (this is extremely important, as the supernatant contains the 
competence factors required for efficient transformation) and 0.5 ml 99 % glycerol. Aliquots 
of 100 µl were frozen in liquid nitrogen and stored at –80°C. 
For transformation, 0.5-1.0 µg DNA were added to 100 µl cells and the cell suspension was 




Peptone 20 g 
Yeast extract 5 g 
NaCl 0.6 g 
KCl 0.17 g 
adjust to pH 7.5 with NaOH and autoclave 
Glucose (autoclave separately) 20 mM 
MgCl2 10 mM 
MgSO4 10 mM 
Magnesium salts (sterile filtered stock solutions) are added prior to use 
3.1.5.1 Transformation of chemically competent E. coli cells 
10 ng DNA or 5 µl of a ligation or Dpn I mutagenesis reaction were added to 50 µl competent 
cells (chapter 3.1.4.1). Cells were incubated on ice for 30 min. A heat shock was performed 
for 45 s at 42°C. After another 2 min incubation on ice, 800 µl SOC medium were added and 
cells were incubated for 1 h at 37°C while shaking. In cases of low transformation efficiency 
all cells were plated. For this purpose, cells were centrifuged for 30 s, 9000 rpm (Eppendorf 
Minispin), resuspended in 50-100 µl of their supernatant and plated. 
3.1.5.2 Transformation of electrocompetent E. coli cells 
Recombinant DNA (10 ng) was introduced into electrocompetent cells by electroporation, 
using a Biorad GenePulser. For this purpose, 10 ng DNA were mixed with 30 µl cells (chapter 
3.1.4.2), transferred into a cuvette (1 mm gap) and incubated on ice for ~1 min. After the 
pulse (1.8 kV; 5 ms, 50 µF, 100 Ω), 1 ml SOC medium (supplemented with 10 mM arabinose 
for strain BW) was added and cells were shaken at 37°C (or 30°C for the temperature-
sensitive strain DW2) for 1 h. Cell suspensions were plated directly at appropriate dilutions 
on LB agar plates containing the appropriate antibiotics. 
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3.1.5.3 Transformation of electrocompetent B. subtilis cells 
Outgrowth Medium (electrocompetent cells B. subtilis) 
LB Medium with  
Sorbitol 0.5 M 
Mannit 0.38 M 
60 µl competent cells (chapter 3.1.4.3) were thawed on ice and mixed with 1-2 µg plasmid 
DNA, transferred into a electroporation cuvette (2 mm gap) and incubated for 3-5 min on ice. 
The electric pulse was performed at 2.1 kV (or varied from 1.8-2.5 if required), 25 µF and 
100 Ω for 5 ms. Directly after the pulse 3 ml outgrowth medium (supplemented with IPTG for 
strain SSB318) was added and incubated for 1 h at 37°C, 900 rpm (Eppendorf 
Thermoshaker). To plate the entire transformation sample, cells were centrifuged and 
resuspended in a smaller volume. 
3.1.6 In vivo complementation tests 
For complementation studies the inductor which was added after transformation was removed 
by washing the cells 1-2 times by successive centrifugation (1 min, 6000 rpm, Eppendorf 
Minispin) and resuspension in 1 ml LB medium. Those cells were plated on agar plates with 
inductor (arabinose, xylose or IPTG) or 0.5 % (v/v) (E. coli)/ 2 % (v/v) (B. subtilis) glucose 
for catabolite repression in strains with IPTG/arabinose inducible promoter systems, followed 
by incubation at 37°C for 20 to 60 h. 
In the case of temperature-sensitive strains like DW2 a set of plates was incubated in parallel 
at 30 and 43°C. For elimination of pDW160, DW2/pDW160 cells harbouring a second 
complementation plasmid (pACYC177 or pSP64 derivatives carrying a functional rnpB gene) 
were grown at 43°C and then tested for loss of pDW160-encoded kanamycin resistance (50 
µg/ml). 
For complementation analysis it was important that comparable numbers of colonies grew 
under permissive and non-permissive conditions. Retarded growth was regarded as a 
defective phenotype. 
In some cases of low transformation efficiency, single colonies were resuspended in 0.6-1 ml 
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3.2 General nucleic acids techniques 
3.2.1 Nucleic acid gel electrophoresis 
Electrophoresis is the separation of charged particles within an electric field. Separation 
efficiency of macromolecules correlates with differences in size and charge. Electrophoretic 
mobility is proportional to the field strength and the net charge of the molecule. 
3.2.1.1 Agarose gel electrophoresis 
5 x TBE buffer cEnd 5 liters 
Tris 445 mM 269.54 g 
Boric acid 445 mM 137.57 g 
EDTA 10 mM 18.61 g 
 
5 x DNA sample buffer 
Bromophenol blue (BPB) 0.25 % (w/v) 
Xylene cyanol blue (XCB) 0.25 % (w/v) 
Glycerol 25 % (w/v) 
In 5 x TBE buffer; pH 8.0 
 
Agarose gels were mainly used for separation of DNA fragments. Agarose is a polysaccharide 
(composed of galactose and galactose derivatives). For gel preparation agarose is dissolved in 
1 x TBE buffer by heating (e.g. in a microwave). When the gel solution has cooled down to 
about 50-60°C, ethidium bromide is added to a final concentration of 40 µg/100 ml, and the 
solution is poured into a prepared gel tray with comb. Agarose concentrations are chosen 
according to the size of the expected fragments (see Table 3.2). Electrophoresis chambers are 
also filled with 1 x TBE buffer. Before loading, 1 volume DNA loading buffer is mixed with 
4 volumes of the sample. Gels are run at 7.5 mA/cm. 
Table 3.2. Separation range of DNA fragments in agarose gels of different concentration 
 
% agarose (w/v) DNA fragment size (kbp) 
0.5 1.0-30 
0.7 0.8 - 12 
1.0 0.5 - 7 
1.2 0.4 – 6.0 
1.5 0.2 – 3.0 
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3.2.1.1.1 Crystal violet gels 
In some cases it is necessary to avoid ethidium bromide for preparative gels, as ethidium 
bromide is mutagenic. Moreover, DNA fragments stained with ethidium bromide are only 
visible under UV light, which may induce mutations. To circumvent this problem, crystal 
violet at a final concentration of 10 µg/ml (stock solution 10 mg/ml) is added to the agarose 
gel solution as well as to the running buffer. Migrating DNA is visible as a dark violet band. 
Staining with crystal violet is less sensitive compared to ethidium bromide staining, which has 
to be taken into account when chosing the pocket size in relation to the amount of DNA. 
3.2.1.2 Polyacrylamide gel electrophoresis (PAGE) 
Polyacrylamide (PAA) is a cross-linked polymer of acrylamide; the crosslinks are introduced 
by bisacrylamide. Unpolymerized polyacrylamide is a neurotoxin, therefore it has to be 
handled extremely carefully. Polymerisation of polyacrylamide is initiated by addition of APS 
(Ammonium persulfate, (NH4)2S2O8) and TEMED (N,N,N,N,-Tetramethylethylendiamin). In 
aqueous solution APS forms radicals, which react with PAA. TEMED also serves as a 
catalyst, as it alleviates radical formation of APS while self being more stable as a radical. 
The length of the polymer chains and therefore the pore size is dictated by the concentration 
of acrylamide used, which is typically between 3.5 and 20 %, and by the ratio of acrylamide –
bisacrylamide (48:2 in our lab).  
3.2.1.2.1 Denaturing PAGE 
5 x TBE, see Agarose gel electrophoresis, 3.2.1.1 
 
denaturing sample buffer 
3 x Stock solution sample buffer 
Urea (f. c. = 8 M) 0.48 g 
5 x TBE 200µl 
Bromophenol blue (BPB) 0.001 % (w/v) 
Xylene cyanol blue (XCB) 0.001 % (w/v) 
H2O ad 1 ml 
Before use mix 1 ml of 3 x Stock solution sample buffer 
with 2 ml formamide  1 x buffer 
For kinetic analyses 504 µl 1 x buffer was supplemented with 
156 µl EDTA (0.5 M, pH 8), in order to complex 
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PAA gel solution cEnd 20 % 10 % 
5 x TBE 1 x TBE 200 ml 200 ml 
Acrylamide (48 %)/ Bisacrylamide (2 %) in appropriate 
concentration 
400 ml 200 ml 
Urea 8 M 480 g 480 g 
H2O  ad 1000 ml ad 1000 ml 
 
In denaturing gels the native structure of macromolecules that run within the gel is disrupted. 
PAA gels are usually supplemented with 8 M urea or another denaturing substance (e.g. 
formamide) before polymerisation.  
Table 3.3 indicates the fragment sizes of single-stranded DNA that comigrate with the BPB 
and XCB dyes of the sample buffer in denaturing polyacrylamide gels of different percentage; 
According to this, tRNAs used in this study (~95 nt) where usually analysed on 8-10 % gels 
and RNase P RNAs (~400 nt) on 5-8 % gels. 
Table 3.3. The size of single-stranded DNA fragments (given in nucleotides) comigrating 
with the dyes of the sample buffer in denaturing polyacrylamide gels. 
% Polyacrylamide Bromophenol blue Xylene cyanol 
5 35 130 
6 26 106 
8 19 70-80 
10 12 55 
20 8 25 
 
For preparation of a PAA gel solution (usually 20 %), urea was dissolved in the appropriate 
volume of 5 x TBE and the required volume of Acrylamide/Bisacrylamide stock solution was 
added. The final volume was adjusted with distilled water if necessary. For gel preparation 
glass plates were cleaned with 70 % ethanol and assembled with spacers. For PAA gel 
solutions of < 20 %, the 20 % PAA gel solution (see above) was diluted by addition of the 
appropriate volume of 8 M urea in 1 x TBE. Polymerisation was initiated by mixing with 
1/100 volume 10 % (w/v) APS and 1/1000 volume TEMED. The gel solution was poured 
between the clamped glass plates, and a comb was inserted between the glass plates at the top, 
to create pockets for later sample loading. After polymerisation (approximately 1 h), the comb 
was removed, and pockets were immediately rinsed using a syringe filled with 1 x TBE buffer 
to remove urea that diffuses from the gel matrix and tends to accumulate in the pockets, and 
to avoid later polymerisation of unpolymerised acrylamide within the pockets. The glass 
plates containing the gel were fixed in the electrophoresis equipment to bridge the buffer 
reservoirs filled with 1 x TBE buffer and electrophoresis was performed at 5–30 mA 
(depending on gel size and PAA concentration). 
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3.2.1.2.2 Native polyacrylamide gels 
Native gels are non-denaturating as they do not contain any denaturing agent. They are 
commonly used for the separation of double-stranded DNA or folded RNAs. The migration 
mobility thus depends not only on the size but also the secondary/tertiary structure of the 
nucleic acid. This can result in substantial migration differences between fragments of the 
same size, but different structure. In Table 3.4 the approximate sizes of DNA fragments (in 
base pairs) that comigrate with the two dyes of the sample buffer in non-denaturing 
polyacrylamide gels of different concentration are listed: 
Table 3.4. The size of DNA fragments (given in base pairs) comigrating with the dyes of 
the sample buffer in non-denaturing polyacrylamide gels. 
% polyacrylamide Bromophenol blue Xylene cyanol 
3.5 100 460 
5 65 260 
8 45 160 
12 20 70 
20 12 45 
 
The PAA gel solution for native gels was the same as for denaturing PAA gels except for the 
omission of urea. The preparation of the gels was identical to the procedure described for 
denaturing gels. As sample buffer 5 x DNA sample buffer (see chapter 3.2.1.1) was used. 
3.2.1.2.3 Non-denaturing polyacrylamide gel electrophoresis for RNA folding analysis 
2 x native loading buffer 
Glycerol 10 % (v/v)   
MgCl2 2 or 10 mM 
Bromophenol blue 0.025 % (w/v) 
Xylene cyanol 0.025 % (w/v) 
 
10 x THE buffer cEnd 1 liter 
Tris 660 mM 38.98 g 
Hepes 330 mM 157.28 g 
EDTA 1 mM 0.37 g 
For folding experiments 1 x THE buffer was supplemented with 100 mM 
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PAA gel solution cEnd 11.25 % 
10 x THE buffer 1 x THE 10 ml 
2 M NH4OAc 100 mM 5 ml 
2 M MgCl2 0.3 - 10 mM x µl 
Acrylamide (48 %)/ 
bisacrylamide (2 %) 
4.5-20 % 22.5 ml 
H2O  ad 100 ml 
 
For RNA folding assays a special buffer system for native gels was used (adapted from Buck 
et al., 2005a). Mg2+-ions and monovalent cations as NH4+ are involved in stabilisation of 
RNA tertiary structures. As bound ions they may dissociate irreversibly during 
electrophoresis, resulting in changes in the tertiary structure of RNA. To prevent this effect, 
the running buffer and gel solution were supplemented with 100 mM NH4OAc and varying 
amounts (0.3 – 10 mM) of MgCl2. Samples were diluted with an equal amount of 2 x native 
loading buffer and loaded on thin (< 1 mm) polyarylamide gels. Gels were run in a 4°C cold 
room. Internal gel temperature did not exceed 15°C during electrophoresis. Usually 180-240 
V were applied. 
3.2.1.3 Detection of nucleic acids from gels 
To visualize DNA/RNA within gels, different methods were used depending on the 
experimental context and downstream application. 
3.2.1.3.1 Ethidium bromide staining 
Ethidium bromide intercalates between the stacked bases of DNA and RNA. When excited by 
UV light between 254 nm (short wave) and 366 nm (long wave) it emits fluorescent light at 
590 nm (orange). 
For staining DNA in agarose gels, the agarose gel solution was supplemented with 
40 mg/100 ml ethidium bromide as described in chapter 3.2.1.1. Therefore, DNA fragments 
could be visualized directly after or even during electrophoresis using an UV transilluminator. 
For visualisation of DNA/RNA in PAA gels, glass plates were removed after electrophoresis. 
Gels were carefully inserted into plastic bags, ethidium bromide staining solution (0.5 µg/ml 
in 1 x TBE) was added, bags were sealed and incubated while shaking for 10 min at room 
temperature. Staining solution was carefully removed and gels were analysed using an UV 
transilluminator. 
 
36  Methods 
3.2.1.3.2 UV-shadowing 
Especially for preparative purposes, DNA and RNA in PAA gels was visualized by UV-
shadowing (254 nm). After electrophoresis glass plates were removed and the gel was 
wrapped in clingfilm. The wrapped gel was then placed on a thinlayer chromatography plate 
with fluorescence indicator (254 nm). Nucleic acid bands were visualized by focussing a 
hand-held UV light source (254 nm) on the surface of the gel; DNA/RNA appears as dark 
band, since the nucleic acids absorb the UV light and fluorescence is extinguished. Time of 
UV exposure was kept as short as possible, as UV light might induce damages to DNA/RNA. 
Bands were marked with an overhead marker, carefully cut out and eluted by diffusion as 
described in chapter 3.2.4. 
3.2.1.3.3 Visualization using crystal violet 
To avoid the use of UV radiation and the fluorescent dye ethidium bromide for visualisation 
and subsequent extraction of DNA from agarose gels, crystal violet was used. Crystal violet 
binds to DNA via electrostatic interactions. In some cases cloning efficiency could be 
improved by this procedure. 
As described for crystal violet agarose gels (3.2.1.1.1), gel solution and electrophoresis buffer 
were supplemented with 1/1000 of a 10 mg/ml aqueous crystal violet solution. Bands could 
be detected under normal light and appeared as dark violet bands. The detection limit of 
crystal violet staining (~50 ng/1 cm band) is below that of ethidium bromide staining (10 ng/1 
cm band), therefore the pocket width had to be reduced with decreasing amounts of DNA. 
3.2.1.3.4 Radioluminography 
32P- labelled RNA or DNA was detected using a phosphoimager. For this purpose, the gel 
was wrapped in clingfilm, and then an image plate was exposed to it. Depending on the 
amount of radioactivity, exposition times varied (e.g. a 1-min exposure for labelling reactions 
and overnight exposure for kinetic analyses with radiolabelled substrate). For preparative 
radioactive gels, stickers with radioactive signs serving as alignment marks are attached to the 
wrapped gel beside the expected bands to define their location. The imaging plate was 
scanned using a BIO-imaging analyser BAS 1000 (Raytest, Fujifilm) and the PC-BAS 
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3.2.2 Photometric concentration determination of nucleic acids 
The concentration of nucleic acids was determined by measuring the absorption at 260 nm. 
Concentration could be calculated according to the Lambert Beer law: 
A = ε · c · d  
(A: Absorbance; c: molar concentration of DNA/RNA [mol/l]; ε: molar extinction coefficient 
[1/(M·cm)]; d: path length of the cuvette [cm]) 
Samples were diluted 1:70 –1:600 in water (depending on the expected concentration) and the 
absorbance at 260 nm was measured against water using a UV spectrophotometer. The 
concentration was calculated using the known values c(1 A260) that represent the 
concentration corresponding to one absorbance unit at 260 nm (1 A260): 
1 A260 double-stranded DNA  corresponds to a c(1 A260) of ~ 50 µg / ml 
1 A260 single-stranded DNA  corresponds to a c(1 A260) of ~ 33 µg / ml 
1 A260 RNA     corresponds to a c(1 A260) of ~ 40 µg / ml 
This results in a general formula for RNA/DNA concentration calculation: 





(c is concentration in µg/µl, Df  is the dilution factor) 
As stable RNAs like RNase P RNA or tRNAs tend to form extensive secondary structures, a 
special method to determine RNA concentrations was used for applications that require highly 
precise quantifications as e. g. kinetic analysis. The classical approach is alkaline or 
ribonuclease hydrolysis of the RNA to mononucleotides and subsequent calculation of RNA 
concentration on the basis of ε260 values for the individual mononucleotides. To obtain ε260 of 
the intact RNA, the sum of mononucleotide ε260 values is then corrected by a factor 
corresponding to the ratio of A260 values of the RNA sample before and after hydrolysis. 
As RNA structure may also depend on ion concentration, measurements were performed in 50 
mM NH4OAc (pH 7.0). RNA was diluted in 50 mM NH4OAc and A260 (A260, intact RNA) was 
measured against 50 mM NH4OAc. Then a mixture of RNases (0.5 µg RNase A, 0.01 U 
RNase T1, 0.01 U RNase T2) was added to this dilution and incubated for at least 3 hours at 
room temperature or 37°C to ensure that the RNA was quantitatively degraded to single 
nucleotides. A260 of this hydrolysed RNA (A260, hydrolysed RNA) was measured. To ensure 
complete hydrolysis, the measurement was repeated after another 30 min of incubation. No 
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significant change in A260 was expected for the two subsequent measurements in the case of 
complete hydrolysis. For the RNA concentration calculation, a specific extinction coefficient 






where εA, εC, εG, εU, are the extinction coefficients for the individual ribonucleotides after 
hydrolysis; nA, nC, nG and nU are the numbers of each nucleotide contained in the RNA 
sequence. 
The ε260 values for mononucleotides at neutral pH: 
εATP: 15.02 [1 / (M·cm)] 
εGTP: 12.08 [1 / (M·cm)] 
εUTP: 9.66 [1 / (M·cm)] 
εCTP: 7.07 [1/ (M·cm)] (Cavaluzzi and Borer, 2004) 








The molecular weight of the respective RNA (MR) was calculated and then the c(1 A260) for 
this particular RNA was determined using the following equation: 






µµ     for d = 1 cm 
3.2.3 Isolation of DNA from agarose gels 
To isolate double-stranded DNA from agarose gels, bands containing the DNA fragment of 
interest were cut out using a scalpel. Commercially available spin columns from Qiagen 
(QIAquick Gel Extraction Kit) were used for further purification. The principle of these spin 
columns is DNA binding to a silica membrane in the presence of chaotropic salts. 
Contaminations like salts and soluble macromolecular components are removed by a simple 
washing step. Pure DNA is finally eluted under low ionic strength conditions. The procedure 
was carried out exactly according to the protocol provided by the manufacturer. In the case of 
crystal violet gels, no attention was paid to the colour code of the binding buffer, as crystal 
violet dominated the colour of the buffer. 
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3.2.4 Isolation of DNA/RNA from PAA gels 
Isolation of DNA oligonucleotides and RNA transcripts from PAA gels was mainly done by 
diffusion elution. The band of interest was detected by UV shadowing or using a 
phosphoimager (for radiolabelled RNA/DNA), cut out and transferred into a 1.5 ml reaction 
tube (or 50 ml falcon e.g. for preparative scale T7 transcriptions) containing elution buffer. 
The volume of buffer depended on the size of the excised gel slice; a standard 15 µl labelling 
reaction was e. g. eluted in 500 µl buffer or in a buffer volume which efficiently covered the 
gel piece. Samples were shaken overnight at 4°C. 
Different elution buffers were used: 
Elution buffer 1  
Tris / HCl, pH 7.0 200 mM 
EDTA 1 mM 
 
Elution buffer 2  
NaOAc pH 5.0 1 M 
3.2.5 Alcohol precipitations 
3.2.5.1 Ethanol precipitation 
Ethanol precipitation is a very common method to concentrate nucleic acids from aqueous 
solutions and to remove salts. The precipitate of DNA/RNA, which is formed at low 
temperature (-20°C or less) in the presence of moderate concentrations of monovalent cations, 
is recovered by centrifugation and redissolved in an appropriate buffer. Salts remain 
predominantly in the ethanol supernatant. For short DNA or RNA (< 30 nucleotides) or very 
small amounts of DNA/RNA, 20-40 µg glycogen were added as carrier for better recovery. 
For precipitation, 1/10 volume of 3 M NaOAc pH 5.0 was added to one volume of DNA/RNA 
solution, followed by mixing with 2.5 volumes of absolute ethanol. Samples were kept at least 
for 30 min at –20°C and were then centrifuged for at least 30 min at 4°C, 13,000 rpm 
(Biofuge fresco). For more efficient removal of salts, the pellet was eventually washed with 
70 % (v/v) ethanol and centrifuged for another 15 min at 13,000 rpm. The supernatant was 
discarded, the pellet was dried at room temperature or at 37°C for ~2-5 min and finally 
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3.2.5.2 Isopropanol precipitation 
Larger volumes of DNA/RNA solution were in some cases precipitated by adding 0.8 
volumes of isopropanol at room temperature. Samples were centrifuged as described for 
ethanol precipitation and if necessary washed with 70 % ethanol. 
3.2.6 Phenol/chloroform extraction 
Phenol/chloroform extraction is a common technique used to purify DNA or RNA samples. 
Such extractions are used whenever it is necessary to inactivate or remove enzymes. The 
procedure takes advantage of the fact that deproteinisation is more efficient when two 
different organic solvents are used instead of one. The final extraction with chloroform also 
removes residual phenol. 
An equal volume of TE-saturated (10 mM Tris-HCl, 1 mM EDTA, pH 7.5-8.0) phenol is 
added to an aqueous DNA/RNA sample, vigorously vortexed (30 s) and then centrifuged (5 
min, 13,000 rpm at room temperature) to achieve phase separation. The upper aqueous layer 
is removed carefully, avoiding the protein-containing interface, and transferred into a new 
tube. The lower organic layer and interface are discarded. The aqueous phase is extracted a 
second time using phenol and then once using chloroform. The aqueous layer is also the upper 
one in chloroform extractions. Afterwards DNA/RNA is concentrated by ethanol precipitation 
or purified using NAP gel filtration columns. 
3.2.7 NAP gel filtration 
The NAP 5 and NAP 10 columns used in this study were purchased from GE Healthcare, and 
are filled with Sephadex 25. They are commonly used to remove salts and single nucleotides 
from reaction mixtures. The columns were equilibrated with double-distilled water according 
to the manufacturer’s protocol. The sample was loaded onto the column (500 µl for NAP 5 
columns; the volume had to be adjusted to 500 µl total volume if smaller) and entered the gel 
matrix by gravity flow. Elution was accomplished by adding an exact volume of double-
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3.3 DNA techniques 
3.3.1 Preparation of genomic DNA 
For isolation of genomic DNA, the DNeasy Tissue Kit (Qiagen) was used. Bacterial cells 
were grown overnight and DNA isolation was done exactly as described in the protocol 
provided by the manufacturer. 
3.3.1.1 Rapid isolation of DNA from bacteria 
In special cases PCR analysis of genomic DNA was not influenced by the presence of 
proteins. For rapid isolation of DNA, bacterial cells were grown overnight under standard 
conditions. 500 µl of this bacterial culture were pelleted by centrifugation (2 min, 13,000 rpm, 
Eppendorf Minispin), and the pellet was resuspended in 300 µl double-distilled water and 
heated for 3 min at 95°C. The suspension was centrifuged for 10 min at 4°C, 13,000 rpm 
(Biofuge fresco) to remove cell debris and the supernatant was used for subsequent PCR 
analysis. 
3.3.2 Preparation of plasmid DNA  
The method used for plasmid DNA isolation is based on a modified alkaline lysis procedure 
(Birnboim and Doly, 1979; Birnboim, 1983). 
3.3.2.1 Preparative plasmid DNA isolation from E. coli cells 
Midi-preps were usually done starting from 50-100 ml bacterial culture, Maxi-preps using 
500 ml bacterial cell culture. Cells were resuspended in a buffer containing RNase A. After an 
SDS/alkaline lysis step, the solution was neutralised and then applied onto an anion exchange 
resin (preparative scale, Midi-/Maxi-prep). Using a buffer of intermediate ionic strength, 
contaminations like proteins, RNA, dyes and soluble macromolecular components were 
removed. Pure plasmid DNA was finally eluted in a high salt buffer. Eluted DNA was 
concentrated by isopropanol precipitation followed by a washing step using 70 % ethanol. 
Commercially available kits from different companies were used (Macherey-Nagel, Qiagen).  
Procedure using the Qiagen Plasmid Midi Kit 
• 50-100 ml bacterial culture are harvested by centrifugation for 15 min at 4°C, 8,000 
rpm. 
• the cell pellet is resuspended in 4 ml resuspension buffer. 
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• 4 ml of lysis buffer are added, followed by gentle mixing and incubation for 5 min at 
room temperature. 
• The solution is mixed with 4 ml of neutralization buffer and incubated for 15 min on 
ice. 
• clear the solution by centrifugation for 30 min at 10,000 rpm. 
• apply clear supernatant to a QIAGEN-tip 100 column, which has been equilibrated 
with 4 ml of equilibration buffer, and allow supernatant to enter resin by gravity flow. 
• Column is washed twice with 10 ml washing solution. 
• Plasmid DNA is eluted with 5 ml elution buffer. 
• DNA is concentrated by isopropanol precipitation and resuspended in water or TE 
buffer. 
Buffers used for preparative plasmid preparation 
Cell resuspension buffer 50 mM Tris / HCl, pH 8.0 
 10 mM EDTA 
 100 µg/ml RNase A 
Lysis buffer 200 mM NaOH 
 1 % (w/v) SDS 
Neutralisation buffer 3 M KOAc, pH 5.5 
Column equilibration buffer 750 mM NaCl 
 50 mM MOPS pH 7.0 
 15 % (v/v) Isopropanol 
 0.15 % (v/v) Triton X-100 
Washing buffer 1 M NaCl 
 50 mM MOPS pH 7.0 
 15 % (v/v) Isopropanol 
Elution buffer 1.25 M NaCl 
 50 mM Tris / HCl pH 8.5 
 15 % (v/v) Isopropanol 
3.3.2.2 Analytical scale preparation of plasmid DNA 
For isolation of plasmid DNA for analytical purposes the commercially available Nucleospin 
Plasmid Kit (Macherey-Nagel) and the supplied protocol were used. 3 ml (for cells containing 
high-copy plasmids like pSP64 derivatives) or 5-10 ml (for cells containing low-copy 
plasmids such as pACYC177 or pBR322 derivatives) of an overnight culture were lysed 
under alkaline conditions. 
DNA yields could be improved for low-copy-number plasmids containing the pMB1 (e.g. 
pBR322) or ColE1 origin of replication by adding chloramphenicol. Therefore, the overnight 
culture was grown as usually, supplemented with chloramphenicol (to a final concentration of 
170 µg/ml) in the morning and incubated at least for another 6 hours under shaking. Plasmid 
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pBR322 does not use the short lifetime host proteins used in host chromosome replication. By 
adding chloramphenicol, chromosomal replication and cell division is stopped without 
stopping plasmid replication, thus increasing plasmid yields. 
For the isolation of plasmid DNA from B. subtilis cells, the cell suspension was incubated 
with 2 mg/ml lysozyme for 5 min at room temperature before addition of lysis buffer to 
improve the effectiveness of lysis. 
After the lysis step, the cell suspension was neutralised and adjusted to high-salt binding 
conditions in one step. After lysate clearing, the sample was ready for purification on a spin 
column with a silica membrane. Elution was performed under low ionic strength conditions, 
and the eluted DNA could be directly used for e. g. digestion by restriction enzymes or 
sequencing. 
For plasmids isolated from endA+ strains (e.g. E. coli wild-type strains), an additional 
washing step with prewarmed buffer AW was performed to completely remove high levels of 
endonucleases. In some cases this procedure was not efficient and residual endonucleases had 
to be removed by phenol/chloroform extraction prior to downstream applications. 
In some cases the cleared supernatant after neutralisation and centrifugation was not loaded 
onto a column, but the plasmid DNA was concentrated by isopropanol precipitation. 
3.3.3 Restriction digest of DNA 
A very common method to analyse DNA is cleavage by restriction endonucleases. Type II 
restriction endonucleases cleave double-stranded DNA at defined positions close to or within 
their (mostly palindromic) recognition sequences. Restriction enzymes generate DNA 
fragments with either 5’- or 3’-overhangs (sticky ends) or blunt ends and 3’-hydroxyl and 5’-
phosphate termini. 
Restriction digest  
DNA (0.1–20 µg) x µl 
10 x buffer 2 µl 
Restriction enzyme  0.2 - 2 µl 
H2O ad 20 µl 
 Σ 20 µl 
Buffer conditions and incubation temperature depend on the specific restriction enzyme. 
Incubation time varies from 1-3 h for analytical digestion to 4 h or overnight for the 
preparative scale. Although the amount of enzyme is varied, the added volume of enzyme 
stock solution (usually provided as a 50 % glycerol solution) should not exceed, as a rule of 
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thumb, 1/10 of the total reaction volume to avoid relaxed cleavage specificities (star 
activities). 
After digestion DNA was analysed on agarose gels (chapter 3.2.1.1). If the DNA was 
subjected to additional reactions, restriction enzymes were heat-inactivated or removed by 
phenol/chloroform extraction. If the DNA was used in cloning experiments, usually gel 
purification was performed to remove primers, small cleavage fragments or, in the case of 
plasmids, to get also rid of uncut plasmid. 
3.3.4 Dephosphorylation of DNA 
Calf intestinal alkaline phosphatase (CIAP) catalyses the removal of terminal 5'-phosphates 
from DNA, RNA and ribo- and deoxyribonucleotide triphosphates. Dephosphorylation was 
required to prevent religation of linearized plasmid vectors in cloning experiments. 
Dephosphorylation reaction 
DNA x µl 1-10 µg
10 x CIAP buffer 3 µl  
CIAP 1 U/µl 3 µl  
H2O ad 30 µl  
 Σ 30 µl 30 min 37°C
10 x CIAP buffer + 2 µl
H2O + 16 µl  
CIAP 1 U/µl + 2 µl  
 Σ 50 µl 30 min 50°C, 30 min 37°C 
Linearised plasmid DNA was mixed with the appropriate buffer and CIAP as specified above 
and then incubated for 1 h at 37°C. Especially for blunt end vectors a slightly expanded 
protocol was used, as removal of 5’-phosphates from DNA with blunt ends is less efficient. 
After 30 min incubation at 37°C, the reaction volume was increased by adding 10 x buffer, 
water and additional enzyme; the sample was incubated for another 30 min at 50°C and 
finally 30 min at 37°C. Dephosphorylation was usually performed before gel purification of 
the linearised plasmid. Alternatively, the phosphatase was removed by phenol/chloroform 
extraction and the DNA was concentrated by ethanol precipitation. 
3.3.5 5’- Phosphorylation of DNA 
T4 Polynucleotide Kinase (T4 PNK) is a polynucleotide 5'-hydroxyl kinase that catalyses the 
transfer of the γ-phosphate from ATP to the 5'-OH group of single- and double-stranded DNA 
and RNA (forward reaction) or transfers the 5’-phosphate of DNA/RNA to ADP and 
rephosphorylates the 5’-OH of DNA/RNA generated in the first step (exchange reaction). 
For subsequent blunt end ligation of PCR products, primers were 5'-phosphorylated prior to 
the PCR reaction or the DNA fragment was phosphorylated directly following PCR. The 
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DNA oligonucleotide (primer) or double-stranded DNA fragment was phosphorylated as 
specified below. 
Phosphorylation reaction   
DNA x µl 10-1000 pmol 
100 mM ATP 0.5 µl  
10 x T4 PNK buffer (forward) 2 µl or buffer from previous 
reaction if appropriate 
T4 PNK 1 µl  
H2O ad 20 µl  
 Σ 20 µl 1 h 37°C 
The phosphorylated primers could be used directly in the PCR reaction. If necessary the 
enzyme was removed by phenol/chloroform extraction and the DNA was concentrated by 
ethanol precipitation. 
Radioactive labelling of DNA oligonucleotides was done using γ-32P ATP according to the 
protocol for 5’-labelling of RNA (3.4.3). 
3.3.6 Fill-in reaction using Klenow fragment 
The Klenow Fragment DNA polymerase is the large fragment of DNA Polymerase I from 
E.coli. It exhibits 5’→ 3’ polymerase activity and 3’→ 5’ exonuclease (proofreading) activity, 
but lacks the 5’→ 3’ exonuclease activity of DNA polymerase I. 
Klenow treatment 
DNA (digested) x µl 0.1 - 4 µg 
10 x buffer 2 µl e.g. Y+, Fermentas 
Klenow fragment 10 U/µl 0.5 µl  
H2O ad 19.5 µl 5 min 37°C 
2 mM dNTPs + 0.5 µl 10 min 37°C, 10 min 70°C 
To convert the sticky ends of digested plasmid DNA to blunt ends, either by removing the 
overhanging nucleotides or by the fill-in reaction, DNA was treated with Klenow fragment. 
DNA, buffer and Klenow fragment were incubated for 5 min 37°C in the absence of dNTP 
substrates, conditions under which the Klenow fragment exhibits primarily exonuclease 
activity. After addition of dNTPs the reaction was incubated for 10 min at 37°C (5’→ 3’ fill-
in activity) and the enzyme finally inactivated at 70°C for 10 min. Klenow-treated DNA was 
5’-phosphorylated (see 3.3.5), concentrated by ethanol precipitation and directly used for 
ligation reactions. 
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3.3.7 Ligation 
Ligation was used to clone DNA fragments (‘inserts’) into linearized vectors. T4 DNA 
Ligase, which catalyses the formation of a phosphodiester bond between juxtaposed 5'-
phosphate and 3'-hydroxyl termini in duplex DNA with blunt or cohesive termini, was 
incubated with insert DNA (5’- phosphorylated) and plasmid vector (dephosphorylated). 
DNA fragments and plasmid vectors were gel purified prior to ligation (chapter 3.2.3). 
Concentration was estimated based on an ethidium bromide agarose gel. 
A typical ligation reaction is shown below. A control reaction with plasmid vector only 
permitted to monitor for the presence of uncut/inefficiently dephosphorylated vector. Molar 
ratios of vector : insert were usually 1:3 or 1:9. For difficult ligation reactions a broader range 
of ratios, including excess of vector DNA, was applied. 
Ligation reaction control 1:3 1:9  
Vector 2 µl 2 µl 2 µl 30-100 ng 
Insert - 1 µl 3 µl  
5 x T4 DNA ligase buffer 2 µl 2 µl 2 µl  
H2O 5 µl 4 µl 2 µl  
T4 DNA ligase 1 µl 1 µl 1 µl  
 Σ 10 µl Σ 10 µl Σ 10 µl 1 h 37°C or 
overnight 16°C or 4°C 
Ligation of DNA with ‘sticky ends’ was incubated for 1 h at 37°C. Problematic ligations or 
blunt end ligations were incubated overnight at 16°C or even at 4°C. T4 DNA ligase was heat 
inactivated for 10 min at 65°C and then the ligation reaction was directly used for 
transformation of E. coli cells (chapter 3.1.5.1). 
3.3.8 Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) is a method for the amplification of very small amounts 
of DNA. The following components are required: 
A thermostable DNA polymerase; for cloning experiments, usually Pfu polymerase 
(originally isolated from Pyrococcus furiosus) was used, as Pfu polymerase exhibits a 
proofreading activity (3'→ 5' exonuclease activity) and does not produce 3’-overhangs. For 
templates that could not be amplified by Pfu polymerase or for analytical PCR, Taq 
polymerase (originally isolated from Thermus aquaticus) was used. Taq polymerase has an 
error rate of 1/10,000 and produces adenine overhangs, which permit to use the PCR product 
directly for TA-cloning. As template, single- or double-stranded DNA is required. A forward 
and a reverse DNA primer, a buffer containing Mg2+ and dNTPs complete the reaction mix. 
The reaction is basically performed in three steps: 
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Denaturation of the double-stranded DNA at 95°C. 
Annealing of primers to the DNA template at a temperature specific for the primers used. 
Elongation at 68-72°C for 5’→ 3’ elongation of the annealed primer; elongation velocity is 1 
min/1 kb using Taq polymerase and 2 min/1 kb using Pfu polymerase. 
The components listed below were mixed in a PCR reaction tube. Polymerase was added 
during the initial denaturation step at 95°C to prevent unspecific elongation (hot start PCR). 
PCR program    
Initial denaturation 95 °C 2 min  
denaturation 95 °C 30 s  
annealing 45- 65°C 30 s  
elongation 68 –72°C 30 s – 5 min 25-30 cycles 
Final elongation 68 –72°C 5 min  
  
PCR reaction   
template x µl single bacterial colony, 
10 ng plasmid or 
500 ng genomic DNA 
10 x PCR buffer MBI 
(–MgCl2, + KCl) 
5 µl  
25 mM MgCl2 3 µl or cEnd = 1.5 – 4.5 mM 
10 mM dNTPs 0.5 µl  
Primer forward 100 pmol/µl 0.5 µl  
Primer reverse 100 pmol/µl 0.5 µl  
H2O ad 49.5 µl  
Pfu/Taq (5 U/µl) + 0.5 µl added at 95°C during initial 
denaturation step 
 Σ 50 µl  
An 5-10 µl aliquot of each reaction was checked on an agarose gel. If the PCR fragment was 
used for cloning, the PCR reaction was concentrated by ethanol precipitation, digested if 
required and gel purified prior to ligation. 
For PCR of overlapping DNA fragments, 5-10 cycles were performed in the absence of 
primers for overlap extension. Thereafter, the primers were added and the PCR reaction was 
continued as usually. 
TA-cloning 
For cloning of PCR fragments amplified with Taq polymerase and carrying single 3’-adenine 
overhangs, the TOPO-TA cloning Kit from Invitrogen was used. The reaction was carried out 
exactly according to the protocol provided by the manufacturer. 0.5-2 µl of the PCR reaction 
(depending on PCR efficiency) were incubated with 0.5 µl salt solution (provided) and 0.5 µl 
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of vector pCR2.1-TOPO for 5-25 min at room temperature. 2 µl of this reaction were used for 
transformation of chemically competent E. coli cells. 
3.3.9 Site-directed Dpn I mutagenesis 
PCR mutagenesis was performed according to the protocol provided with the QuikChange 
Site-Directed Mutagenesis Kit (Stratagene). This method can be used to introduce point 
mutations or single base deletions. Melting temperature Tm of primers introducing point 
mutations was calculated using the following equation: 
Tm = 81.5 + 0.41· (% GC) – 675/N - % mismatch 
N is the length of the primer, and % GC (GC content) and % mismatch are whole numbers.  
Calculation example for a 38 nt primer, 45 % GC, 1 mismatch: 
Tm = 81.5 + 0.41· 45  – 675/38 – (1/38 · 100) = 79.6 
Primers were designed to have a Tm of  > 78°C and a length of 25-55 nucleotides. The desired 
mutation should be approximately in the middle of the primer sequence. 
As template, 50 ng plasmid DNA (isolated from dam+ strains) was used. Reaction 
components were mixed in a PCR tube and the PCR program was run as described below. As 
a control, one reaction was run in parallel in the absence of Pfu polymerase.  
PCR mutagenesis control mutagenesis 
template (10 ng/µl) 5 µl 5 µl 
10 x Pfu buffer (Promega) 5 µl 5 µl 
10 mM dNTPs 2 µl 2 µl 
Primer forward (100 pmol/µl) 0.25 µl 0.25 µl 
Primer reverse (100 pmol/µl) 0.25 µl 0.25 µl 
H2O 39.5 µl 39 µl 
Pfu (2 U/µl) - 0.5 µl 
 Σ 50 µl Σ 50 µl 
 
PCR program mutagenesis  
95°C 1 min  
95°C 1 min  
50 – 60°C 90 s  
70°C 2 min/ kb 16 cycles 
70°C 10 min  
10°C pause  
 
6-8 µl of the PCR mutagenesis reaction were checked on an agarose gel. Usually an additional 
band compared to the control reaction could be seen in the case of successful PCR 
mutagenesis. 
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20 µl of the PCR reaction were directly digested with 1 µl Dpn I for 1-4 h at 37°C. As Dpn I 
is a dam- sensitive restriction enzyme, only methylated DNA (plasmid DNA isolated from 
dam+ strains) containing the recognition sequence GATC is digested, whereas the newly 
synthesised unmethylated DNA is not affected. The control reaction was digested in parallel 
to test for efficient digestion. 4 µl of Dpn I digested DNA were used to transform chemically 
competent cells (3.1.5.1). Plasmid DNA from single colonies was isolated, checked by 
restriction digestion and finally the region of interest was confirmed by sequencing. 
3.4 RNA Techniques 
For all experiments with RNA double distilled-water was used. 
3.4.1 Preparation of total RNA 
3.4.1.1 Growth of DW2 bacteria for total RNA isolation 
DW2 bacteria harbouring derivatives of plasmid pSP64 were grown at 30°C overnight in LB 
medium containing 100 µg/ml ampicillin and 30 µg/ml chloramphenicol. On the next 
morning, the same culture was incubated for 2 h at 43°C, followed by inoculation of fresh 
prewarmed LB medium (100 or 250 ml) to a starting OD578 of 0.05 to 0.1, and further 
cultivation at 43°C until cell density reached an OD578 of about 0.6. Cultivation at 43°C was 
necessary to repress expression of E. coli rnpB wt encoded on the temperature-sensitive 
plasmid pDW160. In the case of kanamycin-sensitive clones (loss of pDW160 encoding E. 
coli rnpB wt) cells could be grown at 37°C. 
3.4.1.2 Growth of BW bacteria for total RNA isolation 
BW cells harbouring pACYC177 and pBR322 derivatives were grown at 37°C overnight in 
3 ml LB medium supplemented with 100 µg/ml ampicillin, 25 µg/ml chloramphenicol, 
10 mM arabinose and 10 µg/ml tetracycline if cells contained pBR322 derivatives. Cells were 
then used to inoculate 50 ml of the same medium to a starting OD578 of 0.05 to 0.1, followed 
by incubation at 37°C. At an OD578 of about 0.5, cells were centrifuged for 5 min at 5,000 
rpm (Eppendorf 5810R) at room temperature and washed once with 20 ml LB medium to 
remove residual arabinose. Cells were resuspended in 100 ml LB supplemented with 
antibiotics and 0.5 % (v/v) Glucose and incubated for another 3 h at 37°C and 180 rpm. Under 
these conditions, the chromosomally encoded rnpB gene was not transcribed. 
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3.4.1.3 Growth of SSB318/SSB320 bacteria for total RNA isolation 
SSB318/SSB320 cells were grown at 37°C overnight in 3 ml LB medium supplemented with 
12.5 µg/ml lincomycin, 0.5 µg/ml erythromycin, 1 mM IPTG and in the case of cells 
harbouring pHY300 derivatives 30 µg/ml tetracycline. Cells with pDG364 derivatives 
integrated into the amyE locus were additionally grown in the presence of 5 µg/µl 
chloramphenicol. Cells were washed twice by centrifugation (6000 rpm Eppendorf Minispin, 
1 min) and resuspension in 1 ml LB medium to remove residual IPTG and were used to 
inoculate 50 ml LB medium supplemented with the respective antibiotics to a starting OD578 
of 0.05-0.1, followed by incubation at 37°C at 180 rpm. Depending on the purpose of the 
following experiments, cells were grown in the presence or absence of IPTG, and, for xylose-
inducible genes provided on pHY300 derivatives, in the presence of 2 % xylose or 2 % 
glucose until OD578 reached 0.6-0.8. 
3.4.1.4 Trizol RNA preparation 
Total cellular RNA from strains DW2, BW, SSB318 and SSB320 was isolated by the TRIzol 
method (Invitrogen) according to the protocol provided by the manufacturer: 
2.2 ml TRIzol were used to resuspend 1 g cell pellet. The cell suspension was incubated for  
5 min at room temperature. 0.2 ml chloroform were added per 1 ml TRIzol and shaken for 15 
s. After another 2 min incubation at room temperature, the suspension was centrifuged for 15 
min at 4°C and 13,000 rpm (Biofuge fresco, Heraeus). The aqueous phase (approximately  
60 % of the starting TRIzol volume) was transferred into a new reaction tube and RNA was 
precipitated by adding 0.5 ml isopropanol per ml TRIzol, and, after incubation for 10 min at 
room temperature, centrifugation for at least 15 min at 4°C and 13,000 rpm. The pellet was 
washed once with 70 % ethanol (at least 1 ml 70 % ethanol per ml TRIzol) and centrifuged as 
described above. 
RNA was dissolved in double-distilled water and further digested with DNase I (Turbo 
DNase, Ambion) in order to remove residual DNA, which interferes with subsequent 
experiments. As DNA digestion often turned out to be incomplete, 3 digestion steps were 
performed in a row (see reaction scheme below). In the presence of high copy plasmids 
eventually up to 6 DNase I digestion steps were performed. To remove proteins a 
phenol/chloroform extraction was performed followed by an ethanol precipitation in the 
presence of 0.12 M NaOAc, pH 5.0. RNA was dissolved in double-distilled water and 
concentrations were measured in H2O at 260 nm (1 A260 unit = 40 µg). 
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RNA 40 µl   
H2O  + 16 µl + 16 µl 
10x Turbo DNase buffer 5 µl + 2 µl + 2 µl 
Turbo DNase (2 U/µl) 5 µl + 2 µl + 2 µl 
 Σ 50µl Σ 70 µl Σ 90 µl 
 1 h 37°C 1 h 37°C 1 h 37°C 
3.4.2 T7 Transcription 
RNA can be transcribed in vitro using DNA-dependent phage RNA polymerases (e. g. T7 
RNA polymerase). T7 RNA polymerase recognises the specific T7 phage promoter sequence 
(5’-TAA TAC GAC TCA CTA TA -3’; sense strand) and starts polymerisation immediately 
downstream in 5’→ 3’ direction. To synthesize RNA run-off transcription was used (i.e. 
polymerisation is terminated when the polymerase reaches the end of the template). Therefore 
either linearized plasmids or PCR products were used as templates. If the RNA synthesized 
should be used for 5’-end labelling with γ-32P ATP, guanosine was added in excess over 5’-
GTP to the transcription reaction to compete with 5’-GTP for incorporation at the 5’-end 
(provided that the template encodes a G residue a position +1). The majority of transcripts 
start with guanosine providing the 5’-terminal hydroxyl group for 5’-end labelling purposes. 
T7 transcription reaction     




HEPES pH 8.0  1 M 80 mM 4 µl 80 µl 
DTT  100 mM 15 mM 2.5 µl 50 µl 
MgCl2 3 M 33 mM 0.55 µl 11 µl 
Spermidine  100mM 1 mM 0.5 µl 10 µl 
NTP mix  25 mM each 3.75 mM each 7.5 µl 150 µl 
BSA  20 mg/ml 0.12 mg/ml 0.3 µl 6 µl 
Template (linearised plasmid) 1 µg/µl 40 µg/ml 4 µl 80 µl 
guanosine 30 mM 9 mM 15 µl 300 µl 
pyrophosphatase  200 U/ml 2 U/ml 0.25 µl 5 µl 
T7 RNA Polymerase  200 U/µl 4000 U/ml 1 µl 20 µl 
RNase-free water   ad 50µl ad 1000 µl 
   Σ 50 µl Σ 1000 µl 
The guanosine stock solution is only soluble at 72°C and was only added if the RNA 
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If a PCR product was used as template the final concentration was adjusted to 5 µg/ml DNA. 
All components (see above) were mixed in a 1.5 ml reaction tube, T7 RNA polymerase was 
added at the end, followed by incubation at 37°C for 2-4 h. To check the efficiency of 
transcription, aliquots of 2 to 10 µl were analysed by denaturing PAGE. For analysing 
transcription efficiency, a small scale (50 µl) reaction was performed and optimised if 
necessary (this was necessary especially for new templates), before preparative scale reactions 
were performed in larger volumes (see 1000 µl reaction). Preparative scale 1000 µl reactions 
were divided into 2 aliquots of 500 µl each (for better thermal equilibration) and T7 RNA 
polymerase was added in two steps: at the beginning only 5 µl (1000 U) T7 RNA polymerase 
were added individually to each aliquot and incubated at 37°C. After two hours 5 µl (1000 U) 
T7 RNA polymerase were added to each aliquot and incubated for two additional hours at 
37°C. Transcription efficiency was analysed by denaturing PAGE. For concentration 
estimation a defined amount of RNA (of the same or similar size) was loaded in parallel. 
After successful transcription, RNA was purified by the following steps:  
• If the DNA template roughly comigrated with the RNA transcript on denaturing PAA 
gels (e.g. for PCR templates), 1 µl DNase I (20 U/µl) was added to each 500 µl aliquot 
and incubated for 1 h at 37°C. 
• Proteins were removed by phenol/chloroform extraction (3.2.6.).  
• For desalting and removal of mononucleotides samples were loaded on NAP 5 or 
NAP 10 columns (depending on the reaction volume for T7 transcription) (3.2.7.).  
• The eluate was concentrated by ethanol precipitation (3.2.5.). The pellet was dissolved 
in double-distilled water and RNA sample buffer was added at a ratio of 1:1. 
• The sample was purified by denaturing PAGE. If not stated otherwise, 1 mm thick 
gels were used. The pocket size was chosen according to the efficiency of T7 
transcription (for example, if the transcription efficiency check revealed RNA 
amounts of ~1.5 µg/5 µl, then the RNA transcribed in a 1 ml reaction sample was 
loaded into a 12.5 cm wide pocket). If available, an RNA sample of comparable size 
was loaded in parallel as control. Gel percentage was adapted to the size of the RNA 
transcript (Table 3.3, chapter 3.2.1.2.1). For good resolution, gels were run at medium 
speed to avoid extreme heating of the gel; the running time should be long enough to 
get good band separation.  
• Bands were cut out using UV shadowing and transferred into 1 M NaOAc for elution 
(overnight at 4°C under shaking; chapter 3.2.4). A subsequent second elution step was 
optional. 
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• RNA was concentrated by ethanol precipitation from the elution buffer and 
resuspended in double-distilled water. 
• Concentration determination was performed as described in 3.2.2.  
• The quality of purified RNA was checked by denaturing PAGE. 
3.4.2.1 Homogeneous 3’-ends of RNA transcripts 
In some cases (template pSBpt3’HH and variants thereof), the DNA template encoded a 
hammerhead cassette 3’-adjacent to the structural RNA gene. Hammerhead ribozymes are 
small autocatalytic RNA motifs that catalyse phosphodiester bond hydrolysis at a single 
defined position. Naturally the hammerhead ribozyme has been found to be involved in the 
replication of a plant viroid and some plant viral satellite RNAs. Immediately after synthesis 
the hammerhead ribozyme folds into its active conformation. Cleavage occurs already during 
transcription provided that Mg2+ ions are present at sufficiently high concentrations, thus 
generating homogeneous 3’-ends. A prerequisite for the application of hammerhead 
ribozymes at 3’-ends of RNA transcripts is the presence of a trinucleotide upstream of the 
cleavage site, optimally 3’-GUC (Fig. 3.1). Hammerhead cleavage leaves a 2’, 3’-cyclic 
phosphate at the 3’-end of the RNA. 
 
Fig. 3.1: Secondary structure of ptRNAGly from Thermus thermophilus encoded on plasmid pSBpt3’HH. 3’-
proximal nucleotides in grey indicate the hammerhead sequence; the grey and black arrows indicate the 
hammerhead and RNase P cleavage site, respectively. The two C residues highlighted in red within the 3’-CCA 
terminus of the tRNA show the nucleotides, which were changed to G residues by site-directed mutagenesis 
within this study.  
In the case of pSBpt3’HH with introduced point mutations G74 or G75, base paring of the 
hammerhead ribozyme was partially affected. As a consequence, the activity of these 
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ribozymes was decreased compared with optimal sequence hammerhead ribozyme. For better 
stimulation of hammerhead cis-cleavage activity, T7 transcription was supplemented with  
10 µl 3 M MgCl2 per 500 µl transcription sample after the regular reaction and incubated for 
another 3 h at 37°C. If these tRNAs are to be purified in large scale, one should think about 
introducing compensatory mutations within the hammerhead ribozyme in order to restore full 
ribozyme activity.  
3.4.3 5’- end labelling of RNA 
For 5’- end labelling of RNA the T4 polynucleotide kinase (T4 PNK) from E. coli phage T4 
was used (see 3.3.5). As T4 PNK requires 5’-OH ends, RNA transcripts have to be started 
with guanosine (see chapter 3.4.2) or ApG, or have to be dephosphorylated prior to the 
reaction. For radioactive labelling γ-32P ATP was used. 
5’- end labelling reaction 
10 x T4 PNK buffer (forward reaction) 1.5 µl 
25 mM DTT 1.5 µl 
RNA (purified by denaturing PAGE) x µl (10-25 pmol) 
RNase-free water ad 11 µl 
γ-32P ATP (3000 Ci/mmol, 10 µCi/µl, 3.3 µM) 3.0 µl 
T4 PNK (10 U/µl) 1.0 µl 
 Σ 15 µl 
Components were mixed in a reaction tube in the order listed above and incubated for 1-2 
hours at 37°C. Sample volume was adjusted to 100 µl and ethanol precipitated in the presence 
of 10 µg glycogen as precipitation adjuvant. The sample was mixed with RNA sample buffer 
and purified by denaturing PAGE using thin (< 1mm) spacers. For localization of labelled 
RNA bands, small stickers were fixed on the clingfilm covering the gel and marked with 
radioactivity and detected using imaging plates which can be scanned by a phosphoimager. 
The band of interest was cut out, eluted by diffusion (see 3.2.4), concentrated by ethanol 
precipitation and finally resuspended in 10-20 µl double-distilled water. Efficiency of the 
labelling reaction was determined by measuring 1 µl of labelled RNA using a scintillation 
counter. 
3.4.4 3’- end labelling of RNA 
3'- end labelling is carried out by T4 RNA ligase, which 'ligates' a single labelled nucleotide 
(32P-pCp ) to the 3'-OH end of the RNA (England and Uhlenbeck, 1978). The smallest 
recognized substrates are nucleoside- 3', 5'- bis-phosphates (such as cytidine 5', 3'- bis-
phosphate, pCp); the resulting 3'-end is a phosphate, and no longer a substrate for the enzyme. 
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3’- end labelling reaction 
10 x T4 RNA ligase buffer  0.6 µl 
1.5 mM ATP (use fresh dilution) 0.33 µl 
RNA (purified by denaturing PAGE) x µl (5-10 pmol) 
[5’-32P] pCp (3000 Ci/mmol, 10 µCi/µl,) 3.0 µl 
T4 RNA Ligase (10 U/µl) 1.0 µl 
 Σ 6 µl 
Components were mixed in a reaction tube in the order listed above and incubated overnight 
at 8°C. 6 µl RNA loading buffer was added and the radiolabelled RNA was purified by 
denaturing PAGE (3.2.1.2.1). The band of interest was cut out, eluted and concentrated by 
ethanol precipitation as described for 5’- end labelling of RNA in chapter 3.4.3. 
3.4.5 Primer extension 
Primer extension assays were performed with total cellular RNA or in vitro transcribed RNA 
as template. The primers were either specific to E. coli RNase P RNA, B. subtilis RNase P 
RNA, S. aureus RNase P RNA, E. coli 4.5S RNA or mutated 4.5S RNA. This assay was 
either used to verify expression of mutant rnpB genes of E. coli, B. subtilis and S. aureus, or 
to map the 5’-end of 4.5S RNA to estimate the ratio of mature to precursor 4.5S RNA. 
5 x RT Annealing Buffer 
KCl 275 mM 
Tris/HCl pH 8.3 340 mM 
 
Annealing mix  
RNA x µl 10-30 µg of total RNA, or 
20 ng of in vitro transcribed RNA 
5 x RT Annealing Buffer 0.3 µl  
5’- end labelled primer x µl 5000 Cerenkov cpm 
H2O ad 3 µl  
 Σ 3 µl  
 
RT mix 
Annealing mix (see above) 3 µl 
5 x first strand synthesis buffer 2 µl 
100 mM DTT 1 µl 
dNTPs, 10mM each 0.5 µl 
H2O 2.85 µl 
Thermoscript (15 U/µl) 0.15 µl 
 Σ 10 µl 
 
Primer extension – PCR Program 
Annealing mix  
90°C 2 min 
cool down in 1 h to 55°C 
+ RT mix  
55°C 45 min 
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Primer annealing was conducted in 1 x RT Annealing Buffer for about 60 min applying a 
linear temperature gradient from 90 to 55°C. Reverse transcription was then performed at 
55°C for 45 min using Thermoscript reverse transcriptase (Invitrogen) by preparing the RT 
mix as described above. 
For primer extension assays to verify expression of E. coli rnpBC292/C293 mutant alleles, 
primer 49 was used and 0.5 mM dGTP was replaced with ddGTP (see also Fig. 3.2). To 
verify expression of B. subtilis rnpBC258/C259 (primer 93) or S. aureus rnpBC238/C239 
(primer 53) mutant alleles, dGTP and dTTP were replaced with ddGTP and ddTTP 0.5 mM 
each. To distinguish in parallel B. subtilis rnpB from S. aureus rnpB primer 92 was used and 
either dTTP was replaced with ddTTP or dGTP was replaced with ddGTP. 
 
Fig. 3.2: Schematic representation of primer extension assays to verify expression of mutant E. coli rnpBC292/3 
alleles. The arrow marked with an asterisk indicates the position of the radioactively labelled primer. Broken 
lines indicate primer extension in the presence of ddGTP for E. coli P RNA wt (left) or C292/3 mutant P RNAs 
(right). 
For analysing E. coli 4.5S RNA primer 96 was used for wild-type or primer 215 for mutated 
4.5S RNA. For in vitro transcribed precursor 4.5S RNA serving as size marker 0.5 mM each 
dGTP and ddGTP was used. Precursor 4.5S RNA was transcribed from a PCR template under 
control of the T7 promoter; the PCR template was amplified from plasmid pT7-4.5S 
(constructed and kindly provided by Norman R. Pace and coworkers), a derivative of plasmid 
pT71 (Tabor and Richardson, 1985) encoding E. coli 4.5S RNA with 23 nt of its natural 5’-
flanking sequence and 17 additional 5’-flanking nt; the 4.5S RNA precursor transcript carried 
an additional AUA at the 3’ end in comparison with natural mature 4.5S RNA (Peck-Miller 
and Altman, 1991); PCR primers to produce the PCR template for T7 transcription were 
primer X1 (including T7 promoter) and primer X2. 
3.4.6 RT-PCR 
Verification of gene expression on the RNA level can be performed by reverse transcription 
(synthesis of cDNA), coupled with the polymerase chain reaction. 
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In this study, the Quick Access RT-PCR Kit (Promega) was employed. As template either 
total cellular RNA or in vitro transcribed RNA was used. In the case of total RNA special 
attention had to be paid to efficient DNase I treatment. For the RT-PCR reaction components 
as listed below were mixed in a PCR tube except for AMV reverse transcriptase. The 2 x MM 
(Mastermix) contains buffer, dNTPs, Mg2+ and Tfl DNA polymerase. The first strand was 
synthesised by AMV reverse transcriptase (a reverse transcriptase isolated from Avian 
Myeloblastosis Virus) at 45°C. As this enzyme is not thermostable, it was just added when the 
reaction temperature had reached 45°C after the initial denaturation step. As a control, to 
check for DNA contamination, one reaction was performed in parallel omitting AMV reverse 
transcriptase. In the subsequent PCR reaction the thermostable Tfl DNA polymerase (from 
Thermus flavus) completed the synthesis of the second strand DNA. The annealing 
temperature was adjusted according to the primers used. Products were analysed (6-8 µl of 
total reaction) on agarose ethidium bromide gels. In some cases, for better sensitivity, one 
primer was radioactively labelled (*) and added in trace amounts (20,000 Cerenkov cpm per 
25 µl reaction). 






(200-500 ng total RNA, or  
~5 pg of in vitro transcribed RNA)
x µl x µl 
Primer forward (100 pmol/µl) 0.25 µl 0.25 µl 
Primer reverse (100 pmol/µl) 0.25 µl 0.25 µl 
2 x MM Quick Access Kit 12.5 µl 12.5 µl 
H2O ad 24.5 µl ad 25 µl 
AMV 0.5 µl - 
 Σ 25 µl Σ 25 µl 
 
RT-PCR program 
90°C 2 min add AMV at 45°C  
45°C 45 min  
95°C 45 s  
54°C 1 min  
70°C 1 min 12-30 cycles 
70°C 2 min  
10°C pause  
For verification of E. coli RNase P RNA we used primers 49 (49*) and 150. For B. subtilis 
RNase P RNA we used primers 149, 93 (93*). Radioactive RT-PCRs were checked on 10 % 
denaturating polyacrylamide gels. 
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For semi-quantitative concentration estimation we performed an RT-PCR with different 
amounts of in vitro transcribed RNA, to define the range in which product yields correlated 
with RNA concentration. 
3.4.7 5’- RACE 
5’- RACE (rapid amplification of cDNA ends) experiments are used to map the 5’- ends of 
RNA transcripts. 
Within this study, SSB320 cells were grown as described in chapter 3.4.1.3 (Growth of 
SSB318/SSB320 bacteria for total RNA isolation) and total RNA was isolated as described in 
chapter 3.4.1.4 (Trizol RNA preparation). In order to also include primary transcripts in the 
analysis, one half of the total RNA preparation was treated with Tobacco Acid 
Pyrophosphatase (TAP, Epicentre). During this procedure, the RNA 5’- triphosphates of 
primary transcripts are converted to monophosphates as a prerequisite for amplification by 
RACE. The second half of the total RNA was treated identically, except that TAP was 
omitted. Components as listed below were mixed, including an RNase Inhibitor to prevent 
RNA degradation, and incubated for 1 h at 37°C.  
5’-RACE (I) TAP treatment 
 Total RNA  
(from cells grown + IPTG) 
Total RNA  
(from cells grown – IPTG) 
RNA (~25 µg) x µl x µl 
10 x  TAP buffer 20 µl 20 µl 
RNase Inhibitor (40 U/µl) 1 µl 1 µl 
ddH2O ad 196 µl ad 196 µl 
divide in 2 portions each     
 98 µl 98 µl 98 µl 98 µl 
TAP (10 U/µl) - 1.5 µl - 1.5 µl 
 1 h 37°C 1 h 37°C 1 h 37°C 1 h 37°C 
To remove proteins a phenol/chloroform extraction (chapter 3.2.6) was performed; for 
concentration and salt removal the samples were ethanol precipitated including a subsequent 
washing step using 70 % ethanol (chapter 3.2.5.1). RNA pellets were resuspended in 14.5 µl 
double-distilled water each. In the following step, an adapter oligonucleotide A1 (5’- GTC 
AGC AAT CCC TAA GGA G; the last three underlined nucleotides were ribonucleotides, all 
others were deoxyribonucleotides) was ligated to the RNA. 
RNA was mixed with adapter oligonucleotide, heated for 5 min at 90°C, and then incubated 
for 5 min on ice to allow adapter annealing. Then components as listed below were added, 
gently mixed and incubated at 4°C overnight for ligation. 
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5’-RACE (II) Adapter ligation reaction 
RNA  14.5 µl 
Adapter oligo (100 pmol/µl) 10 µl 
 heat 5 min at 90°C, followed by 5 min 
incubation on ice 
0.1 % (w/v) BSA 4 µl 
10 x T4 RNA Ligation buffer 4 µl 
10 mM ATP 4 µl 
RNase Inhibitor (40 U/µl) 0.5 µl 
T4 RNA Ligase 3 µl 
 Σ 40 µl, 4°C overnight 
The ligation reaction was treated with phenol/chloroform, concentrated by ethanol 
precipitation and resuspended in 36 µl H2O. 
Subsequently, RT-PCR was performed, but here using a protocol that differed from the one 
described in chapter 3.4.6 (RT-PCR). 
For cDNA (first strand) synthesis, the RNA from the adapter ligation reaction was mixed with 
primers specific for trnSL-Val2 (primer 177, 178) or trnSL-Ala1 (primer 179, 180), heated for 
5 min at 65°C and then kept on ice. The RNA/primer mixture was then mixed with the 
components listed below, and the program for reverse transcription was run as described. 
5’-RACE (III) RT reaction 
RNA  4.5 µl  
Primer (4 pmol/µl) 0.5 µl  
 Σ 5 µl 5 min 65°C,  on ice 
+ RT-Mix:   
5 x first strand synthesis buffer 2 µl 
dNTPs, 10 mM each 1 µl 
100 mM DTT 0.5 µl 
H2O 0.75 µl 
RNase Inhibitor (40 U/µl) 0.25 µl 
Thermoscript Reverse 
Transcriptase (15 U/µl) 
0.5 µl 
 
 Σ 10 µl  
 
5’-RACE (III) RT program 
42°C 5 min 
55°C 20 min 
60°C 20 min 
65°C 20 min 
85°C 5 min 
 
The synthesised cDNA was used as template for the subsequent PCR reaction. The reverse 
primer was specific for the RNA under investigation (same primer as used for the RT 
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reaction), Primer X3 matched the sequence introduced by adapter ligation. 10 µl of PCR 
reaction were analysed on a native 8 % polyacrylamide gel. For size estimation, a 10 bp 
ladder (Invitrogen) was loaded in parallel. 
5’-RACE (IV) PCR reaction 
cDNA 2 µl 
10 x PCR buffer (−MgCl2/+KCl) 5 µl 
25 mM MgCl2 (cEnd= 2.5 mM) 5 µl 
dNTPs, 10 mM each 1 µl 
Primer reverse (specific) 100 pmol/µl 0.25 µl 
Primer X3 (adapter) 100 pmol/µl 0.25 µl 
H2O 35 µl 
Taq (5 U/µl, MBI) 0.5 µl 
 Σ 50 µl 
 
5’-RACE (IV) PCR program 
94°C 2 min  
94°C 1 min  
52°C 65 s  
72°C 1 min 35 cycles 
72°C 7 min  
8°C pause  
Primers 177 and 178 were specific for B. subtilis trnSL Val2 and primers 179 and 180, 
specific for trnSL Ala1. 
3.4.8 Folding analysis on non-denaturing gels 
Buffer A (FPLC)  
NH4Cl 100 mM 
Mg(OAc)2 2 or 10 mM 
DTT 6 mM 
Tris-HCl, pH 7.2 to 7.5 50 mM 
 
Buffer F 2/10  
Mes, pH 6.1 50 mM 
KCl 100 mM 
MgCl2 2 or 10 mM 
 
Buffer KN 2/4.5 (Dinos et al., 2004) 
Hepes-KOH, pH 7.4 20 mM 
Mg(OAc)2 2 or 4.5 mM 
NH4OAc 150 mM 
Spermidine 2 mM 
Spermine 0.05 mM 
β-mercaptoethanol 4 mM 
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Folding analysis  cEnd 
M1 RNA (50 fmol) x µl 10 nM 
5 x buffer A/F/KN 1 µl 1 x 
RNase P protein x µl 37 or 50 nM 
H2O ad 5 µl  
 Σ 5 µl  
Preincubation: a) No preincubation (4°C)  
 b) 55 min 37°C, +/- protein 15 min 37°C 
 c) 5 min 55°C, 50 min 37°C, +/- protein 15 min 37°C 
 + 5 µl 2 x native loading buffer 
 Analysis on 11.25 % PAA  
(1 x THE, 100 mM NH4OAc, x mM MgCl2) 
50 fmol wt or mutant RNase P RNA, including trace amounts of 3’- or 5’-end labelled 
material of the same RNA, were incubated in buffer A (containing 2 or 10 mM Mg(OAc)2) or 
buffer KN (containing 2 or 4.5 mM Mg[OAc]2) or buffer F (containing 2 or 10 mM MgCl2). 
Conditions were chosen to mimic those of the kinetic experiments (chapter 3.6.1). RNase P 
RNAs were either kept at 4°C (no preincubation) or preincubated for 55 min at 37°C, or 5 min 
at 55°C followed by 50 min at 37°C. We also tested a protocol starting with 2 min at 85°C, 
followed by 5 min at 55°C and 50 min at 37°C. The results were, however, identical to those 
obtained with 5 min at 55°C plus 50 min at 37°C.  
For samples including the protein subunit, the E. coli or B. subtilis P proteins were added to 
final concentration of 50 and 37 nM, respectively, after the preincubation step. All samples, 
except those kept at 4°C, were incubated for another 15 min at 37°C and finally adjusted to 
room temperature. Immediately before gel loading, 1 volume of loading buffer (3.2.1.2.3) was 
added. The non-denaturing 11.25 % (v/v) polyacrylamide gels (thickness < 1 mm) contained 
66 mM Hepes, 33 mM Tris, pH 7.4 and 0.1 mM EDTA (1 x THE), supplemented with  
100 mM NH4OAc and 0.3-10 mM MgCl2 (3.2.1.2.3). Gels were run at 180-250 V until 
xylene cyanol had migrated 11.5 cm from the top. The gel temperature was controlled to not 
exceed 15°C. 
RNA bands were visualized with a Bio-Imaging Analyzer (FLA 3000-2R, FUJIFILM). 
Results were the same for 5’- and 3’-end labelled P RNAs. End homogeneity of P RNAs was 
checked on denaturing gels. Results for RNase P RNAs incubated in buffer KN containing 4.5 
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3.5 Protein methods 
3.5.1 TCA-Precipitation 
PUV Buffer  
Tris/HCl pH 7.4 50 mM 
NaCl 100 mM 
Urea 8 M 
To isolate and, particulary, concentrate proteins from bacteria a TCA precipitation was 
performed. Cells were grown at 37°C in the presence of 25 µg/ml chloramphenicol,  
100 µg/ml ampicillin (for BW cells harbouring pACYC177), 10 µg/ml tetracycline (for cells 
containing pBR322 derivatives), 10 mM arabinose and 1 mM IPTG or in the presence of 12.5 
µg/ml lincomycin, 0.5 µg/ml erythromycin, 30 µg/ml tetracycline, 1 mM IPTG and 2 % 
xylose (for SSB318 bacteria harbouring pHY300 derivatives) to an OD578 of ~ 0.7. If not 
stated otherwise cultures were grown in 50 ml LB. Cells were cooled on ice for 10 min. 45 ml 
of this bacterial suspension were transferred to a 50 ml falcon tube containing 5 ml ice-cold 
50 % (w/v) TCA (Trichloro acetic acid). This suspension was incubated for another 15 min on 
ice and then centrifuged for 10 min at 6000 rpm at 4°C (centrifuge Eppendorf 5810R). The 
supernatant was discarded and the protein pellet was washed 3 times with 2 ml ice-cold 
acetone by resuspension of the pellet and centrifugation (5 min, 4°C, 13000 rpm, Biofuge 
fresco). For easier handling, the protein pellet was transferred into a 2 ml reaction tube for this 
procedure. The protein pellet was dried at room temperature and resuspended in ~200-400 µl 
PUV-Buffer. 
3.5.2 SDS-PAGE 
Sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) is used to separate 
proteins in polyacrylamide gel systems according to their molecular weight. Based on the 
protocol by Laemmli (1970), SDS, an anionic detergent, denatures proteins by binding to 
hydrophobic amino acid side chains. Thereby, SDS attaches negative charge to the 
polypeptide roughly in proportion to its length. Another modified protocol was established by 
Schägger and Jagow (1987). In this gel system the resolution for small proteins (5-20 kDa) 
was improved by increasing the molarity of the buffer and replacing glycine with tricine. This 
system is also more resistant to samples with high salt concentrations (up to 2.2 M NaCl are 
tolerated). For Schägger/Jagow gels, different buffers are used in the cathode and anode 
reservoirs. The pH of stacking and separation gel is identical, because the mobility of tricine 
is largely independent of pH. 
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3.5.2.1 Schägger/Jagow SDS-PAGE 
3 x Gel buffer (Schägger) 
Tris/HCl pH 8.45 3 M 
SDS 0.4 % (w/v) 
 
5 x Anode buffer (Schägger) 
Tris/HCl pH 8.9 1 M 
 
5 x Cathode buffer (Schägger) 
Tris/HCl pH 8.25 0.5 M  
Tricine 0.5 M 
 1 x concentrated buffer has to be supplemented with 0.1 % (w/v) SDS! 
 
4 x SDS-PAGE sample buffer (Schägger) 
Tris/HCl pH 6.8 100 mM 
SDS 8 % (w/v) 
Glycerol 24 % (v/v) 
β-mercaptoethanol 4 % (v/v) 
 after adjustment of pH, 0.04 % (w/v) bromophenol blue is added 
For the analysis of the RNase P protein (~13 kDa), stacking gels of 4 % and separation gels of 
13 % were used (the composition below is calculated for 2 mini gels). Gels for the Mini 
Protean 3 cell chamber system (Biorad) were prepared with 0.75 mm combs (approximate 
total volume for 2 gels: 5 ml). 
SDS-PAGE (Schägger) Stacking gel (4 %) Separation gel (13 %)
Acrylamide (48 %)/ bisacrylamide (2 %) 400 µl 2.6 ml 
3 x Gel buffer (Schägger) 1.25 ml 3.35 ml 
H2O 3.3 ml 4.05 ml 
TEMED 5 µl 10 µl 
APS (10 %) 50 µl 100 µl 
After addition of the starting reagents (TEMED and APS) to the acrylamide solution, the 
separation gel solution was poured between the glass plate assembly and overlaid with 
isopropanol to ensure a smooth surface and to exclude air. Isopropanol was washed away with 
water after gel polymerization (~15 min). The stacking gel was then poured onto the 
separation gel and the comb was inserted. 
The glass plates with the gel were inserted into the electrophoresis apparatus, and the 
electrode tanks were filled with the appropriate electrophoresis buffer. Protein samples were 
mixed with 3 volumes of 4 x SDS-PAGE sample buffer and heated for 2 min at 95°C before 
gel loading. A commercially available protein marker (e.g. prestained protein marker broad 
range, Fermentas) was loaded in parallel for size estimation. If not stated otherwise, two gels 
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with identical samples were run in parallel; one was stained with Coomassie Brilliant Blue  
and the second was used for Western blotting. 
The gel was run at 35 V until BPB had traversed the stacking gel, after which the voltage was 
increased to 90 V.  
3.5.2.2 Laemmli SDS-PAGE  
4 x Separation gel buffer (Laemmli)  
Tris/HCl pH 8.8 1.5 M 
 
8 x Stacking gel buffer (Laemmli)  
Tris/HCl pH 6.8 1 M 
 
5 x Gel running buffer (Laemmli)  
Tris/HCl pH 8.3 20 mM 
Glycine 0.25 M 
SDS 0.1 % (w/v) 
minigels are run in 1 x running buffer (25 mA/180 V) 
 
4 x Loading buffer (Laemmli)  
SDS 4 % (w/v) 
Glycerol 20 % (w/v) 
β-mercaptoethanol 5 % (w/v) 
Tris/HCl pH 6.8 250 mM 
Bromophenol blue 0.001 % 
 
SDS-PAGE gels (Laemmli) 
Separation gel (5 ml) 10 % 13 % 15 % 17 % 
Acrylamide (48 %)/ bisacrylamide (2 %) 1 ml 1.3 ml 1.5 ml 1.7 ml 
4 x Separation gel buffer (Laemmli) 1.25 ml 1.25 ml 1.25 ml 1.25 ml 
20 % (w/v) SDS 25 µl 25 µl 25 µl 25 µl 
H2O 2.73 ml 2.45 ml 2.23 ml 2.03 ml 
10 % (w/v) APS  50 µl 50 µl 50 µl 50 µl 
TEMED 5 µl 5 µl 5 µl 5 µl 
     
Stacking gel (5 ml) 4 %    
Acrylamide (48 %)/ bisacrylamide (2 %) 400 µl    
8 x Stacking gel buffer (Laemmli) 625 µl    
20 % (w/v) SDS 25 µl    
H2O 3.95 ml    
10 % (w/v) APS  50 µl    
TEMED 5 µl    
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Gels were prepared as described for SDS-PAGE according to Schägger/Jagow, but using the 
Laemmli buffer solutions (see above). Note that cathode and anode buffers are identical for 
Laemmli SDS-PAGE. 
3.5.3 Coomassie Staining 
Gel staining solution  
Methanol 40 % (v/v) 
Acetic acid 10 % (v/v) 
Coomassie Brilliant Blue R250 0.5 % (w/v) 
  
Destaining solution  
same composition, but without Coomassie 
The gel was covered with gel staining solution and left for 30 min at room temperature with 
agitation. The gel was then transferred to the destaining solution and destained overnight 
under shaking. The destaining solution was exchanged in between for more efficient 
destaining. For conservation, the gel was dried on a gel dryer. For this purpose, the gel was 
put on filter paper (GB002, Schleicher and Schuell), moistened with destaining solution, 
covered with clingfilm and dried for 1 h at 60°C under vacuum, followed by 2 h of drying at 
room temperature (Biorad Slab dryer model 483). 
3.5.4 Western Blot 
Western Blotting is the procedure to transfer proteins to a membrane for immobilization. 
Usually Polyvinylidene fluoride- (PVDF-) or Nitrocellulose- (NC-) Membranes are used. The 
semi dry blotting method was used. 
Transfer buffer  
Tris base  pH ~ 9.2 (pH was not adjusted!) 48 mM 
Glycine 39 mM 
Methanol 20 % (v/v) 
SDS 0.04 % (v/v) 
After SDS-PAGE, gels were equilibrated for 10 min in transfer buffer. The PVDF membrane 
(Immobilon P, Millipore; cut to have same size as the gel) was briefly wetted with methanol, 
rinsed by dipping into water and then also equilibrated for 5 min in transfer buffer. 5 filter 
papers (GB004, Schleicher & Schuell) were also moistened with transfer buffer and arranged 
in the following order on the blotting device:  
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• Graphite cathode 
• 2 layers of filter paper  
• Gel 
• PVDF membrane 
• 3 layers of filter paper 
• Graphite anode 
Graphite plates were wetted with water. Special attention was paid to the absence of air 
bubbles, to allow effective transfer. Proteins were blotted applying 1 mA/mm2 for 75 min. (As 
a rule of thumb, the voltage was 6 mV in the beginning and increased to 30 mV at the end of 
the transfer). 
3.5.5 Immunodetection 
The proteins immobilized on the PVDF membrane by Western blotting can be detected with 
specific antibodies. In this study, specific antigen-antibody complexes were detected by 
secondary antibodies, which were conjugated with an alkaline phosphatase (AP). By adding 
Bromo-4-Chloro-3-Indolylphosphate (BCIP) and Nitroblue Tetrazolium (NBT), alkaline 
phosphatase activity on the PVDF membrane could be made visible. BCIP is an AP substrate, 
which reacts further after the dephosphorylation to give a dark blue indigo dye as oxidation 
product. NBT serves herein as the oxidant and gives also a dark blue dye. It thereby 
intensifies the colour and makes the detection more sensitive. 
5 x TBS Buffer  
Tris/HCl pH 7.6 100 mM 
NaCl 2.5 M 
 
Washing Buffer  
TBS 1 x final concentration 
Skim milk powder 0.5 % (w/v) 
Tween 20 0.1 % (v/v) 
 
Blocking Buffer  
TBS 1 x final concentration 
Skim milk powder 5 % (w/v) 
 
Substrate Buffer  
Tris/HCl pH 9.5 100 mM 
NaCl 100 mM 
MgCl2 50 mM 
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Colour reagents for AP  
NBT in 70 % DMF (Promega) 25 mg/ml 
BCIP in 70 % DMF (Promega) 25 mg/ml 
After blotting the PVDF membrane was moistened with methanol. Unspecific protein binding 
sites on the membrane were saturated by incubation in blocking buffer for 30 min at room 
temperature while gently shaking. The membrane was washed twice (5 min each) with 1 x 
TBS buffer. The primary antibody was diluted in 1 x TBS buffer supplemented with 0.5 % 
skim milk powder and incubated with the membrane for 1.5 h under gentle shaking at room 
temperature. E. coli RNase P protein-specific antibodies were diluted 1:900; those specific for 
the B. subtilis RNase P protein were diluted 1:2500. For B. subtilis RNase P protein 
immunodetection, unspecific background bands could be reduced by incubating the primary 
antibody with 3 ml E. coli cell lysate (11 mg protein/ml) in 27 ml TBS/0.5 % skim milk 
powder for 30 min at room temperature prior to incubation with the PDVF membrane. The 
membrane was then washed 3 times (5 min each) with washing buffer before the secondary 
antibody (goat-anti-rabbit-AP, 1:4000 diluted) was added in 1 x TBS/0.5 % skim milk 
powder, followed by incubation for 1 hour at room temperature. The membrane was again 
washed twice (5 min each) with washing buffer. Afterwards, the membrane was equilibrated 
for 10 min in substrate buffer. Colour reagents were diluted (BCIP 1:750 and NBT 1:1500) in 
substrate buffer and the colour reaction was started by adding this solution to the membrane. 
When the band intensities reached a satisfactory extent, the reaction was stopped by 
transferring the membrane into distilled water. The membrane was dried and scanned for 
documentation purposes. 
3.5.6 Preparation of recombinant RNase P proteins  
E. coli and B. subtilis RNase P proteins carrying an N-terminal His-tag (His-tagged peptide 
leader: MRGSHHHHHHGS, encoded in plasmid pQE-30 in E. coli JM109) were expressed 
essentially as described (Rivera-León et al., 1995). Cell cultures (LB broth containing 100 
µg/ml ampicillin) were grown to an OD578 of 0.6 and IPTG was added to a final concentration 
of 1 mM. Cells were harvested after 3 h (OD578 ~ 2.5) by centrifugation for 10 min at 5,000 
rpm at 4°C. The following steps were performed at 4°C or on ice, and all buffers contained 40 
µg/ml of the protease inhibitor phenylmethylsulfonyl fluoride (PMSF). Cells were then 
resuspended in 10 to 15 ml sonication buffer SB (50 mM Tris-HCl, pH 8.0, 0. 3 M NaCl,  
0.1 % triton X-100, 1 M NH4Cl). After sonication (Branson Sonifier 250, output 20, duty 
cycle 50 %, 15 min on ice), the sample was centrifuged for 30 min (4°C, 14,500 g), and the 
supernatant was mixed with Ni-NTA agarose (400 µl for 2 liters of cell culture) which had 
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been prewashed twice with 10 ml SB buffer. The sample was incubated for 1 to 2 h at 4°C 
under gentle mixing or rotating. The Ni-NTA agarose slurry was washed threetimes 
(centrifugation-resuspension cycles; centrifugation at 4°C and 8,500 rpm in a desktop 
centrifuge) with ice-cold washing buffer (30 mM imidazol, 50 mM Tris-HCl, pH 8.0, 8 M 
urea, 0.1 % triton X-100); the RNase P protein started to precipitate during this procedure; 
therefore, the supernatant after each washing step was removed carefully to avoid release of 
protein aggregates from the matrix. The protein was then eluted with 500 µl elution buffer (50 
mM Tris-HCl, pH 7.0, 10 % glycerol, 7 M urea, 20 mM EDTA, 0.3 M imidazol) for 45 min at 
4°C under gentle shaking. Eluates were dialyzed twice for 1 h and subsequently overnight 
against volumes of 500 ml dialysis buffer (50 mM Tris-HCl, pH 7.0, 0.1 M NaCl, 10 % 
glycerol; dialysis bags: Roth, molecular weight cut off 12-14 kDa); during dialysis, a white 
precipitate formed. The content of dialysis bags was transferred to a 2- ml Eppendorf tube and 
centrifuged for 20 min at 4°C and 12,000 rpm in a desktop centrifuge. The supernatant 
contained RNase P protein devoid of any RNase P RNA contamination, whereas the pellet 
included traces of RNase P RNA and was therefore discarded. All purification steps were 
monitored by 17 % SDS-PAGE to assess the purity and concentration of RNase P proteins. 
3.5.7 Partial purification of RNase P from E. coli cells 
Buffer A (FPLC)  
NH4Cl 60 mM/550 mM 
Mg(OAc)2 10 mM 
DTT 6 mM 
Tris-HCl, pH 7.2 to 7.5 50 mM 
DW2 cells were grown at 43°C as described (chapter 3.4.1.1), and SSB318 cell were grown in 
the absence of IPTG as described (chapter 3.4.1.3). Cell pellet (~600 mg) was resuspended in 
about 4 ml of buffer A (FPLC), containing 60 mM NH4Cl, and lysed by sonication (Branson 
Sonifier 250, output 20, duty cycle 30-40 %, 10 min on ice), followed by centrifugation for  
45 min at 4°C and 10,000 g. For the preparation of DEAE fractions, the supernatant was 
loaded onto a DEAE fast flow sepharose column (column XK16, Pharmacia). Flow rate was 
adjusted to 2 ml/min. After the first peak, indicating unbound flow through, had been detected 
and absorbance again reached the basal level, a NH4Cl gradient from 60 to 550 mM NH4Cl 
was applied. Active fractions eluted at about 300 to 400 mM NH4Cl. The fractions were 
collected in 2 ml reaction tubes on ice; a small aliquot was taken from each fraction to check 
for RNase P processing activity, whereas the rest was frozen in liquid nitrogen. For washing, 
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the column was eluted with 1 M NaCl and then rinsed with double-distilled water followed by 
washing with 70 % ethanol. The activity was checked as described in 3.6.1.1. 
The most active fraction was divided into 2-10 µl aliquots and stored at –80°C after freezing 
in liquid nitrogen. 
For verification of wt and mutant rnpB alleles, DEAE fractions were phenol/chloroform 
extracted, concentrated by ethanol precipitation and used as template for primer extension 
analyses (3.4.5). 
3.6 Kinetic Analysis  
3.6.1 Kinetic analysis of RNase P holoenzymes 
Buffer F 2/10  
Mes, pH 6.1 50 mM 
KCl 100 mM 
MgCl2 2 or 10 mM 
 
Buffer KN 2/4.5 (Dinos et al., 2004) 
Hepes-KOH, pH 7.4 20 mM 
Mg(OAc)2 2 or 4.5 mM 
NH4OAc 150 mM 
Spermidine 2 mM 
Spermine 0.05 mM 
β-mercaptoethanol 4 mM 
 
Kinetic analyses of RNase P holoenzymes were all performed under multiple turnover 
conditions. In multiple turnover kinetics substrate is present in excess over enzyme; thus, one 
enzyme can cleave more than one substrate during reaction. Rates were calculated as kobs 
(turnover µmol substrate per min and µmol enzyme). The rate-determining step can be either 
substrate association (k1), cleavage (k2) or product release (k3) or a conformational 
rearrangement of the substrate/enzyme or product/enzyme complex (the later is not 
considered in the scheme below). 
   k1  k2  k3 
E  + S    ES  →  EP   E  +  P 
   k-1    k-3 
Reaction scheme for RNase P processing under multiple turnover conditions; E: enzyme; S: 
substrate; kn: rate constants. 
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For all processing assays Thermus thermophilus ptRNAGly (ptRNAwt) or G74 or G75 
variants thereof were used. This tRNA contains a 14-mer 5’-flank. The sequence of ptRNAwt 
is shown in Fig. 3.1. 
3.6.1.1 Kinetic analysis of in vivo assembled holoenyzmes 
For analysing RNase P-catalysed processing by in vivo assembled RNase P holoenzymes, 
active DEAE fractions (0.25 to 1.0 µl; equal amounts based on A260 measurements; chapter 
3.5.7) were incubated in buffer A (see chapter 3.5.7; 2 or 10 mM Mg(OAc)2, 6 mM DTT, 50 
mM Tris-HCl, pH 7.5) containing 100 mM NH4Cl for 10 min at 37°C (reaction volume  
16 µl). Trace amounts (< 1 nM) of the 5’-end labelled ptRNAGly substrate were preincubated 
under the same conditions for 5 min at 55°C and 25 min at 37°C. Processing reactions were 
started by combining enzyme and substrate solutions and assayed at 37°C (final volume  
20 µl). As the negative control, the substrate mix was incubated in parallel under same 
conditions. For each time point, a 4 µl aliquot was withdrawn from the reaction mix and 
mixed immediately with 4 µl denaturing sample buffer/EDTA solution and kept on ice.  
denaturing sample buffer/EDTA  
denaturing sample buffer (3.2.1.2.1) 504 µl 
0.5 M EDTA pH 8.0 156 µl 
3.6.1.2 Kinetic analysis of in vitro reconstituted RNase P holoenzymes 
Processing assays of in vitro reconstituted RNase P holoenzymes were performed either in 
buffer F (containing 2 or 10 mM Mg2+) or in buffer KN (containing 2 or 4.5 mM Mg2+), 
originally optimised for functional analyses of E. coli ribosomes. The magnesium 
concentration was decreased to 2 mM to closely mimic physiological conditions. In vitro 
reconstitution of RNase P holoenzymes was performed as follows: If not stated otherwise,  
10 nM RNase P RNAs were incubated in buffer KN or buffer F for 5 min at 55°C and 50 min 
at 37°C, after which RNase P protein (concentration varied) was added, followed by another 5 
min at 37°C before addition of substrate (the volume was 8 or 16 µl). 100 nM ptRNAGly 
supplemented with trace amounts (< 1 nM) of 5’-end labelled ptRNAGly, were preincubated 
under the same conditions for 5 min at 55°C and 25 min at 37°C (substrate mix). Processing 
reactions were started by combining enzyme and substrate mixes, and assayed at 37°C (final 
volume 10 or 20 µl). 
The Mg(OAc)2 concentration was raised to 100 mM in control reactions with E. coli RNase P 
RNA alone.  
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3.6.2 Evaluation of kinetic anaylses 
Samples were analysed on 20 % denaturing PAA gels and imaging plates were exposed to the 
gel overnight. This permitted to detect the bands corresponding to (uncleaved) ptRNA or 
released 5’-flank (equals mature tRNA). Bands were quantified using a Bio-Imaging System 









Further evaluation was done using the software Grafit to calculate the kobs values by fitting 
the data to a single order rate equation as follows: 
( )teAA kobst ⋅⋅= −1  
with At: amount of tRNA cleaved at timepoint t, A: maximum amount of tRNA that could be 
cleaved, kobs: observed rate constant. 
3.7 Cloning experiments 
3.7.1 One Step inactivation of chromosomal genes in E. coli 
One strategy for efficient recombination between short linear DNA fragments and the 
bacterial chromosome involves phage recombination systems (reviewed in Court et al. 2002). 
The phage λ Red locus, which encodes a system that promotes homologous recombination, 
includes three genes: bet (β), exo, and gam (γ) (Datsenko and Wanner, 2000; Murphy, 1998; 
Yu et al., 2000; Poteete and Fenton, 2000; Kuzminov, 1999). Exo is a 5'→ 3' exonuclease that 
degrades the 5'-ends of linear DNA molecules. Bet is a single-stranded DNA binding protein 
that binds to the single-stranded 3'-ends generated by Exo and promotes annealing to 
complementary DNA. Gam binds to the host RecBCD complex and inhibits its exonuclease 
activity (Murphy 1991; Murphy 1998; Karu 1975).  
In our lab we used pKD46, a low copy plasmid which encodes γ, β and exo under the IPTG-
inducible pBAD promoter (Datsenko and Wanner, 2000). As the plasmid has the temperature-
sensitive origin of replication repA101ts it is easily to eliminate from the cells afterwards. The 
pBAD promoter system can be tighly repressed and therefore prevents unwanted 
recombination under uninduced conditions. In the literature homologous flanking regions as 
short as 36 nt were described to be sufficient for successful recombination (Datsenko and 
72  Methods 
Wanner, 2000). However, in our case the cloning was only successful after increasing the 
homologous regions to 370-630 nt.  
3.7.1.1 Construction and verification of rnpB mutant strain BW 
To inactivate essential genes, it is necessary to put the gene of interest under an inducible, 
tight regulatable promoter system. Construction of rnpB mutant strain BW followed the 
strategy described by Roux et al. (2005), which applies the IPTG-inducible pBAD promoter 
system for this purpose. The so-called catRExBAD cassette, carrying the chloramphenicol 
resistance gene (cat), a gene coding for an arabinose operon regulatory protein (araC), and 
the arabinose-inducible pBAD promoter (see chapter 4.2 and Fig. 3.3), was amplified from 
strain TG1 cat-AraC (Roux et al., 2005) using primers 135 (containing sequences identical to 
the region upstream of the E. coli rnpB promoter) and 134 (partially overlapping with nt 1-50 
of rnpB). Initially, we could isolate a recombinant strain, which had the 5’-end of the 
described catRExBAD cassette successfully recombined within the 5’ rnpB promoter 
upstream region, but the 3’-boundary was altered. This strain was used to amplify a 326-bp 
fragment, containing the 5’-boundary, with primers 137 and 138. The E. coli rnpB gene was 
amplified from E. coli K12 with primers 163 and 150. This rnpB fragment and the 326-bp 
fragment with E. coli rnpB upstream sequence were combined with the catRExBAD cassette 
by overlap extension PCR. The resulting PCR product was purified by agarose gel 
electrophoresis and transformed into E. coli MG1655 bacteria carrying pKD46 (the Red 
helper plasmid, encoding the λ Red recombinase system, temperature-sensitive for 
replication, Datsenko and Wanner, 2000). For this purpose, MG1655/pKD46 cells were 
grown to an OD578 of 0.15 at 28°C and then induced with 10 mM arabinose. Induced cultures 
were grown to an OD578 of 0.6 at 28°C and made electrocompetent by 100-fold concentration 
and three washing steps with ice-cold 10 % glycerol. Electroporation was performed with a 
Biorad Gene Pulser in 1 mm cuvettes (1.8 kV, 200 µF, 25 Ω) using 40 µl competent cells and 
100-200 ng purified PCR fragment. Shocked cells were added to 1 ml SOC medium 
supplemented with 10 mM arabinose, shaken for 1 h at 37°C and 900 rpm (Eppendorf 
Thermomixer comfort), and then plated and incubated at 37°C on LB agar plates containing 
25 µg/ml chloramphenicol and 10 mM arabinose. Clones were analysed by PCR for correct 
5’- and 3’-boundaries of the integrated catRExBAD cassette and screened for ampicillin 
sensitivity to test for the loss of the temperature-sensitive helper plasmid pKD46. The primers 
195, 194, 193, 158, 157, 136, 138, 49, 186, and 183 were used to scrutinize correct insertion 
and sequence of the integrated cassette (primer locations within the recombined region are 
shown in Fig. 3.3): 
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Integrity of the 5’-boundary was checked by primer combinations 157/138 and 138/186, and 
that of the 3’-boundary by the combinations 136/158 and 136/183; the absence of the native 
rnpB promoter region was verified with the primer pair 193/49, which produced a PCR 
fragment with genomic DNA from strain MG1655 (the original strain), but not with DNA 
from correct recombinants. Primer pairs 194/49 and 195/157 were used to amplify the 
inserted cassette in roughly two halves (upstream and downstream of araC, see Fig. 3.3) for 
verification by sequencing. Verified recombinant bacteria were named strain BW. 
Detailed sequence information on the rnpB environment in strain BW can be found in the 
appendix (8.15). 
 
Fig. 3.3: E. coli rnpB environment after recombination with the fragment containing the catRExBAD cassette. 
Arrows above indicate positions of primers used for strain analysis and verification. 
3.7.2 Plasmids for complementation studies in E. coli rnpB mutant strains 
3.7.2.1 pSP64 E. coli rnpB EP 
For complementation studies in strain DW2/pDW160, complementing rnpB genes were under 
control of the native E. coli rnpB promoter (termed EP or PE.c rnpB) and cloned in plasmid 
pSP64 as described (Hardt and Hartmann, 1996). Note, that there is no terminator sequence 
encoded adjacent to the rnpB gene on the plasmid. The pSP64 derivative carrying E. coli 
rnpB (pSP64 E. coli rnpB) served as template to introduce the point mutations C292 or C293 
by site-directed Dpn I mutagenesis (3.3.9). 
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3.7.2.2 Construction of the low copy plasmid pACYC177 Ecoli rnpB  
To construct derivatives of low copy plasmid pACYC177 encoding E. coli rnpBwt, 
rnpBC292 and rnpBC293, plasmids pSP64 E. coli rnpBwt, rnpBC292 or rnpBC293 were 
digested with Nhe I and Hind III and the fragments carrying the E. coli rnpB variants were 
inserted into pACYC177 also cut with Hind III and Nhe I. 
 
3.7.2.3 Construction of pBR322 derivatives for expression of E. coli rnpA 
To put E. coli rnpA under the control of the IPTG-inducible pTrc promoter (Amann et al., 
1988), the rnpA gene was amplified with primer 196 (introducing an Nco I site at the 5’-end 
of rnpA) and primer 197 (introducing an Xba I site at the 3’-end of rnpA). The E. coli rnpA 
fragment was digested with Nco I and Xba I, and ligated into pTrc99a (Amann et al., 1988) 
also linearized with Nco I and Xba I, resulting in plasmid pTrc99a E. coli rnpA. This plasmid 
was unsuitable for transformation of bacteria harbouring pACYC177 derivatives, because it 
encodes the ampicillin resistance as plasmid pACYC177; also, the high copy number of 
pTrc99a E. coli rnpA would have potentially increased an imbalance between rnpA 
expression and that of rnpB genes encoded by the low copy plasmid pACYC177. Therefore, 
the rnpA gene including the pTrc promoter and the rrnBt1t2 terminator from pTrc99a E. coli 
rnpA was amplified, using the primers 203 (introducing an Mph1103 I site) and 206 
(introducing a Mun I site) and ligated the fragment into pBR322 cut with Pst I and Eco RI 
(ends compatible with those of Mph1103 I and Mun I, respectively). Digestion of pBR322 
with Pst I and Eco RI destroyed the ampicillin resistance, only leaving the tetracycline 
resistance.  
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3.7.2.4 Construction of pBR322 encoding mutated 4.5S RNAs 
The chromosomal region of E. coli K12 harbouring the bicistronic trancription unit of ffs 
(encoding 4.5S RNA) and ybaA, including the native promoter upstream of ffs as well as  
100 bp downstream of ybaA, was amplified and cloned into pBR322. During PCR 
amplification, the terminal stem region was already altered by inversion of 4 base pairs within 
the stem structure (chapter 4.2) for specific reverse transcriptase priming in order to be able to 
distinguish native from plasmid-encoded 4.5S RNA. The promoter region and the 5’-end of 
ffs were amplified using primers 207 (introducing an Eco RI site) and 208 (including the 5’-
terminal 4.5S RNA stem mutations); the 5’-portion of the ffs gene was amplified with the 
primers 209 and 216 (introducing Mlu I and Pst I sites). These two fragments were combined 
by overlap extension PCR, cut with Eco RI and Pst I, followed by ligation into pBR322 cut 
with the same enzymes. The 3’-half of ffs was amplified with primer 209 and 210 (3’-terminal 
stem with mutations). The chromosomal region spanning the 3’-portion of ffs and the ybaA 
cistron was amplified using forward primer 211 and reverse primer 214. To further introduce 
point mutations into the 3’-CCC end of 4.5S RNA, the same PCR reaction was performed, 
except that primer 212 (3’-GCC“76”) or primer 213 (3’-CGC“76”) were used as the forward 
primer. The latter amplification products were combined with the PCR fragment harbouring 
the 3’-half of ffs (see above) by overlap extension PCR. The resulting product was then cut 
with Pst I/Mlu I and ligated into the pBR322 derivative containing the promoter and 5’-half of 
ffs and cut with the same restriction enzymes. 
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3.7.2.5 Construction of pSP64 B. subtilis rnpB BPT (B. subtilis rnpB promoter and 
terminator) 
For cloning of B. subtilis rnpB gene into pSP64, B. subtilis rnpB including its natural 
promoter (PB.s. rnpB) and terminator sequence was amplified from genomic B. subtilis DNA 
(strain W168) using primer 19 (including the native Hind III site upstream of rnpB) and 
primer 21 (introducing a Hind III site at the 3’-end of B. subtilis rnpB). The resulting PCR 
fragment was cloned into the Hind III site of pSP64; the orientation of the rnpB gene was 
such that its 3’-portion was adjacent to the Xba I site in the pSP64 multi-cloning site. The 
plasmid is referred to as pSP64 B. sub rnpB BPT (BPT: native B. subtilis rnpB promoter and 
terminator) 
                            
 
 
Methods   77 
3.7.2.6 Construction of pSP64 B. subtilis rnpB EP/BT (E. coli rnpB promoter and B. 
subtilis rnpB terminator) 
To clone the B. subtilis rnpB gene under control of the native E. coli rnpB promoter (PE.c. 
rnpB), the E. coli rnpB promoter region was amplified from E. coli K12 genomic DNA using 
primers 157 and 156 (introducing an overlap with the 5’-end of B. subtilis rnpB). B. subtilis 
rnpB including its native terminator was amplified with primers 149 and primer 21 (including 
a Hind III site). rnpB promoter and terminator fragments were combined by overlap extension 
PCR, digested with Kpn I and Hind III and cloned in pSP64 E. coli rnpB EP (Busch et al. 




3.7.2.7 Construction of pACYC177 B. subtilis rnpB EP/BT (E. coli rnpB promoter, B. 
subtilis rnpB terminator) 
To transfer the B. subtilis rnpB insert with E. coli rnpB promoter and B. subtilis rnpB 
terminator (EP/BT) into the low copy plasmid pACYC177, we amplified the corresponding 
fragment from pSP64 B. sub rnpB EP/BT with primers 12 and 223 (introducing an Nhe I site 
at the 5’-end of the E. coli rnpB promoter), digested the PCR product with Nhe I and Hind III 
and cloned it into pACYC177 cut with the same enzymes. 
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3.7.3 Chromosomal integration in B. subtilis 
For the integration of DNA sequences into the genome of B. subtilis special integration 
vectors are used. One feature of these vectors is that they can replicate e. g. in E. coli (and 
allow therefore easy cloning in E. coli), but lack an origin of replication recognized in B. 
subtilis. Integration is targeted to a particular locus on the chromosome by including 
homologous sequences in the plasmid. If there is a single homologous region, the whole 
plasmid will be integrated by single crossover. In the case of two homologous regions, which 
are in close proximity on the chromosome, a double crossover recombination will result in 
integration of a cassette between the two targeted chromosomal regions.  
3.7.3.1 Construction of the B. subtilis conditional RNase P mutant strain SSB318 (done 
by Ciaran Condon) 
The B. subtilis conditional RNase P mutant (SSB318) was constructed as follows: a 251-nt 
PCR fragment, containing nucleotides +1 to +231 of the rnpB gene, was amplified using 
oligonucleotides HP499 (introducing a Hind III site) and HP500 (introducing a Bam HI site), 
digested with Hind III and Bam HI and cloned into pMUTIN-4M (Vagner et al., 1998) 
digested with the same enzymes. The resulting plasmid pMUTIN-rnpB was transformed into 
B. subtilis wild-type strain W168, selecting for erythromycin resistance in the presence of 1 
mM IPTG. 95 out of 100 transformants tested showed IPTG-dependent growth, indicating 
correct insertion into the rnpB gene which is predicted to be essential. One of these 
transformants, SSB318, was retained for subsequent studies. In this strain, the chromosomal 
rnpB gene is under control of the IPTG-inducible spac promoter. In the absence of IPTG, cell 
growth becomes dependent on the expression of a complementing rnpB gene (Fig. 3.4). 
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Fig. 3.4: Schematic representation of B. subtilis rnpB mutant strain SSB318. In SSB318 the chromosomal rnpB 
gene is put under the control of an IPTG-inducible Pspac promoter (left). In the absence of IPTG cell growth 
becomes dependent on a complementing rnpB gene provided on a plasmid (right). 
3.7.3.2 Construction of a strain containing E. coli rnpB BPT integrated into the 
chromosome of B. subtilis SSB318 
For construction of a strain containing E. coli rnpBwt with the native B. subtilis promoter and 
terminator (BPT) integrated into the chromosome of B. subtilis SSB318, the E. coli rnpBwt 
fragment containing B. subtilis rnpB promoter and terminator was cloned into the Hind III site 
of pDG364, a vector suitable for chromosomal integration into the amyE locus of B. subtilis 
(Cutting and Vander-Horn, 1990). Toward this goal, E. coli rnpB was amplified from plasmid 
pSP64 E. coli rnpBwt (Hardt and Hartmann, 1996) with primers 41 and 46 (introducing 
sequences that overlap with the B. subtilis rnpB promoter and terminator). For amplification 
of the B. subtilis promoter, primer pair 19 and 44 was used. The B. subtilis terminator was 
amplified with primer 45 and primer 21 (introducing a Hind III site at the 3’-end of the 
terminator). The E. coli rnpB fragment was combined with B. subtilis promoter and 
terminator fragments by overlap extension PCR, cut with Hind III and ligated into pDG364 
cut with the same enzyme. The plasmid was linearised with Xho I prior to transformation in 
SSB318 applying the protocol that makes use of the HS/LS medium (3.1.4.4.1). 
3.7.4 Plasmids for complementation studies in B. subtilis mutant strain SSB318 
3.7.4.1 Construction of pHY300 B. subtilis rnpB BPT 
B. subtilis rnpB was excised from pSP64 B. sub rnpB BPT via Hind III digestion and inserted 
into pHY300 (obtained from Takara Shuzo Co., Kyoto, Japan) cut with the same enzymes. 
The orientation of the rnpB gene was such that its 3’-portion was adjacent to the Eco RI site 
in the pHY300 multi-cloning site. 
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3.7.4.2 Construction of pHY300 xylRP B. subtilis rnpB (xylose promoter) 
B. subtilis complementation plasmids for B. subtilis mutant strain SSB318 were constructed in 
2 steps: first, the fragment encoding xylose repressor (xylR) and promoter (Pxyl) was 
amplified from pX2 (Mogk et al. 1997) with phosphorylated primer 100 (introducing a Bam 
HI site) and phosphorylated primer 105 (introducing Psc I/Sma I sites) cut with Sma I and 
Bam HI, and cloned into pHY300 cut with the same enzymes, resulting in plasmid pHY300 
xylRP. B. subtilis rnpB wt was amplified from genomic DNA with primers 102 (introducing 
an overlap with the xylose promoter at the 5’-end of B. subtilis rnpB) and primer 103 
(introducing a Sma I site downstream of rnpB) and cloned into Psc I/Sma I sites of pHY300 
xylRP. This plasmid is referred to pHY300 xylRP B. subtilis rnpB. Mutations C258 and C259 
were introduced by the site-directed Dpn I mutagenesis method (see 3.3.9). 
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3.7.4.3 Construction of pHY300 xylRP B. subtilis rnpB + xyl rnpA (B. subtilis) 
The B. subtilis rnpA gene under control of the inducible xylose promoter was amplified from 
strain sb (Gößringer, 2004; Gößringer et al., 2006) using primers 115 and 116 (both 
introducing a Bam HI site) and cloned into the Bam HI site of pHY300 xylRP B. subtilis 
rnpB. Constructs with insert “xyl rnpA-stop” carried point mutations close to the 5’- end of 
the xylose-inducible rnpA gene, resulting in two stop codons (xyl rnpA-stop). For 
construction of inserts with the xylose-inducible rnpA-stop gene, the xylose promoter region 
was first amplified from genomic DNA of strain sb (Gößringer, 2004; Gößringer et al., 2006) 
with primers 114 and 115. The rnpA gene with the two stop codons was then amplified from 
plasmid p3dstop (Gößringer, 2004; Gößringer et al., 2006) with primers 113 and 116. The 
two fragments were combined by overlap extension PCR using primers 115 and 116 (both 
introducing Bam HI sites) and cloned into the Bam HI site of pHY300 xylRP B. subtilis rnpB. 
 
 
3.7.4.4 Construction of pHY300 S. aureus rnpB BPT 
For complementation studies with S. aureus rnpB in B. subtilis strain SSB318, S. aureus rnpB 
gene was cloned under control of the natural B. subtilis rnpB promoter and terminator (BPT). 
For amplification of the B. subtilis promoter, primers 19 (including the naturally occurring 
Hind III site upstream of the B. subtilis rnpB promoter) and 44 ( 3’ B. sub. promoter) were 
used. The B. subtilis terminator was amplified using primers 45 and 21 (introducing a Hind III 
site at the 3’-end of the B. subtilis rnpB terminator). S. aureus rnpB was amplified with 
primers 42 and 47 (containing overlapping regions with the B. subtilis rnpB promoter and 
terminator, respectively) from genomic DNA of Staphylococcus aureus subsp. aureus 
Rosenbach (ATCC 12600). Fragments carrying the B. subtilis rnpB promotor, S. aureus rnpB 
and B. subtilis rnpB terminator were combined by overlap extension PCR. The resulting S. 
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aureus rnpB BPT fragment was cloned into the Hind III site of pHY300. Point mutations at 
position G238 and G239 within the S. aureus rnpB gene were introduced by the site-directed 
Dpn I method (3.3.9). 
       
3.7.4.5 Construction of pHY300 S. aureus rnpB BPT + xyl B. subtilis rnpA  
For parallel overexpression of the B. subtilis RNase P protein, B. subtilis rnpA was amplified 
from strain sb including the inducible xylose promoter (Gößringer, 2004; Gößringer et al., 
2006) using phosphorylated primers 108 and 107, and cloned in the Sma I site of pHY300  
S. aureus rnpB BPT. 
As mentioned before, constructs with the insert “xyl rnpA-stop” carried point mutations close 
to the 5’-end of the xylose-inducible rnpA gene, resulting in two stop codons (xyl rnpA-stop). 
Here again, first the xylose promoter region was amplified from genomic DNA of strain sb 
(Gößringer, 2004; Gößringer et al., 2006) with primers 114 and 108. The rnpA gene with the 
two stop codons close to the beginning was amplified from plasmid p3dstop (Gößringer, 
2004; Gößringer et al., 2006) with primers 107 and primer 113. Those two fragments were 
combined by overlap extension PCR using phosphorylated primers 107 and 108, and cloned 
into pHY300 S. aureus rnpB BPT cut with Sma I as performed for the wild-type rnpA gene. 
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3.7.4.6 Construction of pHY300 E. coli rnpB BPT 
E. coli rnpB under control of the B. subtilis rnpB promoter and terminator (BPT) for 
complementation in B. subtilis SSB318 was constructed as follows: B. subtilis rnpB promoter 
and terminator, and E. coli rnpB were amplified exactly as described in 3.7.3.2. Fragments 
were combined by overlap extension PCR and digested with Hind III. This recombinant E. 
coli rnpB gene was cloned into the Hind III site of pHY300. 
 
 
3.7.4.7 Construction of pHY300 E. coli rnpB EP 
For complementation analysis of E. coli rnpB in B. subtilis mutant strain SSB318, an  
Nhe I/Hind III fragment from plasmid pSP64 carrying the E. coli rnpB gene (Hardt and 
Hartmann, 1996) under control of the native E. coli rnpB promoter was cloned into pHY300 
cut with Xba I (compatible ends with Nhe I) and Hind III. 
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3.7.4.8 Construction of pHY300 E. coli rnpB EP + xyl B. subtilis rnpA  
B. subtilis rnpA under the control of the xylose-inducible promoter was amplified from strain 
sb (Gößringer, 2004; Gößringer et al., 2006) using primers 115 and 116 (both introducing 
Bam HI sites). The PCR product was cut with Bam HI and cloned into the Bgl II site of 
pHY300 E. coli rnpB EP. Inserts containing rnpA encoding two stop codons close to the  
5’-end were amplified from plasmid pHY300 S. aureus rnpB + xyl rnpA-stop (see 3.7.4.5) 
with primers 115 and 116 and cloned into the Bgl II site of pHY300 E. coli rnpB EP. 
        
 
3.7.4.9 Construction of pHY300 + xyl B. subtilis rnpA 
B. subtilis rnpA under the control of the xylose-inducible promoter was amplified from 
plasmid pHY300 S. aureus rnpB BPT + xyl B. subtilis rnpA with phosphorylated primers 107 
and 108. The fragment was then cloned in the Sma I site of pHY300. The same was done for 
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Type A and B RNase P RNAs are interchangeable
in vivo despite substantial biophysical differences
Barbara Wegscheid1, Ciarán Condon2 & Roland K. Hartmann1+
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We show that structural type A and B bacterial ribonuclease P
(RNase P) RNAs can fully replace each other in vivo despite the
many reported differences in their biogenesis, biochemical/
biophysical properties and enzyme function in vitro. Our findings
suggest that many of the reported idiosyncrasies of type A and B
enzymes either do not reflect the in vivo situation or are not
crucial for RNase P function in vivo, at least under standard
growth conditions. The discrimination of mature tRNA by RNase
P, so far thought to prevent product inhibition of the enzyme
in the presence of a large cellular excess of mature tRNA relative
to the precursor form, is apparently not crucial for RNase P
function in vivo.
Keywords: RNase P; in vivo complementation studies; Escherichia
coli; Bacillus subtilis
EMBO reports advance online publication 10 February 2006;
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INTRODUCTION
Ribonuclease P (RNase P) is an essential ribonucleoprotein
enzyme responsible for the 50-end maturation of transfer RNAs
(Schön, 1999). Bacterial RNase P enzymes recognize the stacked
acceptor stem/T-arm module of precursor tRNA (ptRNA) sub-
strates (Harris & Christian, 2003, and references therein), and their
RNA subunits have been shown to be catalytically active in the
absence of the protein subunit (Guerrier-Takada et al, 1983). In
bacteria, the RNA subunit (about 380 nt) forms a specific complex
with a small basic protein of about 13 kDa, encoded by the rnpA
gene. RNase P RNAs (P RNAs, encoded by the rnpB gene) from
bacteria are subdivided into two distinct structural groups, termed
type A (for ‘ancestral’) and type B (for ‘Bacillus’; Hall & Brown,
2001). Escherichia coli and Bacillus subtilis have been the
principal model systems for type A and B RNase P RNAs,
respectively. Although subunits of E. coli and B. subtilis RNase P
enzymes have been shown to be interchangeable in vitro
(Guerrier-Takada et al, 1983), more recent studies have indicated
that the differences between the type A and B RNase P RNA
architectures are associated with numerous differences in their
biogenesis, biochemical/biophysical properties and enzyme
function in vitro. There is evidence for autolytic processing of
B. subtilis P RNA 50 and 30 ends after association with its protein
subunit (Loria & Pan, 2000), whereas the E. coli P RNA precursor
is processed by RNase E at its 30 end and by an as yet unidentified
ribonuclease at the 50 end (Lundberg & Altman, 1995). B. subtilis,
but not E. coli, RNase P was found to form a specific dimer
consisting of two RNA and two protein subunits (Fang et al, 2001).
Dimer formation is favoured in the absence of substrate, or in the
presence of a tandem tRNA substrate, but disfavoured in the
presence of a monomeric ptRNA (Barrera et al, 2002). The dimeric
form of B. subtilis RNase P was further observed to bind to 30S
ribosomal subunits, and this association has been proposed
to modulate the enzyme’s activity on potential, but as yet
unidentified non-tRNA substrates (Barrera & Pan, 2004). The
B. subtilis RNase P holoenzyme binds to ptRNA with a much
higher affinity than mature tRNA (mtRNA), but this discrimination
against mtRNA seems substantially attenuated in E. coli RNase P
(Tallsjö & Kirsebom, 1993; Kurz et al, 1998). Indeed, a recent
study reports a 1,600-fold preference of B. subtilis RNase P for
ptRNA versus mtRNA, whereas this factor is reduced to 3 in the
case of the E. coli holoenzyme (Buck et al, 2005). Finally, E. coli
and B. subtilis P RNAs have distinct metal ion requirements
(Warnecke et al, 1999).
In this report, we present the results of in vivo complementa-
tion experiments in RNase P mutant strains of E. coli and
B. subtilis. The type B RNase P RNA of B. subtilis can functionally
replace the type A RNA from E. coli in vivo and vice versa. Even
a single copy of the E. coli rnpB gene inserted into the B. subtilis
chromosome can fully rescue the growth defect caused by
repression of endogenous B. subtilis rnpB gene expression.
RESULTS
In vivo complementation studies
The substantial differences between E. coli and B. subtilis RNase P
outlined above raise the question as to whether the two RNAs can
replace each other in vivo. An earlier study reported the successful
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complementation of an E. coli rnpB mutant strain by B. subtilis
rnpB, but not by rnpB genes from the related bacteria B. brevis and
B. megaterium (Waugh & Pace, 1990). Here, we describe cross-
species complementation analyses in both E. coli and B. subtilis.
In the E. coli mutant strain DW2/pDW160, the chromosomal rnpB
gene is replaced with a chloramphenicol resistance cassette and
a complementing rnpB gene is provided on a plasmid (pDW160)
with a temperature-sensitive origin of replication (Waugh & Pace,
1990). Suppression of the conditionally lethal phenotype at 43 1C
is achieved by expression of functional P RNA from a second
compatible plasmid. For complementation in B. subtilis, we
constructed a conditionally lethal mutant strain (SSB318), the
endogenous rnpB expression of which is dependent on isopropyl-
b-D-thiogalactoside (IPTG).
Complementation in E. coli
E. coli DW2 cells were transformed with the multicopy plasmid
pSP64 encoding the E. coli or B. subtilis rnpB gene (pSP64-EcrnpB
or pSP64-BsrnpB; Table 1). For growth curve monitoring,
corresponding transformants were cured of plasmid pDW160
(loss of kanamycin resistance), and loss of the E. coli rnpB gene
was verified by colony PCR for DW2 cells harbouring pSP64-
BsrnpB. Consistent with the aforementioned study (Waugh &
Pace, 1990), the B. subtilis rnpB gene rescued growth of the DW2
mutant strain at the non-permissive temperature of 43 1C (Table 1).
Remarkably and for reasons as yet unknown, bacteria expressing
B. subtilis rnpB formed larger colonies than cells transformed with
the plasmid containing the homologous E. coli rnpB gene at 43 1C.
This was also reflected in the faster growth rate of the cured
strain in liquid cultures at 37 1C (64 versus 75 min doubling time
in Luria-Bertani medium for DW2 cells transformed with pSP64-
BsrnpB and pSP64-EcrnpB, respectively). Thus, B. subtilis P RNA
can provide full RNase P function in E. coli, despite a tenfold
lower affinity of this RNA for the E. coli RNase P protein
(Day-Storms et al, 2004). It is possible that higher levels of
expression of B. subtilis rnpB from the multicopy complementa-
tion plasmid compensate for the lower protein–RNA affinity.
Activity of hybrid holoenzymes from E. coli
E. coli DW2 bacteria expressing E. coli or B. subtilis rnpB from
the complementation plasmid were cured of pDW160 and grown
at 30 1C for partial purification of RNase P holoenzymes. Holo-
enzymes were tested under standard assay conditions (10 mM
Mg2þ , 100 mM NH4þ ) for processing of ptRNAGly, as well as
ptRNAG74 and ptRNAG75 variants (Fig 1), to assess cleavage
efficiency and processing site selection following loss of the CCA
interaction. Both enzymes cleaved ptRNAGly at the canonical site
(þ 1/1). However, whereas the E. coli holoenzyme promoted
substantial miscleavage of the mutant substrates at 1/2, the
hybrid enzyme containing B. subtilis P RNA did not significantly
miscleave ptRNAG74 or ptRNAG75 (Fig 2A,B). These findings
show that hybrid RNase P holoenzymes consisting of B. subtilis
P RNA and E. coli P protein form stable complexes in vivo that can
withstand biochemical purification. The results obtained with the
mutant substrates further illustrate in vitro differences in substrate
recognition between RNase P enzymes harbouring type A versus
type B RNA subunits.
Complementation in B. subtilis
For complementation studies in B. subtilis, we constructed strain
SSB318. This strain expresses the chromosomal B. subtilis rnpB
gene under control of the spac promoter, and cell survival depends
on the presence of IPTG. The conditionally lethal phenotype
cannot be rescued by overexpression of the B. subtilis protein
subunit (rnpA) from a plasmid (data not shown), indicating that
small quantities of P RNA that may persist owing to spac promoter
leakiness cannot be coaxed into activity by increased amounts of
the protein subunit. SSB318 grows slower in the presence of 1 mM
IPTG (doubling time 67 min; Table 2) than the wild-type strain
W168 (57 min), suggesting that the fully induced spac promoter is
not as strong as the native B. subtilis rnpB promoter and that P RNA
is limiting for cell growth under these conditions. This is supported
by the observation that the SSB318-derived strain SSB318EcrnpB
(see below) has about 3.5-fold less B. subtilis P RNA in the
presence of IPTG than W168 (Fig 3, lane 9 versus 17).
When expressed from a multicopy plasmid, under control of
either its own or the B. subtilis rnpB promoter, the heterologous
rnpB gene from E. coli fully rescued the conditionally lethal
phenotype of SSB318 (Table 2). The generation time of the strain
containing the B. subtilis rnpB-expressing plasmid was shorter
(49 min) than that containing the E. coli rnpB genes (60 and 63 min
for the constructs driven by the E. coli and B. subtilis promoters,
respectively). Although this experiment might suggest that E. coli
rnpB is not as efficient at restoring optimal growth as its B. subtilis
counterpart, it is also possible that this was because of unrelated
effects on plasmid copy number or stability. To eliminate
complications of gene dosage from the plasmid-derived rnpB
genes and differences in expression due to varying promoter
Table 1 | Complementation of the Escherichia coli RNase P mutant strain by Bacillus subtilis rnpB
DW2/pDW160 DW2 doubling time (min)*
RNase P RNA source 30 1C 43 1C 37 1C
pSP64-EcrnpB +++ +++z 7577
pSP64-BsrnpB +++ +++y 6474
pSP64 +++ —
Growth of mutant strains transformed with E. coli or B. subtilis rnpB was analysed on LB plates at the permissive (30 1C) and non-permissive (43 1C) temperature. RNase P,
ribonuclease P; +++, good complementation; —, no colonies.
*Measured after elimination of pDW160.
zColonies at 43 1C were smaller than those at 30 1C; for growth at 43 1C, the phenotype of cells transformed with E. coli rnpB was set as the standard.
yColonies at 43 1C were larger than those for cells transformed with E. coli rnpB, set as the standard.
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Fig 1 | Secondary structure illustrations (Tsai et al, 2003) of Escherichia coli (type A, top left) and Bacillus subtilis (type B, top right) ribonuclease P
(RNase P) RNAs, and a phylogenetic minimum consensus RNase P RNA secondary structure (bottom left; Marquez et al, 2005); C-domain, catalytic
domain; CR, conserved region; S-domain, specificity domain. Bottom right: Thermus thermophilus ptRNAGly; the arrow indicates the canonical RNase
P cleavage site between nucleotides 1 and þ 1; the point mutations in 30-CCA of ptRNAGly are highlighted by black squares; tertiary interactions
inferred from the crystal structure of yeast tRNAPhe are indicated by dotted lines (adapted from Heide et al, 2001).
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strength, we constructed strain SSB318EcrnpB, which carries a
single copy of the E. coli rnpB gene under control of the B. subtilis
rnpB promoter in the amyE locus on the B. subtilis chromosome.
Constitutive expression of E. coli rnpB in this strain was confirmed
by radioactive reverse transcription–PCR (RT–PCR; Fig 3, lanes
7,11). The single-copy chromosomal E. coli rnpB gene efficiently
rescued the lethal phenotype in the absence of IPTG, even when
the lac repressor was overproduced from plasmid pMAP65 to
tighten repression of the spac promoter (Table 2). The growth rates
of SSB318EcrnpB and SSB318EcrnpB pMAP65 (57 and 64 min,
respectively) were indistinguishable from those of the wild-type
strains W168 and W168 pMAP65 (56 and 65 min, respectively),
suggesting that E. coli P RNA not only carries out all the essential
RNase P functions in the heterologous B. subtilis host, but is also
highly efficient at catalysing any of its potential minor functions
(see below). It is also interesting to note that expression of both P
RNA types in the same cell, whether in single copy or on a
plasmid, did not pose any problem for B. subtilis growth (Table 2).
In experiments similar to those performed with the E. coli DW2
strain, we partially purified holoenzymes from B. subtilis SSB318
transformed with E. coli or B. subtilis rnpB and grown in the
absence of IPTG. In agreement with the complementary data in
Fig 2A,B, the B. subtilis holoenzyme did not significantly
miscleave ptRNAG74 or ptRNAG75, whereas the hybrid enzyme
containing E. coli P RNA promoted substantial miscleavage of the
mutant substrates (Fig 2C,D).
DISCUSSION
Our study shows that type A and B RNase P RNAs are inter-
changeable in vivo under standard growth conditions, indicating
that the hybrid enzymes can carry out all essential cellular
functions of RNase P. These findings are surprising for several
reasons. First, the lower stability of hybrid holoenzyme complexes
(Day-Storms et al, 2004) evidently does not pose a problem for
holoenzyme assembly in vivo, as a single E. coli rnpB copy can
provide full RNase P function in B. subtilis SSB318. Second, Buck
et al (2005) determined that the native B. subtilis holoenzyme has
a 1,600-fold preference for ptRNA compared with that for mtRNA,
whereas this selectivity is reduced twofold for the hybrid enzyme
containing E. coli P RNA. Our results show that this change in the
relative affinities for ptRNA and mtRNA does not abrogate RNase
P function in vivo. Third, the E. coli protein reduces the Mg2þ
concentration requirement for tertiary structure formation of P
RNA and increases the melting temperature at physiologically
relevant Mg2þ concentrations (Buck et al, 2005). In contrast, the
B. subtilis protein does not exert such stabilizing effects on its
cognate or E. coli P RNA (Buck et al, 2005). As E. coli P RNA can
ptRNA
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Fig 2 | Processing and cleavage site selection of hybrid ribonuclease P
(RNase P) holoenzymes isolated from Escherichia coli and Bacillus subtilis
complementation strains. (A,B) RNase P partially purified from E. coli
DW2 or (C,D) B. subtilis SSB318; holoenzymes contained E. coli P RNA in
(A,D) or B. subtilis P RNA in (B,C). con, control cleavage by E. coli RNase
P RNA. For details, see Methods. 50-Cleavage products are indicated on
the left (canonical cleavage site at þ 1/1, miscleavage at 1/2).
Although the amount of extract added to processing assays was equalized
in (A–D), based on absorption at 260 nm, holoenzyme concentrations are
probably identical only within one panel; E.c., E. coli; B.s., B. subtilis.
b
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provide RNase P function in B. subtilis (Table 2), these differences
in their biochemical and biophysical properties apparently do not
have important consequences for hybrid RNase P function in vivo.
B. subtilis RNase P can form symmetric dimers consisting of
two RNA and two protein subunits, whereas E. coli P RNA tends to
form aggregates (Fang et al, 2001). Buck et al (2005) reinvestigated
dimerization by B. subtilis and E. coli RNase P, and observed
weak dimer formation by the E. coli holoenzyme in addition to
higher order aggregation. The KD of dimer formation was about
50–100 nM for B. subtilis and 500–1000 nM for E. coli RNase P,
with the dimerization properties mainly determined by the type
of P RNA subunit (Buck et al, 2005). Unlike the B. subtilis enzyme,
dimers containing E. coli P RNA readily dissociated to monomers
in the presence of mtRNA, which correlated with the high-affinity
binding of mtRNA by holoenzymes containing E. coli P RNA. As
the mtRNA concentration in an E. coli cell is estimated to be
500 mM in the presence of 2 mM (Hansen et al, 2001) or lower
(Buck et al, 2005) concentrations of cellular RNase P, the
biological relevance of dimer formation by holoenzymes contain-
ing E. coli P RNA is questionable. Our observation that E. coli P
RNA functions in B. subtilis RNase P mutant strains also makes
it unlikely that RNase P dimer formation exerts an important
regulatory role in B. subtilis.
The maturation pathways of the primary P RNA transcripts
differ in E. coli and B. subtilis. The E. coli pathway requires RNase
E, an essential enzyme that is not found in B. subtilis, whereas
processing of B. subtilis P RNA may be at least partly
autocatalytic. The results presented here indicate that not only
are the P RNAs interchangeable, but so too are their maturation
pathways, assuming the P RNA primary transcripts have to
undergo processing for proper function.
Finally, E. coli RNase P is known to process several non-tRNA
substrates in vivo (Li & Altman, 2003), whereas non-tRNA
substrates have not yet been identified in B. subtilis. As B. subtilis
P RNA provided full RNase P function in E. coli, hybrid
holoenzymes containing this RNA subunit are able to process at
least the essential non-tRNA substrates in E. coli, such as 4.5S
RNA (Brown & Fournier, 1984). The fact that B. subtilis strains
expressing single-copy E. coli or B. subtilis rnpB genes have the
same doubling time suggests that, should B. subtilis RNase P also
have alternative functions, the E. coli hybrid enzyme is highly
efficient at performing them.
In vivo analyses of the kind reported here provide a framework
to test the functional relevance of the numerous biochemical,
biophysical and enzymatic differences that have been observed
between bacterial type A and B RNase P enzymes. Our results
show that, despite these differences, the heterologous hybrid
enzymes are capable of carrying out the essential functions of
RNase P in vivo, although potential defects under particular stress
conditions cannot be excluded at present. This poses the question
Table 2 | Complementation of Bacillus subtilis SSB318 RNase P mutant strains by Escherichia coli rnpB (cell doubling times given in
minutes)
rnpB gene source Promoter* IPTG No IPTG
B. subtilis W168 (wild type)
W168 B.s. native 5772 5672
W168+pMAP65z B.s. native 6272 6572
B. subtilis SSB318 (Pspac:rnpB)
SSB318 spac 6773 —
SSB318+pMAP65z spac 8176 —
Multicopy
pHY300 (empty plasmid) None 6974 —
pHY300-BsrnpB B.s. native 4971 4972
pHY300-EcrnpB E.c. native 5272 6072
pHY300-EcrnpB B.s. native 5873 6373
Single copy
pDG364y None 6373 —
SSB318EcrnpBJ B.s. native 5271 5771
SSB318EcrnpB+pMAP65z B.s. native 5672 6474
RNase P, ribonuclease P; IPTG, isopropyl-b-D-thiogalactoside; —: no growth at all; for determination of cell doubling times, see the supplementary information online.
*Promoter used for the respective rnpB gene; B.s. native and E.c. native, native rnpB promoters from B. subtilis and E. coli, respectively.
zPlasmid pMAP65 (pUB110 lacI; Petit et al, 1998) was used to overexpress the lac repressor to fully silence expression from the spac promoter in strain SSB318.
yVector used for chromosomal integration into the amyE locus.
JE. coli rnpB integrated into the amyE locus under control of the native B. subtilis rnpB promoter and terminator.
Exchange of type A and B RNase P RNAs in vivo
B. Wegscheid et al
&2006 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports
scientificreport
5
as to which conserved features of bacterial RNase P RNA and
protein subunits are essential for in vivo function. Both the E. coli
and B. subtilis P proteins increase the affinity of P RNA for ptRNA
by factors of 700–1400 for hybrid and native enzymes containing
E. coli P RNA, and 13,000–33,000 for those containing B. subtilis
P RNA (Buck et al, 2005). As the E. coli P RNA/B. subtilis P protein
complex permitted rescue of the mutant phenotype of B. subtilis
strain SSB318, we can conclude that a 700-fold increase in ptRNA
affinity conferred by the protein subunit is sufficient to support
in vivo function. This increase in affinity for ptRNA is linked to
an increase in the affinity for key metal ions involved in ptRNA
binding and catalysis (Kurz & Fierke, 2002), probably achieved
by the protein’s stabilization of conserved local structure in the
catalytic core of type A and B RNase P RNAs. These central
functions are evidently conserved across bacterial species barriers.
In the course of evolution, type A and B RNase P enzymes
have developed RNA subunits with different architecture and
individually tailored protein subunits, optimized for their
specific cellular milieu. It is thus fascinating to observe that
these RNase P enzymes still retain their biological function
when their RNA subunit is exchanged with one representing a
different architectural type.
METHODS
Strains. E. coli strain DW2/pDW160 was used for complemen-
tation studies (see text). For construction of the B. subtilis
conditional RNase P mutant strain SSB318, its derivative
harbouring a single copy of E. coli rnpB, as well as complementa-
tion plasmids, see the supplementary information online.
In vitro transcription and 50-end labelling. Runoff transcription
with bacteriophage T7 RNA polymerase and 50-end labelling
was performed as described previously (Busch et al, 2000).
The ptRNAGly substrate, and G74 and G75 variants (Fig 1; for
construction, see the supplementary information online) were
transcribed from plasmid pSBpt30HH, and B. subtilis and E. coli P
RNA from plasmids pDW66 and pJA20, respectively (Busch et al,
2000).
Partial purification of RNase P. Cells resuspended in about 4 ml
of buffer A (60 mM NH4Cl, 10 mM Mg[OAc]2, 6 mM dithiothreitol,
50 mM Tris–HCl, pH 7.2–7.5) per 600 mg cell pellet were lysed by
sonication (Branson Sonifier 250, output 20, duty cycle 30–40%,
10 min on ice), followed by centrifugation for 45 min at 4 1C and
10,000g. For the preparation of DEAE fractions, the supernatant
was loaded onto a DEAE fast-flow Sepharose column (Aekta basic,
GE Healthcare Europe, Munich, Germany). Elution was carried out
by applying a continuous NH4Cl gradient from 60 to 550 mM
NH4Cl. Active fractions eluted at about 300–400 mM NH4Cl.
Processing assays. For RNase P-catalysed processing of Thermus
thermophilus ptRNAGly (and G74 or G75 variants; Fig 1), active
DEAE fractions (0.25–1.0 ml; equal amounts based on A260
measurements) were incubated in buffer A (10 mM Mg[OAc]2,
6 mM dithiothreitol, 50 mM Tris–HCl, pH 7.5) containing 100 mM
NH4Cl for 10 min at 37 1C. Trace amounts (o1 nM) of 50-end-
labelled substrate were preincubated under the same conditions
for 5 min at 55 1C and 25 min at 37 1C. Processing reactions were
started by combining enzyme and substrate solutions and assayed
at 37 1C. For control cleavage by E. coli RNase P RNA (Fig 2), trace
amounts (o1 nM) of 50-end-labelled ptRNAGly were incubated
with 5 mM E. coli RNase P RNA for 5 s at 37 1C in 50 mM PIPES,
0.1 M Mg[OAc]2 and 1 M NH4OAc (pH 7.0 at 37 1C).
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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Construction of the B. subtilis conditional RNase P mutant strain SSB318 
The B. subtilis conditional RNase P mutant (SSB318) was constructed as follows: a 251-nt 
PCR fragment, containing nucleotides +1 to +231 of the rnpB gene, was amplified using 
oligonucleotides HP499 (5’-ACC AAA GCT TGT TCT TAA CGT TCG GGT AAT CGC 
TG) and HP500 (5’-TCC AGG ATC CGT TTA CCG CGT TCC ACT CTC ACC ATT TC), 
digested with HindIII and BamHI at the underlined sites and cloned in pMUTIN-4M (Vagner 
et al., 1998) digested with the same enzymes. The resulting plasmid pMUTIN-rnpB was 
transformed into B. subtilis wild-type strain W168, selecting for erythromycin resistance in 
the presence of 1 mM IPTG. 95 out of 100 transformants tested showed IPTG-dependent 
growth, indicating correct insertion into the rnpB gene which is predicted to be essential. One 
of these transformants, SSB318, was retained for subsequent studies. In this strain, the 
chromosomal rnpB gene is under control of the IPTG-inducible spac promoter. In the absence 
of IPTG, cell growth becomes dependent on the expression of a complementing rnpB gene. 
Plasmid cloning of rnpB genes for complementation analyses 
For analyses in E. coli mutant strains, the complementing E. coli rnpB gene was expressed 
under control of the natural E. coli rnpB promoter from plasmid pSP64 as described (Hardt 
and Hartmann, 1996). For cloning of B. subtilis rnpB gene into the same plasmid, B. subtilis 
rnpB including its natural promoter and terminator was amplified from genomic B. subtilis 
DNA (strain W168) using primers 5’- GGC AGC AAG CTT TAT GAT TGA TCA C 
(including the native HindIII site upstream of rnpB) and 5’- CGC CCA AGC TTG TGT ATA 
CTT CTT CAT CGT ATC ACC CTG TC. The resulting PCR fragment was cloned in the 
HindIII site of pSP64; the orientation of the rnpB gene was such that its 3’-portion was 
adjacent to the XbaI site in the pSP64 multi-cloning site.  
B. subtilis rnpB was excised from this pSP64 construct via HindIII and inserted into pHY300 
(obtained from Takara Shuzo Co., Kyoto, Japan) cut with the same enzymes for 
complementation in B. subtilis SSB318. For complementation of E. coli rnpB in B. subtilis 
SSB318, an NheI/HindIII fragment from plasmid pSP64 carrying the E. coli rnpB gene (Hardt 
and Hartmann, 1996) under control of the native E. coli rnpB promoter was cloned into 
pHY300 cut with XbaI and HindIII. E. coli rnpB under control of the B. subtilis rnpB 
promoter and terminator for complementation in B. subtilis SSB318 was constructed as 
follows. For amplification of the B. subtilis promoter, the primer pair 5’- GGC AGC AAG 
CTT TAT GAT TGA TCA C and 5’- ATG AAT TAT TAT ATA ACA ACT GAT TAC was 
used; the B. subtilis terminator was amplified using the primer pair 5’- ACA TTT AAA ATG 
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ATG AAA ACA AGC and 5’- CGC CCA AGC TTG TGT ATA CTT CTT C; E. coli rnpB 
was amplified with primers 5’- GTA ATC AGT TGT TAT ATA ATA ATT CAT GAA GCT 
GAC CAG ACA GTC and 5’- GCT TGT TTT CAT CAT TTT AAA TGT AGG TGA AAC 
TGA AAC TGA CCG ATA AG, containing overlapping regions with the B. subtilis rnpB 
promoter and terminator, respectively. The B. subtilis rnpB promotor, the E. coli RNase P 
RNA-coding sequence and the B. subtilis rnpB terminator were combined by overlap 
extension PCR. This recombinant E. coli rnpB gene was cloned into the HindIII site of 
pHY300. 
Construction of a strain containing E. coli rnpB with the native B. subtilis promoter and 
terminator integrated into the chromosome of B. subtilis SSB318 
For construction of a strain containing E. coli rnpB with the native B. subtilis promoter and 
terminator integrated into the chromosome of B. subtilis SSB318, the E. coli rnpB fragment 
was cloned into the HindIII site of pDG364, a vector suitable for chromosomal integration 
into the amyE locus of B. subtilis (Cutting and Vander-Horn, 1990). E. coli rnpB was 
amplified with primers 5’- GTA ATC AGT TGT TAT ATA ATA ATT CAT GAA GCT 
GAC CAG ACA GTC and 5’- GCT TGT TTT CAT CAT TTT AAA TGT AGG TGA AAC 
TGA AAC TGA CCG ATA AG, using plasmid pSP64 harbouring E. coli rnpB (Hardt and 
Hartmann, 1996) as template, and combined with B. subtilis promoter and terminator 
fragments by PCR as described above.  
Transformation of E. coli complementation strains  
Recombinant pSP64 plasmids (10 ng) were introduced in DW2/pDW160 by electroporation, 
using a Biorad GenePulser (1.8 kV; 5 ms, 50 µF, 100 Ω). After the pulse, 1 ml SOC medium 
(per liter: 20 g peptone, 5 g yeast extract, 0.6 g NaCl, 0.17 g KCl, 20 mM glucose, 10 mM 
MgCl2, 10 mM MgSO4, pH 7.5) was added and cells were shaken at 30°C for 1 h. Cell 
suspensions were plated directly in appropriate dilution on LB agar plates containing 100 
µg/ml ampicillin and 30 µg/ml chloramphenicol. The two sets of plates were incubated in 
parallel at 30°C or 43°C, respectivlely, for 20 to 40 h. For elimination of pDW160, 
DW2/pDW160 cells harboring a second complementation plasmid cells were grown at 43°C 
and then tested for loss of pDW160-encoded kanamycin resistance (50 µg/ml).  
Transformation of B. subtilis complementation strain SSB318 
B. subtilis SSB318 was grown overnight at 37°C in HS medium (Spizizen, 1958) without 
glucose, but complemented with 0.8% arginie, 0.04% histidine, 0.1% yeast extract 0.0005% 
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L-tryptophan, 0.0005% L-phenylalanine and 0.02% casamino acids in the presence of 0.5 
µg/ml erythromycin, 12.5 µg/ml lincomycin and 1 mM IPTG. Cultures were then diluted into 
20 ml of LS medium (Spizizen minimal salts complemented with 0.1% yeast extract, 0.5 mM 
spermine, 2.5 mM MgCl2, 0.01% casamino acids 0.0005% L-tryptophan and 0.0005% L-
phenylalanine; Spizizen, 1958) to a starting OD600 of 0.05 - 0.1. Cells were then grown to an 
OD600 of 0.5 - 0.7 at 30°C under shaking. Approximately 1 µg DNA was added to 1 ml of this 
culture which was grown for another 1 to 2 h at 37°C. Cells were plated in parallel on LB agar 
plates with or without 1 mM IPTG and containing 0.5 µg/ml erythromycin, 12.5 µg/ml 
lincomycin and 30 µg/ml tetracycline (to select for the presence of pHY300). In cases of poor 
transformation efficiency, cells were first plated only in the presence of IPTG. For 
transformation of pDG364 derivatives, cells were plated on 0.5 µg/ml Erythromycin, 12.5 
µg/ml lincomycin, 10 µg/ml chloramphenicol (encoded by pDG364) and 1 mM IPTG. 
Determination of cell doubling time 
E. coli DW2 cells harboring  complementation plasmids were tested for the loss of kanamycin 
resistance (loss of pDW160). Kanamycin-sensitive and ampicillin- and chloramphenicol-
resistant clones were grown overnight at 37°C and then diluted to a starting OD578 of 0.05 - 
0.1 and grown at 37°C under aeration (180 rpm in a GFL Shaking Incubator 3033). In the 
case of complementation with B. subtilis rnpB, kanamycin-sensitive clones were verified by 
PCR to lack a chromosomal E. coli rnpB copy. B. subtilis cells were grown overnight at 37°C 
in the presence of the appropriate antibiotics and 1 mM IPTG. IPTG was then washed out by 
centrifugation and resuspension of the cell pellet in LB without IPTG, which was repeated; 
the final cell pellet was then resuspended in LB, adjusted to a starting OD578 of 0.05 - 0.1 in 
50 mM LB and grown at 37°C without antibiotics at 180 rpm as above. After growth curve 
monitoring, samples were withdrawn from the cultures, diluted and plated in parallel on plates 
with and without antibiotics to exclude the loss of plasmids/resistance gene markers, both 
types of plates containing 1 mM IPTG. Cell doubling times were derived from early 
exponential phases and reproduced in at least 3 independent experiments. 
Construction of ptRNAGly templates encoding variants with C to G exchanges at 
position 74 or 75  
Mutations G74 and G75 were introduced by the site-directed DpnI mutagenesis method 
according to the manual provided with the QuikChange XL Site-Directed Mutagenesis Kit 
(Stratagene); the primer pair for introduction of the G74 mutation was 5’-CCG TCT CCC 
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GCT GCA GTC ACC GGA TGT GC and 5’-GCA CAT CCG GTG ACT GCA GCG GGA 
GAC GG; for introduction of the G75 mutation, 5’-CCG TCT CCC GCT CGA GTC ACC 
GGA TGT GC and 5’-GCA CAT CCG GTG ACT CGA GCG GGA GAC GG were used. 
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The precursor tRNA 39-CCA interaction with
Escherichia coli RNase P RNA is essential for catalysis
by RNase P in vivo
BARBARA WEGSCHEID and ROLAND K. HARTMANN
Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, D-35037 Marburg, Germany
ABSTRACT
The L15 region of Escherichia coli RNase P RNA forms two Watson–Crick base pairs with precursor tRNA 39-CCA termini
(G292-C75 and G293-C74). Here, we analyzed the phenotypes associated with disruption of the G292-C75 or G293-C74 pair in
vivo. Mutant RNase P RNA alleles (rnpBC292 and rnpBC293) caused severe growth defects in the E. coli rnpB mutant strain
DW2 and abolished growth in the newly constructed mutant strain BW, in which chromosomal rnpB expression strictly
depended on the presence of arabinose. An isosteric C293-G74 base pair, but not a C292-G75 pair, fully restored catalytic
performance in vivo, as shown for processing of precursor 4.5S RNA. This demonstrates that the base identity of G292, but not
G293, contributes to the catalytic process in vivo. Activity assays with mutant RNase P holoenzymes assembled in vivo or in
vitro revealed that the C292/293 mutations cause a severe functional defect at low Mg2+ concentrations (2 mM), which we infer
to be on the level of catalytically important Mg2+ recruitment. At 4.5 mM Mg2+, activity of mutant relative to the wild-type
holoenzyme, was decreased only about twofold, but 13- to 24-fold at 2 mM Mg2+. Moreover, our findings make it unlikely that
the C292/293 phenotypes include significant contributions from defects in protein binding, substrate affinity, or RNA
degradation. However, native PAGE experiments revealed nonidentical RNA folding equilibria for the wild-type versus mutant
RNase P RNAs, in a buffer- and preincubation-dependent manner. Thus, we cannot exclude that altered folding of the mutant
RNAs may have also contributed to their in vivo defect.
Keywords: E. coli ribonuclease P; CCA-RNase P RNA interaction; in vivo complementation studies; point mutations
INTRODUCTION
Ribonuclease P (RNase P) is an essential ribonucleoprotein
enzyme responsible for the 59-end maturation of tRNAs
(Altman and Kirsebom 1999; Schön 1999; Hartmann and
Hartmann 2003; Evans et al. 2006). The bacterial RNase P
holoenzyme consists of an RNA subunit of z380 nucleo-
tides (nt) and a small basic protein (z13 kDa), and in
vitro, RNA subunits of bacterial RNase P enzymes are
catalytically active in the absence of the protein subunit
(Guerrier-Takada et al. 1983). Bacterial RNase P enzymes
recognize the stacked acceptor stem-T arm module of
precursor tRNA (ptRNA) substrates, including specific
elements at the cleavage site, such as the residue at nucleo-
tide –1 and the 39-73NCCA76 end (Harris and Christian
2003). The two cytosines of tRNA 39-CCA (C74 and C75)
termini were shown to form Watson–Crick (WC) base
pairs with two conserved G residues (G292 and G293) in
the loop L15 of Escherichia coli RNase P RNA (Fig. 1;
Kirsebom and Svärd 1994). This interaction provides
a substantial contribution to the free energy of ptRNA
binding in vitro (Hardt et al. 1995; Oh et al. 1998; Busch
et al. 2000), supports selection of the correct cleavage site
(Kirsebom and Svärd 1994), and was suggested to play
a role in the binding of catalytic Mg2+ (Oh et al. 1998;
Busch et al. 2000). Another in vitro study provided
evidence that base-pairing with 39-CCA is also relevant to
cleavage site selection in the holoenzyme reaction (Svärd
et al. 1996).
We previously reported a kinetic and thermodynamic in
vitro analysis of the G292-C75 and G293-C74 base-pairing
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interaction in the reaction catalyzed by E. coli RNase P
RNA (Busch et al. 2000). The results were based on the
study of wild-type RNase P RNA along with two variants
carrying a single G-to-C exchange (C292 or C293), either
acting on wild-type ptRNAGly or derivatives with a com-
pensatory mutation in the tRNA 39-end (39-G74CA or 39-
CG75A) (Fig. 1). Disruption of either of the two intermo-
lecular base pairs largely reduced ground state binding to
E. coli RNase P RNA. Disruption of the G293-C74 pair had
a less detrimental effect on the single turnover kinetic
parameters than did disruption of the G292-C75 pair
(Busch et al. 2000). This was consistent with previous
findings (Oh et al. 1998), suggesting that the reduction in
the efficiency of cleavage of a mutant ptRNA-CU75A
substrate resulted from impaired binding of Mg2+ impor-
tant for catalysis. Restoration of base-pairing by compen-
satory base exchanges in the substrate (C293-G74 and
C292-G75) restored catalytic performance in vitro, almost
fully for the C293-G74, but clearly less for the C292-G75
combination (Busch et al. 2000).
Here, we investigated the role of the CCA interaction in
vivo in E. coli to clarify how far previous in vitro findings,
observed under unphysiologically high Mg2+ concentra-
tions, are relevant to the cellular situation. This included
the construction of a novel E. coli rnpB mutant strain
(named BW), in which chromosomal rnpB expression is
efficiently knocked down when glucose is substituted for
arabinose in growth media. We demonstrate that the
rnpBC292 and rnpBC293 mutant alleles are lethal in strain
BW. In the case of the C293, but not the C292 mutant,
a compensatory mutation in the substrate 39 end fully
restored processing capacity in vivo and in vitro. Processing
assays with partially purified and in vitro assembled
holoenzymes further revealed that the defect of the C292/
293 enzymes is most evident at free Mg2+ concentrations
assumed to be close to those in vivo. Since our results
indicate that the phenotypes of the C292 and C293
mutations do not include substantial contributions from
defects in protein binding, substrate affinity, or RNA
degradation, we propose that the defect is primarily on
the level of recruitment of catalytically important Mg2+.
Native PAGE experiments revealed nonidentical RNA
folding equilibria for the wild-type versus mutant RNase
P RNAs, in a buffer- and preincubation-dependent man-
ner. Thus, a contribution from nonnative folding to the
defect of the mutant RNAs in vivo cannot be ruled out
at present.
RESULTS
In vivo complementation in E. coli DW2
To investigate the ptRNA 39-CCA interaction with RNase P
RNA under in vivo conditions, plasmids carrying the wild-
type RNase P RNA gene (rnpBwt) or the C292 or C293
mutant alleles (rnpBC292, rnpBC293) were introduced into
the temperature-sensitive E. coli RNase P mutant strain
DW2/pDW160. In strain DW2/pDW160, the chromosomal
gene encoding the RNase P RNA subunit (rnpB) is replaced
with a chloramphenicol resistance cassette and a comple-
menting rnpB gene is provided on a plasmid (pDW160)
temperature sensitive for replication (Waugh and Pace,
1990). Suppression of the conditionally lethal phenotype at
43°C is achieved by expression of functional RNase P RNA
from a second compatible plasmid.
As expected, E. coli rnpBwt provided on the multicopy
plasmid pSP64 rescued growth of the mutant strain at
the nonpermissive temperature of 43°C (Table 1). The
rnpBC292 mutant allele caused only a partial rescue, and
rnpBC293 showed very weak complementation. For bacte-
ria transformed with rnpBC292 and rnpBC293 mutant
alleles and grown at 43°C, the corresponding mutant RNAs
were verified to be the dominant RNase P RNA species
in the cell by primer extension analyses (data not shown;
see Materials and Methods). These control experiments
excluded reversion of mutant alleles to the wild-type
sequence.
Construction of a novel E. coli rnpB knockdown strain
The impaired phenotype of the rnpBC293 allele relative to
rnpBC292 in E. coli DW2 cells (Table 1) was the reverse of
what we had expected based on our previous in vitro results
(Busch et al. 2000). Moreover, the DW2 strain has the
drawback that complementation analyses are performed
under stress conditions at 43°C. The heat-shock response
has a global effect on gene expression (Richmond et al.
1999; Li et al. 2003), and induced metabolic changes could
alter the mutant phenotype. Also, even cells expressing the
FIGURE 1. Interaction of Thermus thermophilus ptRNAGly with the
L15 loop of E. coli RNase P RNA. Highlighted nucleotides mark the
sites of mutation investigated in this study. The arrow indicates the
canonical RNase P cleavage site (between nucleotides 1 and +1).
Nucleotides 291–295 of E. coli RNase P RNA are also termed J16/15.
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wild-type allele (pSP64 E. coli rnpBwt) (Table 1) grew
slower at 43°C compared with 30°C. We thus constructed
a novel E. coli mutant strain in which the chromosomal
rnpB gene was put under control of the arabinose promoter
and repressor system (Fig. 2A). In the absence of arabinose
and presence of glucose, rnpB expression is switched off,
and cell survival depends on a second functional rnpB gene
provided on a plasmid. The E. coli mutant strain (termed
BW) exactly displayed the anticipated phenotype (Fig. 2B).
In the BW strain, only the rnpBwt allele, but not rnpBC292
and rnpBC293, restored growth in the absence of arabinose
(Fig. 2C; Table 2A).
Defect in maturation exemplified for 4.5S RNA
We then analyzed if the rnpBC292 and rnpBC293 mutant
alleles are associated with an RNase P processing defect in
BW bacteria. For this purpose, BW cells expressing rnpBwt,
rnpBC292, or rnpBC293 from plasmid pACYC177 were
initially grown in medium containing arabinose, followed
by transfer into medium without arabinose, further in-
cubation for 3 h at 37°C, and preparation of total cellular
RNA. We then analyzed processing of 4.5S RNA, a prom-
inent non-tRNA substrate of E. coli RNase P (Bothwell et al.
1976; Peck-Miller and Altman 1991), by primer extension
(Fig. 3). Exclusively mature 4.5S RNA was detected in RNA
extracts from cells expressing plasmid-encoded rnpBwt
(Fig. 3, lane 2), whereas cells harboring rnpBC292 and
rnpBC293 accumulated a 4.5S RNA precursor extended by
3 nt at the 59 end. Since the native 4.5S RNA primary
transcript carries a 59 leader of 24 nt (see Fig. 4), nucleolytic
activities other than RNase P apparently trimmed the
leader to 3 nt. Likewise, accumulation of immature RNA
with an extra 2–5 nt at the 59 end were observed for the
bacteriophage P1/P7 regulatory C4 RNA, another non-
tRNA substrate of E. coli RNase P, when processing by
RNase P was defective (Hartmann et al. 1995). The ratio of
59-extended to mature 4.5S RNA was reproducibly higher
in the rnpBC292 than rnpBC293 background (Fig. 3, lanes
3,4), providing evidence that the processing defect of the
C292 mutant RNA is more severe than that of the C293
variant, in line with the kinetic in vitro data (Busch et al.
2000).
TABLE 1. Complementation analyses of E. coli RNase P mutant
strain DW2 by rnpB alleles
DW2/pDW160
RNase P RNA variant 30°C 43°C
pSP64 E. coli rnpBwt + + + + + +a
pSP64 E. coli rnpBC292 + + + + +
pSP64 E. coli rnpBC293 + + + (+)
pSP64 + + + 
Growth of mutant strain DW2 transformed with different rnpB
alleles (E. coli rnpBwt, rnpBC292, and rnpBC293) was analyzed on
LB plates at the permissive (30°C) and nonpermissive (43°C)
temperature. + + + > + + > (+) > , decreasing order of
complementation efficiency based on number and size of colonies.
aGrowth phenotype of cells harboring pSP64 E. coli rnpBwt at
43°C was set as standard, although colonies at 43°C were smaller
than at 30°C.
FIGURE 2. Construction and analysis of the E. coli rnpB mutant
strain BW. (A) Schematic presentation of the strain construction
strategy. The native rnpB promoter region was replaced with a cassette
(catRExBAD, 2136 bp) carrying the chloramphenicol resistance gene
(cat), a gene coding for an arabinose operon regulatory protein
(araC), and the arabinose-inducible pBAD promoter. The cassette for
homologous recombination (2669 bp) additionally contained flanking
regions identical in sequence to E. coli rnpB and to a segment up-
stream of rnpB. (B) Cell growth rescue of strain BW in the presence
of glucose (Glu) with a plasmid-encoded copy of E. coli rnpB
(pACYC177 Ecwt). Note that growth curves in the presence of glucose
versus arabinose differ in the same manner for strain BW and its
progenitor MG1655. (C) Growth analyses of BW bacteria express-
ing plasmid-encoded rnpBwt, rnpBC292, or rnpBC293 alleles
(pACYC177 Ecwt, Ec292, or Ec293) in the presence of arabinose
(Ara) or glucose (Glu).
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Restoration of 4.5S RNA maturation in the rnpBC293
background by a compensatory substrate mutation
From our previous results obtained in the RNA-alone
reaction (Busch et al. 2000), it seemed possible that an
isosteric C293-G74 pair in enzyme–substrate complexes
may fully restore activity to that of wild-type complexes.
To test if this also holds for the cellular context, we
constructed a plasmid-borne 4.5S RNA gene, in which we
switched the identity of four consecutive base pairs in the
terminal stem region. Expression of the mutated 4.5S RNA
was not detrimental to cell viability. The sequence alter-
ation in 4.5S RNA permitted primer annealing exclusively
to this 4.5S RNA variant, but not the chromosomally
encoded wild-type 4.5S RNA. In addition, two variants
with C-to-G exchanges (G‘‘74’’ or G‘‘75’’) in the dangling 39-
CCC terminus were constructed (Fig. 4A). Primer exten-
sion analysis, performed essentially as in Figure 3, indeed
revealed full restoration of 4.5S RNA maturation efficacy
for the C293 holoenzyme acting on the precursor 4.5S RNA
with a 39-G‘‘74’’ CC terminus (Fig. 4, cf. lanes 1,6 and 2–
5,7–9). In contrast, the combination of C292 P RNA and
p4.5S RNA 39-CG‘‘75’’C (Fig. 4, lane 8), although restoring
base-pairing, did not reestablish maturation capacity to
wild-type levels.
Overexpression of rnpA
We speculated that overexpression of the E. coli RNase P
protein might increase the steady-state level of the RNase P
holoenzyme and thereby alleviate the processing defects
TABLE 2. Complementation analyses in E. coli RNase P mutant strain BW
(A) Complementation of E. coli RNase P mutant strain BW by rnpB alleles
RNase P RNA variant 10 mM arabinose 0.5% glucose
pACYC177 E. coli rnpBwt + +
pACYC177 E. coli rnpBC292 + 
pACYC177 E. coli rnpBC293 + 
pACYC177 + 
(B) Complementation of E. coli RNase P mutant strain BW by rnpB alleles and simultaneous overexpression of E. coli rnpA
RNase P RNA variant rnpAa 10 mM arabinose,1 mM IPTG 0.5% glucose,1 mM IPTG
pACYC177 E. coli rnpBwt + E. coli rnpA + +
pACYC177 E. coli rnpBC292 + E. coli rnpA + b
pACYC177 E. coli rnpBC293 + E. coli rnpA + +c
pACYC177 + E. coli rnpA + 
Growth of BW bacteria transformed with different rnpB alleles (E. coli rnpBwt, rnpBC292 and rnpBC293, part A) and simultaneously
overexpressing E. coli rnpA (part B); growth was analyzed on LB plates in the presence of 10 mM arabinose or 0.5% (w/v) glucose; for bacteria
expressing rnpA, 1 mM IPTG was added to the medium. + indicates growth with equal numbers of colonies on arabinose and glucose plates;,
no growth;
aCloned in plasmid pBR322 under control of the inducible pTrc promoter.
bRetarded growth and less colonies on glucose plates (z10% of that of arabinose plates), likely revertants.
cCells showed retarded growth.
FIGURE 3. Primer extension analysis using a primer specific to E. coli
4.5S RNA and total RNA from strain BW expressing pACYC177-
encoded E. coli rnpBwt (lane 2), rnpBC292 (lane 3), and rnpBC293
(lane 4); Con (lane 1) indicates products of reverse transcription in
the presence of ddGTP and using in vitro transcribed precursor 4.5S
RNA as the template; prominent bands resulted from premature
termination of reverse transcription at template C residues (marked
by asterisks); the precursor segment of the in vitro transcribed p4.5S
RNA had the natural sequence up to residue –23, but was different
beyond this position and carried additional nucleotides for cloning
reasons (59-ggg aga ccg gaa uuc ccC GUU GGU UCU CAA CGC UCU
CAA U1, deviations from the wild-type sequence in small letters).
Samples were analyzed by 20% PAGE in the presence of 8 M urea. For
growth of BW cells harboring the different plasmids (lanes 2–4) and
preparation of total cellular RNA, see Materials and Methods.
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caused by the rnpBC292 and rnpBC293 mutant alleles.
Indeed, for BW cells expressing rnpBC293, concomitant
overexpression of rnpA partially restored viability, although
growth was retarded relative to cells harboring the rnpBwt
allele (Table 2B). In contrast, the defect caused by the
C292 mutation could not be cured by overexpressing rnpA.
Overexpression of the E. coli RNase P protein (C5) was
verified by Western blotting using an antiserum against the
E. coli C5 protein (data not shown).
Processing of ptRNA by partially purified
holoenzymes assembled in vivo
We partially purified in vivo assembled holoenzymes by
anion exchange chromatography from DW2 cells grown at
43°C and either expressing rnpBwt, rnpBC292, or
rnpBC293 from plasmid pSP64. Holoenzymes were ana-
lyzed by primer extension in the presence of ddGTP (see
Materials and Methods) and confirmed to contain $95%
of the respective mutant RNase P RNA (data not shown).
We then tested these holoenzymes for processing of
ptRNAGly (Fig. 1, termed ptRNAwt in the following) and
the two variant substrates thereof, ptRNAG74 and
ptRNAG75, with point mutations in 39-CCA (39- G74CA
and 39- CG75A) to compensate the C292/293 mutations in
RNase P RNA. This enabled us to investigate rescue effects
in terms of efficiency and cleavage site selection in the
RNase P holoenzyme reaction. Processing assays contained
0.004 A260 units of the partially purified holoenzyme
fraction and trace amounts (<1 nM) of radiolabeled sub-
strate. As illustrated in Figure 5, the wild-type holoenzyme
substantially miscleaved the two mutant substrates (Fig. 5,
panel A). As the wild-type holoenzyme, the C292 and C293
mutant holoenzymes cleaved ptRNAwt to >95% at the
canonical site. However, the C292 mutation suppressed
miscleavage of the ptRNAG75 substrate (Fig. 5, panel B), as
did the C293 mutant holoenzyme when acting on the
ptRNAG74 substrate (Fig. 5, panel C). These findings were
expected based on restoration of the intermolecular base
pairs and are in line with results from previous in vitro
studies (Kirsebom and Svärd 1994; Svärd et al. 1996; Busch
et al. 2000). However, the mutant holoenzymes cleaved
ptRNAwt, the only substrate relevant to the in vivo situ-
ation, with good efficiency. The purification scheme was
identical for DW2 cells expressing the rnpBwt, rnpBC292,
or rnpBC293 alleles, and equal amounts of extract based on
absorption at 260 nm were used in these processing assays.
Although we are aware that exact holoenzyme concentra-
tions may not have been identical for all three extracts,
good processing efficiencies of the two mutant holoen-
zymes appeared not fully consistent with their severe in
vivo defect. We thus decided to increase the stringency of
our processing assay by lowering the Mg2+ concentration to
2 mM, assuming that this better mimics the free Mg2+
concentration (1–2 mM) in E. coli cells (Alatossava et al.
1985). For wild-type RNase P, the cleavage rate at 10 mM
Mg2+ relative to 2 mM Mg2+ was 25-fold increased (krel =
25), but this difference increased to $650-fold for the C292
and C293 mutant enzymes. Thus, the defect of the mutant
enzymes was exacerbated at low [Mg2+]. However, the
C293 mutant holoenzyme cleaved the ptRNAG74 with the
same efficiencies at 2 and 10 mM [Mg2+] as the wild-type
holoenzyme acting on ptRNAwt (Table 3), demonstrating
that the natural G293-C74 and the isosteric C293-G74 pair
are fully exchangeable. In contrast, the C292-G75 pair only
FIGURE 4. Primer extension experiments to analyze processing of
pBR322-encoded mutant p4.5S RNA in strain BW expressing E. coli
rnpBwt, rnpBC292, or rnpBC293. (A) Schematic of the mutant p4.5S
RNA: The gray-shaded box indicates base-pair exchanges relative to
wild-type 4.5S RNA, which were introduced to permit specific reverse
transcription of mutant (p)4.5S RNA; two variants carried 39-terminal
C to G exchanges (highlighted) at positions equivalent to nucleotides
74 and 75 of tRNA 39-CCA ends; the arrow aligned to the stem depicts
the reverse transcription primer, with the terminal asterisk illustrating
the 59-32P-endlabel. (B) Analysis of primer extension products by 20%
PAGE in the presence of 8 M urea. (Lanes C1,C2) Primer extension
using total RNA from BW cells grown in the presence of glucose and
expressing pACYC177-encoded E. coli rnpBwt, either utilizing the
primer for wild-type 4.5S RNA (C1) or mutant 4.5S RNA (C2); the C2
control documents that the primer specific for mutant 4.5S RNA
(panel A) did not prime on wild-type 4.5S RNA. (Lanes 1–9) Primer
extension using the primer specific for mutant 4.5S RNA; total RNA
was from BW cells grown in the presence of glucose and expressing
pACYC177-encoded E. coli rnpBwt (lanes 1,4,7), rnpBC292 (lanes
2,5,8), or rnpBC293 (lanes 3,6,9); BW bacteria either expressed the
pBR322-encoded mutant p4.5S RNA with the natural 39-CCC (lanes
1–3), a mutated 39-GCC (lanes 4–6), or a 39-CGC (lanes 7–9)
terminus. The natural 4.5S RNA primary transcript has a 59 leader
of 24 nt (Bothwell et al. 1976; Hsu et al. 1984) as indicated on the left;
longer transcripts in lanes 2–5 and 7–9 are attributable to transcrip-
tional initiation from the b-lactamase promoter region still present in
our pBR322 plasmid constructs.
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showed a partial rescue (krel = 97) of the defect, empha-
sizing the importance of base identity at position 292. Full
restoration of function in the presence of the C293-G74
pair, but not the C292-G75 pair, exactly corresponds with
what we have seen for 4.5S RNA maturation in vivo (Fig. 4).
Processing of ptRNA by holoenzymes reconstituted
in vitro
The findings of Table 3 suggested that conditions of 2 mM
Mg2+ may better mimic the intracellular conditions than
10 mM. Since enzyme concentrations can be better defined
and equalized for in vitro reconstituted enzymes relative to
those purified from cells, we further tested in vitro
assembled E. coli RNase P holoenzymes under conditions
optimized for ribosome function (buffer KN; Materials and
Methods) at two different Mg2+ concentrations, 2 and 4.5
mM, and applying multiple turnover kinetics. The wild-
type holoenzyme cleaved ptRNAwt with identical rates at 2
and 4.5 mM Mg2+ (Table 4). The mutant enzymes showed
cleavage rates reduced by a factor of z2 at 4.5 mM Mg2+,
but this reduction amounted to 13- and 24-fold at 2 mM
Mg2+. The pronounced activity drop for the mutant
holoenzymes when [Mg2+] was only slightly lowered from
4.5 to 2 mM, which made it unlikely but did not exclude
that a defect in substrate affinity or holoenzyme stability
owing to the disruption of the CCA contact might be
responsible for this effect. To address the latter possibilities,
we tested processing activity under the same conditions but
at a fivefold higher holoenzyme concentration (Table 4,
lower part). If substrate binding or holoenzyme stability
were substantially impaired in reactions catalyzed by the
C292/3 mutant enzymes, one would have expected at least
a partial activity rescue for the mutant enzymes at this
higher enzyme concentration, which, however, was not
observed (Table 4).
We then considered the possibility that the C292/3
mutant RNAs have an altered affinity for the protein
subunit. This possibility was addressed by testing the
activity of holoenzymes reconstituted at increasing excess
amounts of RNase P protein over RNase P RNA. However,
the dependence of cleavage rate on RNase P protein
concentration showed a very similar saturation behavior
for the wild-type and mutant RNase P RNAs, since in all
cases activity leveled off above a protein:RNA ratio of 5:1
(Fig. 6). Likewise, the combination of RNase P RNA C293
and substrate ptRNAG74 resulted in essentially the same
activity profile as for wild-type RNase P RNA acting on
ptRNAwt (Fig. 6).
Analysis of RNase P RNA folding equilibria
At low Mg2+ concentrations, such as 2 mM, RNase P RNA
folding may be incomplete (Zarrinkar et al. 1996) and
particularly sensitive to structural alterations. To test the
possibility that differences in RNA folding might have
contributed to the in vivo and in vitro phenotypes of the
C292 and C293 mutant RNase P RNAs, we performed
a native PAGE analysis using the buffer systems applied in
our kinetic analyses. To our surprise, the folding equilibria
of wild-type, C292, and C293 RNase P RNA displayed clear
differences. Without a preincubation step (Fig. 7, lanes
1–3), two major bands appeared, which are interpreted as
folding intermediates (I1 and I2). For the wild-type RNA,
formation of the faster migrating intermediate was favored
relative to the two mutant RNAs.
FIGURE 5. Processing assays using RNase P holoenzymes (0.004 A260
units) partially purified from strain DW2 grown at 43°C and
complemented with E. coli (A) rnpBwt, (B) rnpBC292, and (C)
rnpBC293; trace amounts (<1 nM) of 59-endlabeled ptRNAGly (Fig.
1) and variants ptRNAG74 and ptRNAG75 with single point mutations
were used as substrates in buffer A containing 10 mM Mg2+; con
indicates trace amounts (<1 nM) of 59-endlabeled ptRNAGly in-
cubated with 5 mM E. coli RNase P RNA for 5 sec at 37°C in 50 mM
PIPES, 0.1 M Mg(OAc)2, and 1 M NH4OAc (pH 7.0 at 37°C). 59-
cleavage products are indicated on the left (canonical cleavage site at
+1/1, miscleavage at 1/2).
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In buffers A10 and KN4.5 combined with electrophoresis
at 10 mM Mg2+, a preincubation step at 37°C (Fig. 7, lanes
4–9, A10 and KN4.5) led to formation of a more com-
pacted species assumed to represent a native-like confor-
mation (termed N1), in accordance with a previous study
(Buck et al. 2005). This conformer was in equilibrium with
conformer I2, and the protein subunit
did not influence this folding equilib-
rium (Fig. 7, lanes 4–6 versus 7–9).
Here, the pattern was essentially identi-
cal for the wild-type and C293 mutant
RNA, whereas the C292 RNA was still in
equilibrium with the I1 conformer (Fig.
7, lanes 5,8). An additional temperature
step at 55°C led to almost com-
plete disappearance of the I1 conformer,
thus largely eliminating the difference
between the C292 and wild-type/C293
RNAs (Fig. 7, lanes 10–12).
In buffer KN2 combined with elec-
trophoresis at 2 mM Mg2+, a band
migrating slightly faster than the I2
conformer appeared upon preincuba-
tion at 37°C or 55°C/37°C (Fig. 7, best
visible in lane 1 versus lane 4, KN2),
which we have termed N2. This band
migrated closer to conformer I2 than
did conformer N1, but N2 appeared on
gels containing 2 mM Mg2+ and N1 on
those supplemented with 10 mM Mg2+.
Thus, it remains unclear if N1 and N2
represent identical or different con-
formers. Under KN2 conditions, all
three RNAs mainly populated the N2
fold, although gel migration of the C293
RNA was more smeary than that of
wild-type and C292 RNA, and some I1
conformer was still visible for the C292
RNA (Fig. 7, lanes 5,8). Upon addi-
tional preincubation at 55°C (Fig. 7,
lanes 10–12), the differences between
the wild-type and mutant RNAs were
essentially eliminated.
In buffer A2 combined with electro-
phoresis at 2 mM Mg2+, the N2 con-
former formed only partially with wild-
type RNA (Fig. 7, lanes 7,10, A2), and
apparently not at all with the mutant
RNAs. This suggests that the KN2 buffer
containing spermine and spermidine
favors formation of a native fold relative
to the A2 buffer. When the native PAGE
analysis was conducted with 59- instead
of 39-endlabeled RNase P RNA, results
were identical to those shown in Figure
7 (data not shown).
Although the structural differences between the con-
formers termed I1, I2, N1, and N2 remain to be character-
ized, the data in Figure 7 illustrate that the folding
equilibria of wild-type and C292/293 mutant RNase P
RNAs may differ depending on the particular buffer and
TABLE 3. Activity of mutant E. coli RNase P holoenzymes purified from strain DW2
RNase P RNA substrate [Mg2+] (mM) kobs (min
1) krel
Wild type ptRNA wild type 2 (15 6 0.03) 3 103
10 0.37 6 0.03 25
Wild type ptRNA G74 2 n.d.
10 0.21 6 0.02
Wild type ptRNA G75 2 n.d.
10 0.047 6 0.007
C292 ptRNA wild type 2 (17 6 3) 3 105
10 0.11 6 0.02 647
C292 ptRNA G74 2 n.d.
10 0.31 6 0.02
C292 ptRNA G75 2 (14.5 6 1.5) 3 104
10 0.14 6 0.004 97
C293 ptRNA wild type 2 (47 6 1) 3 105
10 0.38 6 0.04 809
C293 ptRNA G74 2 (17 6 1) 3 103
10 0.42 6 0.04 25
C293 ptRNA G75 2 n.d.
10 0.13 6 0.01
Processing was assayed in buffer A: 50 mM Tris-HCl, 100 mM NH4Cl, 6 mM DTT, 2 or 10
mM Mg(OAc)2 (pH 7.5), 37°C ; assays contained 0.004 A260 units of partially purified
holoenzymes and trace amounts (<1 nM) of 59-endlabeled substrates. n.d. indicates no
cleavage product detectable after 5 h of incubation; for further details, see Materials and
Methods; krel is the ratio of kobs values at 10 versus 2 mM Mg
2+; kobs values are based on at
least three independent experiments.
TABLE 4. Cleavage rates for E. coli wild-type and mutant RNase P holoenzymes at low
Mg2+ concentrations
RNase P RNA Enzyme concentration [Mg2+] kobs
activity
decrease
Wild type 10 nM P RNA/50 nM RnpA 4.5 11.2 6 0.7 —
C292 10 nM P RNA/50 nM RnpA 4.5 4.8 6 0.1 2.33
C293 10 nM P RNA/50 nM RnpA 4.5 6.0 6 0.6 1.87
Wild type 10 nM P RNA/50 nM RnpA 2.0 12.0 6 1.4 —
C292 10 nM P RNA/50 nM RnpA 2.0 0.5 6 0.06 24.0
C293 10 nM P RNA/50 nM RnpA 2.0 0.9 6 0.04 13.3
Wild type 50 nM P RNA/250 nM RnpA 2.0 21.9 6 2.5 —
C292 50 nM P RNA/250 nM RnpA 2.0 0.6 6 0.06 36.5
C293 50 nM P RNA/250 nM RnpA 2.0 0.6 6 0.07 36.5
Processing was assayed in buffer KN: 20 mM Hepes (pH 7.4, 37°C), 2 or 4.5 mMMg(OAc)2,
150 mM NH4OAc, 2 mM spermidine, 0.05 mM spermine, 4 mM b-mercaptoethanol, and
RNase P RNA (P RNA) and E. coli RNase P protein (RnpA) concentrations as indicated; the
ptRNAwt concentration was 100 nM; kobs is given as nmol substrate converted per nmol of
RNase P RNA per min; values are based on at least four independent experiments; activity
decrease is defined as the ratio of kobs obtained with wild-type versus mutant holoenzyme
under the respective conditions.
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preincubation conditions. It thus remains a possibility that
the folding properties of the two mutant RNase P RNAs
contributed to their defect in vivo. Unlike a recent study
(Buck et al. 2005), we did not observe major effects of the
protein component on RNase P RNA folding equilibria.
This may be related to the fact that stabilization of the RNA
fold by the protein was analyzed at <1 mM Mg2+ (Buck
et al. 2005).
DISCUSSION
We have assessed the role of the CCA interaction in vivo by
complementation analyses in two RNase P mutant strains.
In both strains (DW2 and BW), rnpBC292 and rnpBC293
alleles encoding P RNA variants with a disrupted CCA
interaction impaired or abrogated cell vitality (Tables 1, 2).
Particularly, the phenotypes in strain BW (Table 2)
demonstrate that base-pairing of G292 and G293 with
C74 and C75 of RNase P substrates is essential in vivo, and
its disruption is not compensated by the presence of the
RNase P protein subunit in holoenzyme complexes. The
BW strain also reconciles in vivo phenotype with kinetic
data obtained in vitro: RNase P RNA C292 was more
defective than the C293 variant in RNA alone (Busch et al.
2000) as well as in holoenzyme reactions using ptRNAwt as
the substrate (Table 4; Fig. 6). In agreement, concomitant
rnpA overexpression slightly improved viability of BW cells
expressing rnpBC293, but not rnpBC292 (Table 2B).
The molecular basis of increased viability owing to rnpA
overexpression in BW bacteria expressing rnpBC293 is not
fully clear yet. We think it likely that higher levels of RNase
P protein lead to increased steady-state levels of holoen-
zyme, either by shifting the equilibrium between free RNase
P subunits and holoenzyme toward holoenzyme or by
a mechanism that couples RNase P RNA and protein
expression, according to which increased RNase P protein
levels would entail a corresponding increase in the level of
the RNA subunit. The latter possibility has been discussed
in the context of a study on RNase P RNA metabolism in
E. coli (Kim et al. 2005). E. coli rnpB primary transcripts can
undergo either 39-end maturation or oligoadenylation
resulting in degradation. A knockout of poly(A) poly-
merase (pcnB), which blocks the degradation pathway, thus
increased the level of 39-precursor RNase P RNA. However,
this was not associated with a concomitant increase in the
level of mature RNase P RNA, leading to the proposal that
mature RNase P RNA may only stably accumulate when
complexed with its protein subunit (Kim et al. 2005).
Previous in vitro studies, focusing on the E. coli RNA-
alone reaction, have indicated that the CCA contact in-
creases substrate affinity (Hardt et al. 1995; Oh et al. 1998;
FIGURE 7. Analysis of folding equilibria for wild-type and C292/
C293 mutant E. coli RNase P RNAs by native PAGE. RNAs (50 fmol,
39 endlabeled) were preincubated either in buffer A containing 2 mM
(A2) or 10 mM (A10) Mg2+, or in buffer KN containing 2 mM (KN2)
or 4.5 mM (KN4.5) Mg2+ in a volume of 4–5 mL (for buffer A and KN
compositions, see Materials and Methods). (Lanes 1–3) No preincu-
bation (kept at 4°C); (lanes 4–6) preincubation of RNase P RNAs for
70 min at 37°C; (lanes 7–9) preincubation of RNase P RNAs for 55
min at 37°C, addition of 1 mL E. coli C5 protein (final concentration
50 nM) and further incubation for 15 min at 37°C; (lanes 10–12) as in
lanes 7–9, but preincubation of RNase P RNAs for 5 min at 55°C and
50 min 37°C. Samples were run on 11.25% polyacrylamide gels in 13
THE buffer supplemented with 100 mM NH4OAc and either 2 mM
(A2, KN2) or 10 mM (A10, KN4.5) MgCl2. The dashed lines confining
lanes 4–6 in panel A2 indicate that these lanes were taken from
a different gel.
FIGURE 6. Activity of wild-type and mutant holoenzymes recon-
stituted at different RNase P protein/RNA ratios and acting on
ptRNAwt; in addition, the activity profile for cleavage of ptRNAG74
by the C293 mutant holoenzyme is shown. Assay conditions were
20 mM Hepes (pH 7.4, 37°C), 2 mM Mg(OAc)2, 150 mM NH4OAc,
2 mM spermidine, 0.05 mM spermine, and 4 mM b-mercaptoethanol.
RNase P RNA concentration was kept constant at 10 nM, and
substrate concentrations were 100 nM; kobs is given as nmol substrate
converted per nmol of RNase P RNA per min; values are based on at
least four independent experiments. The inset is a magnification of the
lowest activity curves. P RNA, E. coli RNase P RNA.
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Busch et al. 2000) and supports selection of the correct
cleavage site (Kirsebom and Svärd 1994) as well as catalysis
(Oh et al. 1998; Busch et al. 2000; Brännvall et al. 2003).
Based on the data presented here, we infer that disruption
of the CCA interaction primarily causes a defect in the
binding of catalytically important Mg2+ under in vivo con-
ditions, based on the following argumentation: The activity
of mutant holoenzymes, either assembled in vivo (Table 3)
or in vitro (Table 4), was reduced only about two- to three-
fold relative to the wild-type holoenzyme at Mg2+ concen-
trations of 4.5–10 mM. However, a shift from 10 to 2 mM
Mg2+ reduced the rate of ptRNAwt cleavage 25-fold for the
wild-type holoenzyme, but 650- and 810-fold for the C292
and C293 mutant enzymes (Table 3). We are aware that
these rate differences may include contributions from
deviating folding properties of the mutant RNAs in buffer
A containing 2 mM Mg2+ (Fig. 7, panel A2). Since folding
equilibria of the wild-type and mutant RNase P RNAs were
much more similar in the KN buffer system (Fig. 7), the
results shown in Table 4 are thus likely to be most mea-
ningful. Nevertheless, a similar trend was observed: The
shift from 4.5 to 2.0 mM Mg2+ had a negligible effect on
cleavage by the wild-type enzyme but reduced the cleavage
rate 13- and 24-fold for the C293 and C292 mutant enzy-
mes, respectively (Table 4). Such pronounced effects on
cleavage rate in response to a shift from 4.5 to 2 mM Mg2+
are hard to explain by reasons other than a catalytic defect,
although contributions from decreased substrate affinity or
reduced affinity of the protein subunit cannot be excluded.
The latter possibility might be suggested by the finding that
the RNase P protein–RNA complex is stabilized by addition
of substrate in the Bacillus subtilis system (Day-Storms et al.
2004). To test the possibility of decreased substrate affinity
as the cause of low mutant enzyme activity at 2 mM Mg2+,
we increased the holoenzyme concentration by a factor of 5
(Table 4). However, this only increased the cleavage rate for
the wild-type enzyme but not for the mutant holoenzymes,
suggesting that decreased substrate affinity owing to dis-
ruption of the CCA contact is not a major cause for the
defect of the mutant holoenzymes. Likewise, in the RNase P
protein titration experiment (Fig. 6), activity essentially
saturated at a protein/RNA ratio of 5:1 for the wild-type
and mutant holoenzymes acting on ptRNAwt, thus pro-
viding no evidence for a major protein binding defect of the
mutant RNase P RNAs. Finally, this is in line with the fact
that we enriched the wild-type and mutant holoenzymes
with comparable yields from cell extracts by anion ex-
change chromatography (Table 3).
Another potential defect of the C292 and C293 mutant
RNAs in vivo could be aberrant folding leading to increased
degradation. However, the mutant enzymes partially puri-
fied from strain DW2 had similar activities as the wild-type
enzyme at 10 mM Mg2+ (Table 3). The same amounts of
extract based on absorption at 260 nm were used in these
processing assays, providing no evidence for altered RNase
P levels in bacteria expressing rnpBC292 and rnpBC293.
Likewise, wild-type-like maturation of plasmid-encoded
4.5S RNA by the C293 holoenzyme when base-pairing is
restored by a compensatory mutation in the 39 end of this
substrate (Fig. 4) argues against substantial degradation of
the mutant RNA.
On the basis of the data shown in Figure 7, it remains
a possibility that differences in the folding equilibria of the
wild-type versus mutant RNase P RNAs may have contrib-
uted to the mutant defects in vivo. The sensitivity of RNA
folding toward point mutations in loop L15 might also
provide a clue as to why the relative phenotypes of the
C292 and C293 mutant RNAs deviated in strain DW2
grown at 43°C compared with strain BW grown at 37°C. In
any case, the results of Figure 7 point to the sensitivity of
RNase P RNA folding to structural changes as small as
point mutations, particularly in low Mg2+ buffers. This
seems surprising in view of the highly dynamic nature of
the loop L15 region, as inferred from biochemical experi-
ments (Ciesiolka et al. 1994; Brännvall et al. 2003) and
evident in the crystal structure of Thermotoga maritima
RNase P RNA (Torres-Larios et al. 2005). On the other
hand, the dynamic nature of this region might increase its
propensity to interfere with folding of other structural
elements in the molecule. It will be interesting to see if
mutations in other RNase P RNA elements may be able to
exert similarly pronounced effects on folding at low Mg2+
concentrations.
The mutant holoenzymes cleaved the ptRNAwt substrate
predominantly at the canonical site (Fig. 5), which also
pertained to conditions of 2 mM Mg2+ (data not shown).
Only the C292 enzyme showed some increase in miscleav-
age (<5%) (Fig. 5). A low extent of miscleavage is
consistent with a previous study (Oh et al. 1998) analyzing
processing of B. subtilis ptRNAAsp with CCA mutations by
the E. coli wild-type holoenzyme. Oh et al. (1998) did not
observe aberrant cleavage under any set of conditions. The
ptRNAAsp, as the ptRNAGly used here, forms a canonical 7-
bp acceptor stem and lacks any potential for extended
acceptor stem base-pairing involving nucleotide 1/+73.
Miscleavage in vivo may yet be increased for some ptRNAs,
such as E. coli pSu1, which can form a C-1:G73 base pair
(Svärd et al. 1996). In vitro processing of the latter
substrate by reconstituted E. coli mutant holoenzymes gave
substantial miscleavage (27% for the C293, 55% for the
C292 variant) (Svärd et al. 1996). Thus, substantial aber-
rant cleavage of some cellular ptRNAs cannot be excluded
and might contribute to the mutant phenotypes, particu-
larly to that of rnpB292 in strain BW (Table 2).
Our results rationalize some previous in vitro data. For
example, E. coli RNase P-catalyzed cleavage of ptRNA
substrates with single nucleotide substitutions in CCA or
a CCA deletion suggested that the protein subunit sup-
presses the binding defect for catalytic Mg2+ (Oh et al.
1998). However, these experiments were done at 100 mM
tRNA 39-CCA contact with E. coli RNase P in vivo
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Mg2+, conditions that mask the defect, as illustrated by the
sharp activity differences we obtained at 2 versus 4.5 mM
Mg2+ (Table 4).
The P15/L15/P16 region is a central Me2+ binding
module in the active site of RNase P RNA (Kufel and
Kirsebom, 1998; Altman and Kirsebom 1999; Brännvall
et al. 2003). Binding of tRNA CCA ends suppresses, in vitro
and in vivo, prominent Pb2+ hydrolysis at two locations in
the L15 loop (sites III and V) and creates a new prominent
Pb2+ hydrolysis site (IVb) nearby (Ciesiolka et al. 1994;
Lindell et al. 2005). This indicates a structural rearrange-
ment of the P15/L15/P16 region upon formation of the
G292-C75 and G293-C74 intermolecular base pairs. The
P15/L15/P16 module is also predicted to undergo a sub-
stantial conformational rearrangement upon substrate
docking to the active site based on the recent crystal
structure of T. maritima RNase P RNA (Torres-Larios
et al. 2005). These observations combined with our findings
presented here accentuate the need to include enzyme–
substrate complexes in future structural analyses of RNase
P in order to understand the catalytic mechanism of this
ribozyme. Finally, our study suggests that activity tests of
bacterial RNase P holoenzymes are better performed at
Mg2+ concentrations <10 mM in order to be able to draw
conclusions that are biologically relevant.
MATERIALS AND METHODS
Bacteria
E. coli strains DW2/pDW160 (Waugh and Pace 1990) and BW
(this study) were used for complementation studies.
Complementation studies in strain DW2
For strain DW2/pDW160 (named DW2 in the following), com-
plementing rnpB genes were under control of the native E. coli
rnpB promoter and cloned in plasmid pSP64 as described (Hardt
and Hartmann 1996). The pSP64 derivative carrying E. coli rnpB
(pSP64 E. coli rnpB) served as template to introduce the point
mutations C292 or C293 by the site-directed DpnI method
according to the manual provided with the QuikChange XL
Site-Directed mutagenesis Kit (Stratagene), using the primer pair
59-GTA CTG AAC CCG CGT AGG CTG CTT GAGC and 59-GCT
CAA GCA GCC TAC GCG GGT TCA GTA C for the C292
mutation, and 59-GTA CTG AAC CCG GCT AGG CTG CTT
GAG C and 59-GCT CAA GCA GCC TAG CCG GGT TCA GTA C
for the C293 mutation (sites of mutation underlined). Recombinant
rnpB-coding pSP64 derivatives (10 ng) were introduced into DW2
by electroporation, using a Biorad GenePulser (1.8 kV; 5 msec,
50 mF, 100 V). After the pulse, 1 mL SOC medium (per liter: 20 g
peptone, 5 g yeast extract, 0.6 g NaCl, 0.17 g KCl, 20 mM glucose,
10 mM MgCl2, 10 mM MgSO4 at pH 7.5) was added, and cells
were shaken for 1 h at 30°C. Appropriate dilutions of cell suspen-
sions were plated on two LB agar plates, containing 100 mg/mL
ampicillin and 30 mg/mL chloramphenicol. The two sets of plates
were incubated in parallel at 30°C or 43°C, respectively, for 20–40 h.
Construction of rnpB mutant strain BW
Construction of strain BW followed the strategy described by
Roux et al. (2005). The so-called catRExBAD cassette (Fig. 2A)
was amplified from strain TG1 cat-AraC (Roux et al. 2005) using
primers 135 (59-CTT CAG CGT ATT GAC CAG CAT AGG TAC
GTT GGA CGA AGC ATT CCG CGG GCT TGC ATA ATG TGC
CTG TC; the underlined sequence is identical to the region
upstream of the E. coli rnpB promoter) and 134 (59-GTC TCC
CCC GAA GAG GAC GAC GAC GAA GCG GCG ACT GTC TGG
TCA GCT TCT ATG GAG AAA CAG TAG AGA GTT GC; the
underlined sequence is complementary to E. coli rnpB, corre-
sponding to nucleotides 1–50 of mature RNase P RNA). Initially,
we could isolate a recombinant strain, which had the 59 end of the
described catRExBAD cassette successfully recombined within the
59-rnpB promoter upstream region, but the 39 boundary was
altered. This strain was used to amplify a 326-bp fragment,
containing the 59 boundary, with primers 59-rnpB ext (59-CGA
TTG GTG TCG CAA ACG TGG) and 39-catRExBADveri (59-CGC
AAG GCG ACA AGG TGC TG). The E. coli rnpB gene was
amplified from E. coli K12 with primers 39-rnpB (59-AGG TGA
AAC TGA CCG ATA AGC C) and 59-rnpB (59-GAA GCT GAC
CAG ACA GTC GC). This rnpB fragment and the 326-bp
fragment with E. coli rnpB upstream sequence were combined
with the catRExBAD cassette by overlapping PCR. The resulting
PCR product was purified by agarose gel electrophoresis and
transformed into E. coli MG1655 bacteria carrying pKD46
(temperature-sensitive helper plasmid expressing the l red recom-
binase system) (Datsenko and Wanner 2000). For this purpose,
MG1655/pKD46 cells were grown at 28°C to an OD578 of 0.15,
followed by adjusting cultures to 10 mM arabinose to induce the l
red genes. Induced bacteria were then further grown to an OD578
of 0.6 and made electro-competent by 100-fold concentration and
three washing steps with ice-cold 10% glycerol. Electroporation
was performed with a Biorad Gene Pulser in 1-mm cuvettes (1.8
kV, 200 mF, 25 V) using 40 mL competent cells and 100–200 ng
purified PCR fragment. Pulsed cells were added to 1 mL SOC
medium supplemented with 10 mM arabinose, shaken for 1 h at
37°C and 900 rpm (Eppendorf Thermomixer comfort), and then
plated and incubated at 37°C on LB agar plates containing 25 mg/
mL chloramphenicol and 10 mM arabinose. Clones were analyzed
by PCR for correct 59 and 39 boundaries of the integrated
catRExBAD cassette and screened for ampicillin sensitivity to test
for loss of the temperature-sensitive helper plasmid pKD46. The
following primers were used to scrutinize correct insertion and
sequence of the integrated cassette:
primer 195 (39 AraC): 59-GCA TGG AAG CGA TTA ACG AGT
CGC
primer 194 (59 AraC): 59-GCG ACT CGT TAA TCG CTT CCA
TGC
primer 193 (59 E. coli rnpB promoter -58): 59-CAC GTA ATA
TCG CCG CGA CAC TGG
primer 158 (ext veri 39 rnpB): 59-GTG AAA CTG ACC GAT
AAG CCG C
primer 157 (59 ext veri rnpB): 59-TGC AGG AGC TGC GGG
TGG
primer 136 (RExBADveri 59): 59-CGG CGT CAC ACT TTG
CTA TGC C
primer 138 (catBADveri39): 59-CGC AAG GCG ACA AGG
TGC TG
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primer 49 (ecRevT3): 59-CTC ACT GGC TCA AGC AGC CT
primer 186 (Ecm1 up +350): 59-CAT TCG CGT CGC TTG
TGA TGT C
primer 183 (Ecm1+350 39): 59-CGC CGG AAC GGT TTA TTA
CGT AC
Integrity of the 59 boundary was checked by primer combina-
tions 157/138 and 138/186, and that of the 39 boundary by the
combinations 136/158 and 136/183; the absence of the native rnpB
promoter region was verified with the primer pair 193/49, which
produced a PCR fragment with genomic DNA from strain
MG1655 (the original strain), but not with DNA from correct
recombinants. Primer pairs 194/49 and 195/157 were used to
amplify the inserted cassette in roughly two halves (upstream and
downstream from araC) (see Fig. 2A) for verification by sequenc-
ing. Verified recombinant bacteria were named strain BW.
Construction of the low copy plasmid pACYC177
E. coli rnpB
To construct the derivatives of low copy plasmid pACYC177 en-
coding E. coli rnpBwt, rnpBC292, and rnpBC293, plasmids pSP64
E. coli rnpBwt, rnpBC292, or rnpBC293 were digested with NheI
and HindIII and the fragments carrying the different E. coli rnpB
alleles were inserted into pACYC177 cut with HindIII and NheI.
Complementation studies in strain BW
Derivatives of pACYC177 or pBR322 were introduced into strain
BW by electroporation as described for DW2 bacteria. However,
after the pulse, 1 mL SOC medium supplemented with 10 mM
arabinose was added and cells were incubated for 1 h at 37°C; cells
were twice pelleted by centrifugation and resuspended in 1 mL LB
medium. After the second washing step, cells were plated in
appropriate dilutions on LB agar plates containing 100 mg/mL
ampicillin, 25 mg/mL chloramphenicol, and either 10 mM
arabinose or 0.5% (w/v) glucose; 10 mg/mL tetracycline was
added if BW bacteria additionally harbored pBR322 derivatives
expressing E. coli rnpA or mutant 4.5S RNA; 1 mM IPTG was
further added for induction of plasmid-encoded rnpA. For growth
curve measurements, an overnight culture grown at 37°C in LB
medium containing 10 mM arabinose and respective antibiotics
(see above) was washed twice as described above, and then 50 mL
volumes of LB were inoculated to an OD578 of 0.05–0.1, either
supplemented with 10 mM arabinose or 0.5% glucose, followed by
growth curve monitoring at 37°C and 180 rpm (Incubator GFL
3033).
Construction of pBR322 derivatives for expression
of E. coli rnpA
To put E. coli rnpA under the control of the inducible pTrc-
promoter (Amann et al. 1988), the rnpA gene was amplified with
primers 59-AGA CCA TGG TTA AGC TCG CAT TTC C (in-
troducing an NcoI site, underlined, at the 59 end of rnpA) and 59-
ATC TCT AGA GTC AGG ACC CGC GAG CCA (introducing an
XbaI site, underlined, at the 39 end of rnpA). The E. coli rnpA
fragment was digested with NcoI and XbaI, and ligated into
pTrc99a (Amann et al. 1988) also linearized with NcoI and XbaI,
resulting in plasmid pTrc99a E. coli rnpA. This plasmid was
unsuitable for our complementation studies, because it encodes an
ampicillin resistance as plasmid pACYC177; also, the high copy
number of pTrc99a E. coli rnpA would have potentially increased
an imbalance between rnpA expression and that of rnpB genes
encoded on the low copy plasmid pACYC177. Therefore, we
amplified the rnpA gene including the pTrc promoter and the
rrnBt1t2 terminator from pTrc99a E. coli rnpA, using the primers
59-CAC ATG CAT GCA AAA AGG CCA TCC GTC AGG
(introducing an Mph1103 I site, underlined) and 59-ACA ATC
GAT TCA ATT GCG CCG ACA TCA TAA CGG (introducing
a MunI site, underlined) and ligated the fragment into pBR322 cut
with PstI and EcoRI. Digestion of pBR322 with PstI and EcoRI
(ends compatible with those of Mph11103 I and MunI, respec-
tively) destroyed the ampicillin resistance, only leaving the
tetracycline resistance.
Construction of pBR322 encoding mutated 4.5S RNAs
The chromosomal region of E. coli K12 harboring the bicistronic
transcription unit of ffs (encoding 4.5S RNA) and ybaA, including
the native promoter upstream of ffs as well as 100 bp downstream
from ybaA, was amplified and cloned into pBR322. During PCR
amplification, we already altered the terminal stem region by
inversion of 4 bp within the stem structure (Fig. 4A) for specific
reverse transcriptase priming in order to be able to distinguish
native from plasmid-encoded 4.5S RNA. The promoter region and
the 59 end of ffs were amplified using primers 59-ACA GAA TTC
AGC ATA ATC TGG AAA AAC GCC C (introducing an EcoRI
site, underlined) and 59-CCA ACA GAC GGG CCA TTG AGA
GCG TTG AGA ACC (59-terminal 4.5S RNA stem mutations in
bold); the 59 portion of the ffs gene was amplified with the primer
pair 59-CTC AAT GGC CCG TCT GTT GGT TCT CCC GCA AC
and 59-TCT CTG CAG TAA CGC GTC ATC TGC CTT GGC
(introducing MluI and PstI sites, underlined). These two frag-
ments were combined by overlap extension PCR, cut with EcoRI
and PstI, followed by ligation into pBR322 cut with the same
enzymes. The 39 half of ffs was amplified with primer pair 59-CTC
AAT GGC CCG TCT GTT GGT TCT CCC GCA AC and 59-TGG
CCC GCC TGC CAG CTA CAT CCC GG (39-terminal stem
mutations in bold). The chromosomal region spanning the 39-
terminal 19 bp of ffs and the ybaA cistron was amplified using
forward primer 59- GCT GGC AGG CGG GCC ACC CAT TTC
TGC CTC CCA CCG TTT C and reverse primer 59-CAC CTG
CAG CAA GGC ATT ACC GAA AGA AG. To further introduce
point mutations into the 39-CCC end of 4.5S RNA, the same PCR
reaction was performed except that 59- GCT GGC AGG CGG
GCC AGC CAT TTC TGC CTC CCA CCG TTT C (39-GCC‘‘76’’)
or 59- GCT GGC AGG CGG GCC ACG CAT TTC TGC CTC CCA
CCG TTT C (39-CGC‘‘76’’) was used as the forward primer. The
latter three amplification products were combined with the PCR
fragment harboring the 39 half of ffs (see above) by overlap
extension PCR. The resulting product was then cut with PstI/MluI
and ligated into the pBR322 derivative containing the promoter
and 59 half of ffs and cut with the same restriction enzymes.
In vitro transcription and 59 and 39 endlabeling
Runoff transcription with bacteriophage T7 RNA polymerase as
well as 59 and 39 endlabling were performed essentially as
described (Heide et al. 1999; Busch et al. 2000). The ptRNAGly
substrate (Fig. 1) was transcribed from plasmid pSBpt39HH
(Busch et al. 2000). Mutations G74 and G75 were introduced by
tRNA 39-CCA contact with E. coli RNase P in vivo
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the site-directed DpnI mutagenesis method according to the
manual provided with the QuikChange XL Site-Directed Muta-
genesis Kit (Stratagene); the primer pair for introduction of the
G74 mutation was 59-CCG TCT CCC GCT GCA GTC ACC GGA
TGT GC and 59-GCA CAT CCG GTG ACT GCA GCG GGA GAC
GG; for introduction of the G75 mutation, 59-CCG TCT CCC
GCT CGA GTC ACC GGA TGT GC and 59-GCA CAT CCG GTG
ACT CGA GCG GGA GAC GG were used (sites of mutation
underlined). Precursor 4.5S RNA was transcribed from a PCR
template under control of the T7 promoter; the PCR template was
amplified from plasmid pT7-4.5S (constructed and kindly pro-
vided by Norman R. Pace, University of Colorado, Boulder, CO),
a derivative of plasmid pT71 (Tabor and Richardson 1985)
encoding E. coli 4.5S RNA with 23 nt of its natural 59-flanking
sequence and 17 additional 59-flanking nucleotides; the 4.5S RNA
precursor transcript carried an additional AUA at the 39 end in
comparison with natural mature 4.5S RNA (Peck-Miller and
Altman 1991); PCR primers were 59-CCA GAA TTC GAA ATT
AAT ACG ACT CAC TAT A (T7 promoter underlined) and 59-
TAT GGG TGG GGG CCC TGC CAG CTA. E. coli RNase P RNA
and C292/3 mutant variants were synthesized as described pre-
viously (Busch et al. 2000).
RNA isolation for primer extension analysis
DW2 bacteria harboring derivatives of plasmid pSP64 were grown
at 30°C overnight in LB containing 100 mg/mL ampicillin and 30
mg/mL chloramphenicol. On the next morning, the same culture
was incubated for 2 h at 43°C, followed by inoculation of fresh
medium (100 or 250 mL) to a starting OD578 of 0.05–0.1, and
further cultivation at 43°C until cell density reached an OD578 of
z0.6. BW cells harboring pACYC177 and pBR322 derivatives
were grown overnight at 37°C in 3 mL LB medium supplemented
with 100 mg/mL ampicillin, 25 mg/mL chloramphenicol, 10 mM
arabinose, and 10 mg/mL tetracycline in the case of cells harboring
pBR322 derivatives. Cells were then used to inoculate 50 mL of the
same medium to a starting OD578 of 0.05–0.1, followed by
incubation at 37°C. At an OD578 of z0.5, cells were centrifuged
for 5 min at 5000 rpm and washed once with 20 mL LB to remove
residual arabinose. Cells were resuspended in 100 mL LB supple-
mented with antibiotics and 0.5% glucose and incubated for
another 3 h at 37°C and 180 rpm. Total cellular RNA from strains
DW2 and BW was isolated by the TRIzol method (Invitrogen)
according to the protocol provided by the manufacturer. After
concentration by ethanol precipitation, RNA was further digested
with DNase I (Turbo DNase, Ambion) followed by phenol/
chloroform (1:1) and chloroform extractions (Busch et al. 2000)
and ethanol precipitation in the presence of 0.12 M NaOAc (pH
5.0). RNA was dissolved in double-distilled H2O, and concen-
trations were measured in H2O at 260 nm (1 A260 unit = 40 mg).
Primer extension assays
Primer extension assays were performed with total cellular RNA
and primers specific to E. coli RNase P RNA (59-CTC ACT GGC
TCA AGC AGC CT), E. coli wild-type 4.5S RNA (59-GGA GAA
CCA ACA GAG CCC), or E. coli mutant 4.5S RNA (59-GGA GAA
CCA ACA GAC GGG). Primer annealing was conducted in 75
mM KCl and 68 mM Tris-HCl (pH 8.3) for z60 min applying
a linear temperature gradient from 90°C to 55°C. Reverse trans-
cription was then performed at 55°C using ThermoScript reverse
transcriptase (Invitrogen) according to the manufacturer’s in-
structions. Nucleotide (dNTP) concentrations in primer extension
assays were 0.5 mM each. For primer extension assays to verify
expression of E. coli rnpBC292/293 mutant alleles, dGTP was
replaced with ddGTP. For the size marker in Figure 3, lane 1, 0.5
mM dGTP and 0.5 mM ddGTP were used.
Partial purification of RNase P from E. coli cells
DW2 cells grown at 43°C as described (see RNA Isolation for
Primer Extension Analysis) and resuspended in z4 mL buffer A
(60 mM NH4Cl, 10 mM Mg[OAc]2, 6 mM DTT, 50 mM Tris-HCl
at pH 7.2–7.5) per 600 mg cell pellet were lysed by sonication
(Branson Sonifier 250, output 20, duty cycle 30%–40%, 10 min on
ice), followed by centrifugation for 45 min at 4°C and 10,000g. For
the preparation of DEAE fractions, the supernatant was loaded
onto a DEAE fast flow Sepharose column (Aekta basic, Pharma-
cia). Elution was performed by applying a continuous NH4Cl
gradient from 60–550 mM NH4Cl. Active fractions eluted at
z300–400 mM NH4Cl.
Preparation of recombinant RNase P protein
E. coli RNase P protein carrying an N-terminal His-tag (His-
tagged peptide leader: MRGSHHHHHHGS, encoded in plasmid
pQE-30 in E. coli JM109) was expressed essentially as described
(Rivera-León et al. 1995). Cell cultures (LB broth containing 100
mg/mL ampicillin) were grown to an OD578 of 0.6, and IPTG was
added to a final concentration 1 mM. Cells were harvested after
3 h (OD578 z2.5) by centrifugation for 10 min at 5000 rpm at
4°C. The following steps were performed at 4°C or on ice, and all
buffers contained 40 mg/mL of the protease inhibitor phenyl-
methylsulfonyl fluoride (PMSF). Cells were then resuspended in
10–15 mL sonication buffer SB (50 mM Tris-HCl at pH 8.0, 0.3 M
NaCl, 0.1% triton X-100, 1 M NH4Cl). After sonication (Branson
Sonifier 250, output 20, duty cycle 50%, 15 min on ice), the
sample was centrifuged for 30 min (4°C, 14,500g), and the
supernatant was mixed with Ni-NTA agarose (400 mL for 2 L of
cell culture), which had been prewashed twice with 10 mL SB
buffer. The sample was incubated for 1–2 h at 4°C under gentle
mixing or rotating. The Ni-NTA agarose slurry was washed three
times (centrifugation–resuspension cycles; centrifugation at 4°C
and 8500 rpm in a desktop centrifuge) with ice-cold washing
buffer (30 mM imidazol, 50 mM Tris-HCl at pH 8.0, 8 M urea,
0.1% triton X-100). The RNase P protein started to precipitate
during this procedure; therefore, the supernatant after each
washing step was removed carefully to avoid release of protein
aggregates from the matrix. The protein was then eluted with 500
mL elution buffer (50 mM Tris-HCl at pH 7.0, 10% glycerol, 7 M
urea, 20 mM EDTA, 0.3 M imidazol) for 45 min at 4°C under
gentle shaking. Eluates were dialyzed twice for 1 h and sub-
sequently overnight against volumes of 500 mL dialysis buffer (50
mM Tris-HCl at pH 7.0, 0.1 M NaCl, 10% glycerol; dialysis bags:
Roth, molecular weight cut off 12–14 kDa); during dialysis,
a white precipitate forms. The content of the dialysis bags was
transferred to a 2-mL Eppendorf tube and centrifuged for 20 min
at 4°C and 12,000 rpm in a desktop centrifuge. The supernatant
contained RNase P protein devoid of any RNase P RNA
contamination, whereas the pellet included traces of RNase P
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RNA and was therefore discarded. All purification steps were
monitored by 17% SDS-PAGE to assess the purity and concen-
tration of RNase P proteins.
Processing assays
For RNase P-catalyzed processing of T. thermophilus ptRNAGly
(ptRNAwt), or G74 or G75 variants thereof, active DEAE fractions
(0.25–1.0 mL; equal amounts [0.004 A260 units] based on A260
measurements) were incubated in buffer A (2 or 10 mM
Mg[OAc]2, 6 mM DTT, 50 mM Tris-HCl at pH 7.5) containing
100 mM NH4Cl for 10 min at 37°C in a volume of 16 mL. Trace
amounts (<1 nM) of the 59-endlabeled ptRNAGly substrate were
preincubated under the same conditions for 5 min at 55°C and 25
min at 37°C. Processing reactions were started by combining
enzyme and substrate solutions (final volume, 20 mL) and assayed
at 37°C. The Mg(OAc)2 concentration was raised to 100 mM in
control reactions with E. coli RNase P RNA alone. Buffer KN [20
mM Hepes-KOH at pH 7.4, 2 or 4.5 mM Mg(OAc)2, 150 mM
NH4OAc, 2 mM spermidine, 0.05 mM spermine, and 4 mM
b-mercaptoethanol] (Dinos et al. 2004), optimized for functional
analyses of E. coli ribosomes, was used to closely mimic physio-
logical conditions. In vitro reconstitution of RNase P holoenzymes
was performed as follows: RNase P RNAs were incubated in buffer
KN for 5 min at 55°C and 50 min at 37°C, after which RNase P
protein was added, followed by another 5 min at 37°C before
addition of substrate.
Folding analysis by native PAGE
We incubated 50 fmol of E. coli wild-type or C292/C293 mutant
RNase P RNA, including trace amounts of 59- or 39-endlabeled
material of the same RNA, in buffer A (100 mM NH4Cl, 6 mM
DTT, 50 mM Tris-HCl at pH 7.2–7.5, and 2 or 10 mM
Mg[OAc]2) or buffer KN (20 mM Hepes-KOH at pH 7.4, 150
mM NH4OAc, 2 mM spermidine, 0.05 mM spermine, 4 mM
b-mercaptoethanol, and 2 or 4.5 mM Mg[OAc]2) in a volume of
5 mL or 4 mL if protein was added thereafter. Buffer conditions
were the same as those used for the kinetic experiments. RNase P
RNAs were either kept at 4°C (no preincubation) or preincubated
for 55 min at 37°C, or 5 min at 55°C followed by 50 min at 37°C.
We also tested a preincubation protocol starting with 2 min at
85°C, followed by 5 min at 55°C and 50 min at 37°C. The results
were, however, identical to those obtained with 5 min at 55°C plus
50 min at 37°C. For samples including the protein subunit, 1 mL
of E. coli C5 protein was added (final concentration, 50 nM) after
the preincubation step. All samples, except for those kept at 4°C,
were then incubated for another 15 min at 37°C and finally
adjusted to room temperature. Immediately before gel loading, 1
volume of loading buffer (10% [v/v] glycerol, 2 mM MgCl2,
xylene cyanol, bromphenol blue) was added. The nondenaturing
11.25% (v/v) polyacrylamide gels (thickness <1 mm) contained 66
mM Hepes, 33 mM Tris (pH 7.4), and 0.1 mM EDTA (13 THE),
supplemented with 100 mM NH4OAc and 2 or 10 mM MgCl2.
Gels were run at 180–250 V until xylene cyanol had migrated 11.5
cm from the top. The gel temperature was controlled not to
exceed 15°C. The RNA bands were visualized with a Bio-Imaging
Analyzer (FLA 3000–2R, Fujifilm). Results were the same for 59-
and 39-endlabeled RNase P RNAs. End homogeneity of RNase P
RNAs was checked by denaturing PAGE. Results for RNase P
RNAs preincubated in buffer KN containing 4.5 mM MgCl2 were
the same if gels were run in the presence of 4.5 or 10 mM MgCl2
(data not shown).
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4.3 In vivo role of bacterial type B RNase P interaction with tRNA 
3’-CCA 
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ABSTRACT (178 words)  
It has been unclear if catalysis by bacterial type B RNase P involves a specific interaction 
with  p(recursor)tRNA 3’-CCA termini. We show that point mutations at two guanosines in 
loop L15 result in growth inhibition, which correlates with an enzyme defect at low Mg2+. For 
Bacillus subtilis RNase P, an isosteric C259-G74 bp fully and a C258-G75 bp slightly rescued 
catalytic proficiency, demonstrating Watson-Crick base-pairing to tRNA 3’-CCA and 
emphasizing the importance of G258 identity. We infer the defect of the mutant enzymes to 
be primarily on the level of recruitment of catalytically relevant Mg2+, with a possible 
contribution from altered RNA folding. Cell viability of bacteria expressing mutant RNase P 
RNAs could be (partially) restored by RNase P protein overexpression due to increasing 
cellular RNase P levels. Finally, we demonstrate that B. subtilis RNase P is able to cleave 
CCA-less ptRNAs in vivo. We conclude that the in vivo phenotype upon disruption of the 
CCA interaction is either due to a global deceleration in ptRNA maturation kinetics or severe 
blockage of 5’-maturation for a subset of ptRNAs. 
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Introduction 
Ribonuclease P (RNase P), an essential ribonucleoprotein enzyme, catalyzes the 5’-end 
maturation of tRNAs in all Kingdoms of life (Hartmann & Hartmann, 2003; Evans et al, 
2006). The bacterial RNase P holoenzyme consists of an RNA subunit (P RNA) of approx. 
400 nt and a small basic protein (P protein) of approx. 13 kDa. In vitro, RNA subunits of 
bacterial RNase P enzymes are catalytically active in the absence of the protein subunit 
(Guerrrier-Takada et al, 1983), but the protein is essential in vivo (Schedl et al, 1974; 
Gößringer et al, 2006). Two major architectural subtypes of bacterial RNase P RNA are 
known, namely type A (for ancestral, prototype Escherichia coli) and type B (represented by 
Bacillus subtilis; Hall & Brown 2001), each containing several secondary structural elements 
not present in the other. A major difference between type A and B structures is the L15 loop 
of the catalytic domain, which is an internal one in type A but apical in type B (Fig. 1 A-C). 
For E. coli P RNA, the gold standard of type A structures, it has been shown that two 
conserved G residues (G293 and G292) in the loop L15 form Watson-Crick base pairs with 
the two cytosines of tRNA 3’-CCA (C74 and C75) termini (Kirsebom & Svärd, 1994). Several 
in vitro studies, focussing on the E. coli RNA-alone reaction, have indicated that the CCA 
contact increases substrate affinity (Hardt et al, 1995; Oh et al, 1998; Busch et al, 2000), 
supports selection of the correct cleavage site (Kirsebom & Svärd, 1994; Svärd et al, 1996) as 
well as catalysis (Oh et al, 1998; Busch et al, 2000; Brännvall et al, 2003). Recently, 
disruption of this interaction was demonstrated to have lethal consequences for E. coli cells 
(Wegscheid & Hartmann, 2006). Analysis of processing of 4.5S RNA, a non-tRNA substrate 
of RNase P in E. coli, revealed that restoration of base-pairing by an isosteric C293-G74 base 
pair, but not a C292-G75 pair, fully restored catalytic performance in vivo. In vitro activity 
assays of wild-type (wt) and C292/C293 mutant RNase P holoenzymes at magnesium 
concentrations as low as 2 mM Mg2+ suggested a defect in the recruitment of catalytically 
active Mg2+ ions as the major cause for the lethal phentotype of the mutant P RNAs 
(Wegscheid & Hartmann, 2006) 
Type B RNAs, represented by the one from B. subtilis, also encode a conserved GG 
dinucleotide in their L15 loop (Fig. 1 A and B, G258/G259 in B. subtilis and G238/G239 in S. 
aureus P RNA). Comparative photo-crosslinking analyses of E. coli and B. subtilis P RNAs 
using tRNAs with photoreactive groups at the 3’-end of tRNA have indicated that the tRNA 
3’-CCA terminus is positioned close to the L15 loop region in enzyme-substrate complexes of 
both P RNA types (Oh & Pace, 1994). G258 and G259 of B. subtilis P RNA were also shown 
to be protected from kethoxal modification upon complexation with mature tRNA or 
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precursor tRNA (ptRNA), and this protection was reduced with ptRNA lacking 3’-CCA 
(LaGrandeur et al, 1994). Potential base pairing to 3’-CCA was addressed by a mutational 
analysis using another type B RNA from Mycoplasma hyopneumoniae and testing for 
cleavage site selection (Svärd et al, 1996). With E. coli P RNA, C292/C293 mutations 
substantially increased miscleavage of the wt substrate, while compensatory mutations in the 
substrate 3’-CCA restored cleavage at the canonical site. However, with M. hyopneumoniae P 
RNA, corresponding mutations in L15 (C272/C273) had little effect on the proportion of 
miscleaved wt substrate. Also, a compensatory G74 mutation in the substrate did not 
significantly increase the fraction of substrate cleaved at the canonical site by the C273 
mutant ribozyme; the proportion of canonical cleavage, relative to the wt substrate, was even 
decreased when the C272 mutant ribozyme acted on the substrate providing the compensatory 
mutation (3’-CG75A; Svärd et al, 1996).  
These findings did not provide clear evidence as to whether the two G residues in L15 of 
type B RNAs indeed form specific interactions with tRNA 3’-CCA. The physiological role of 
a CCA contact was also questionable based on the observation that B. subtilis P RNA, in 
contrast to its E. coli counterpart, is rather insensitive to 3’-CCA mutations in terms of 
cleavage site selection (Wegscheid et al, 2006). Furthermore, the P protein of B. subtilis 
RNase P increases the affinity for the ptRNA more than 104-fold (Kurz et al, 1998; Buck et 
al, 2005), making a substantial contribution of the CCA interaction to substrate affinity rather 
unlikely. This notion is supported by the finding that E. coli and B. subtilis RNase P 
holoenzymes remained unaffected by the absence of CCA in terms of their Km values in 
multiple turnover reactions (Oh & Pace, 1994).   
In B. subtilis, one-third of tRNAs (27 out of 86) do not have the CCA motif encoded by 
their genes. RNase Z removes the 3’-trailers of such CCA-less tRNA primary transcripts by 
endonucleolytic cleavage 3’ of the discriminator nucleotide as a prerequisite for CCA addition 
by tRNA nucleotidyl-transferase (CCase); RNase Z is blocked by the presence of 3’-CCA and 
thus acts specifically on tRNA transcripts lacking the 3’-CCA motif (Pellegrini et al, 2003). 
However, B. subtilis RNase Z activity inversely correlates with the length of tRNA 5’ 
extensions, which led to the proposal that processing by RNase P precedes that of RNase Z in 
the case of tRNA transcripts with larger 5’ extensions (> 30 nt; Pellegrini et al, 2003). This 
would suggest that 3’-CCA in the substrate is dispensable for processing by B. subtilis RNase 
P in vivo.  
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Fig. 1. Secondary structure illustrations of (A) Bacillus subtilis (type B), (B) Staphylococcus aureus (type B) and 
(C) Escherichia coli (type A) RNase P RNA according to Tsai et al (2003). The two G residues in L15, known 
(E. coli) or suspected (B. subtilis, S. aureus) to be involved in the interaction with tRNA 3’-CCA, are highlighted 
by grey ovals. (D) Proposed interaction of a canonical bacterial ptRNA (Thermus thermophilus ptRNAGly) with 
the L15 loop of B. subtilis RNase P RNA. Highlighted nucleotides mark the sites of mutation investigated in this 
study. The arrow indicates the canonical RNase P cleavage site (between nucleotide –1 and +1). 
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 In vitro evidence for the CCA interaction with type B RNase P RNAs has been at best 
suggestive, and nothing is known on the role of the CCA interaction in vivo in type B bacteria. 
Here we have addressed this question in vitro as well as in vivo by mutational analysis. We 
demonstrate that B. subtilis rnpBC258 and rnpBC259 mutant alleles carrying a G to C258 or 
G to C259 mutation in the L15 loop are lethal in B. subtilis rnpB mutant strain SSB318. We 
also included a second type B RNA from Staphylococcus aureus in our complementation 
study. Corresponding S. aureus rnpBC238 and rnpBC239 mutant alleles also decreased cell 
viability of B. subtilis SSB318 cells, although not being lethal. Even so the growth defects 
could be rescued by parallel overexpression of the B. subtilis P protein, we found no evidence 
for defects of the mutant P RNAs in P protein or substrate binding. Processing assays with in 
vitro assembled holoenzymes then revealed a defect of the C258/C259 mutant enzymes at free 
Mg2+ concentrations assumed to be close to those in vivo. We infer that the defect is primarily 
on the level of recruitment of catalytically important Mg2+. An isosteric C259-G74 base pair 
fully, but a C258-G75 pair only slightly, restored catalytic performance in vitro, demonstrating 
that the identity of G258, but not G259, is crucial for enzyme function. This is surprisingly 
similar to what has been found for E. coli RNase P (Wegscheid & Hartmann, 2006). Native 
PAGE experiments further unveiled some differences in RNA folding equilibria between the 
wt and mutant P RNAs at low [Mg2+], which remained unaffected by the presence of the P 
protein. This raises the possibility that a contribution from non-native folding might have 
exacerbated the defect of the C258/C259 mutant RNAs in vivo. We finally addressed the 
question if RNase P can act on CCA-less ptRNAs in B. subtilis by 5’-RACE experiments in 
B. subtilis strain SSB320, an RNase Z-deficient strain that accumulates ptRNA transcripts 
with CCA-less 3’-extensions. We could demonstrate 5’-end maturation of such ptRNAs by 
RNase P in vivo, documenting that the presence of 3’-CCA is not an absolute requirement for 
catalysis by B. subtilis RNase P in vivo. We propose that the lethal phenotype of the B. 
subtilis rnpBC258 and rnpBC259 mutant alleles results from a global deterioration of tRNA 
5’-end maturation.  
Results 
Complementation studies in B. subtilis 
The B. subtilis rnpB mutant strain SSB318 was employed to investigate the in vivo role of the 
tRNA 3’-CCA interaction with type B RNase P RNA. In strain SSB318, the chromosomal 
rnpB gene is under the control of an IPTG-inducible Pspac promoter (Wegscheid et al, 2006). 
In the absence of IPTG, cell growth depends on the presence of a functional rnpB gene 
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provided on a plasmid (pHY300 derivatives in our study). Complementation was assayed for 
B. subtilis wt RNase P RNA (rnpBwt), and the C258 or C259 mutant alleles (rnpBC258, 
rnpBC259). B. subtilis rnpBwt rescued cell growth in the absence of IPTG, as expected, no 
matter if expressed from the native B. subtilis rnpB promoter (Wegscheid et al, 2006) or the 
xylose-inducible Pxyl promoter (Table I). Even basal expression of Pxyl under repressed 
conditions (medium supplemented with glucose instead of xylose) sufficed for cell growth. In 
contrast, with complementation plasmids encoding B. subtilis rnpBC258 and rnpBC259 under 
control of the native B. subtilis rnpB promoter we could not get a single transformant in strain 
SSB318. For the rnpBC259 allele, some transformants were obtained after substituting the 
native for the Pxyl promoter; for some clones, we could indeed confirm the mutant rnpBC259 
genotype by sequencing, whereas others turned out to be revertants to rnpBwt. However, cells 
expressing rnpBC259 had a lethal phenotype in the absence of IPTG, which may explain our 
severe cloning problems. We could not isolate a single colony expressing C258 P RNA.  
Simultaneous overexpression of B. subtilis rnpA 
We recently reported increased viability of E. coli cells expressing the E. coli rnpBC293 
mutant gene when simultaneously overexpressing the homologous P protein (Wegscheid & 
Hartmann, 2006). We thus transformed B. subtilis SSB318 cells with plasmids encoding the 
B. subtilis rnpA gene and either rnpBwt, rnpBC258 or rnpBC259, with both rnpA and rnpB 
alleles under control of the xylose promoter. In the presence of xylose, conditions which fully 
induced rnpA expression, cell viability in the absence of IPTG could indeed be substantially 
improved for cells expressing rnpBC258 or rnpBC259. For rnpBC259 basal expression of the 
Pxyl promoter (in the absence of xylose) supported (retarded) growth of SSB318 cells in the 
absence of IPTG. In contrast, for rnpBC258 full induction of the xylose promoter was 
required, with growth somewhat retarded relative to rnpBwt and rnpBC259 (Table I). In 
conclusion, P protein overexpression restored growth of bacteria expressing the rnpB mutant 
alleles, but fitness did not fully reach that of bacteria expressing the rnpBwt allele. To 
demonstrate that rnpA-related rescue effects were due to higher expression levels of the B. 
subtilis P protein and not unspecific effects caused by the presence of additional copies of the 
rnpA gene, we also tested complementation with an rnpA gene with two stop codons in its 5’-
portion (rnpA-stop) and thus directing expression of a truncated inactive protein (Gößringer et 
al, 2006). However, rnpA-stop expression was unable to restore growth of SSB318 bacteria 
expressing rnpBC258 or rnpBC259 (Table I). Our findings document a lethal phenotype 
associated with point mutations at G258 and G259 in L15 of B. subtilis P RNA. However, 
concomitant overexpression of the P protein (also verified by Western blot analysis, data not 
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shown) largely rescued cell viability. Furthermore, the phenotype was more severe for the 
C258 than C259 mutant RNA. 
Table I. Homologous complementation of B. subtilis RNase P mutant strain SSB318 by B. 
subtilis rnpB  wild-type and mutant alleles. 
rnpB variants in pHY300                + IPTG          - IPTG          aldose 
B. subtilis PBs rnpB rnpBwt                         + + +  + + +              none 
B. subtilis PBs rnpB rnpBC258            1)              none 
B. subtilis PBs rnpB rnpBC259   1)              none 
 
B. subtilis Pxyl rnpBwt    + + +  + + + 2)    xylose or glucose 
B. subtilis Pxyl rnpBC258    1)     
B. subtilis Pxyl rnpBC259    + + +  -          xylose 
 
B. subtilis Pxyl rnpBwt + Pxyl rnpA   + + +  + + +          xylose 
B. subtilis Pxyl rnpBC258 + Pxyl rnpA  + + +  + + (+)3)       xylose 
B. subtilis Pxyl rnpBC259 + Pxyl rnpA  + + +  + + +4)          xylose 
 
B. subtilis Pxyl rnpBwt + Pxyl rnpA-stop  + + +  + + +          xylose 
B. subtilis Pxyl rnpBC258 + Pxyl rnpA-stop  + + +5)  -          xylose 
B. subtilis Pxyl rnpBC259 + Pxyl rnpA-stop  + + +  -          xylose 
 
 
pHY300      + + +  -          xylose 
pHY300 + Pxyl rnpA     + + +  -          xylose 
pHY300 + Pxyl rnpA-stop    + + +  -          xylose 
 
Growth of mutant strain SSB318 transformed with wild-type B. subtilis rnpB (rnpBwt) and 
mutant (rnpBC258, rnpBC259) alleles on plasmid pHY300; promoter types: PBs rnpB, 
native B. subtilis rnpB promoter; Pxyl, inducible xylose promoter; B. subtilis rnpA was 
ovrexpressed in parallel from the same plasmid as indicated; rnpA-stop designates the B. 
subtilis rnpA gene with two stop codons in the 5’-coding region. Cell growth was analyzed 
on LB plates (with appropriate antibiotics) in the presence (1 mM) or absence of IPTG; an 
aldose (xylose or glucose) at 2% (w/v) was added where indicated.  
+ + +: growth with equal numbers of colonies on +/- IPTG plates 
-: no growth; 
1) unable to construct 
2) basal expression of xylose promoter (in the presence of 2% glucose) is sufficient for cell 
growth in the absence of IPTG 
3) basal expression of xylose promoter (in the presence of 2% glucose) is not sufficient for 
cell growth in the absence of IPTG 
4) basal expression of xylose promoter (in the presence of 2% glucose) is sufficient for cell 
growth in the absence of IPTG, but retarded cell growth 
5) here we succeeded to isolate a single colony with a stable rnpBC258 genotype; however, 
the majority of SSB318 cells transformed with rnpBC258 were still unstable and tended to 
form revertants to the wild-type, most likely by recombination with the chromosomal 
rnpBwt gene. 
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Complementation with S. aureus P RNA  
The heterologous type B RNA from S. aureus was included in our complementation analysis 
to be able to generalize the findings on the CCA interaction of type B RNase P RNAs. 
Residues G238 and G239 in S. aureus P RNA correspond to G258 and G259 of B. subtilis P 
RNA (Fig. 1 A, B). Whereas S. aureus rnpBwt was fully functional in B. subtilis, the mutant 
alleles rnpBC238/C239 resulted in a significant growth defect, though not being lethal (Table 
II). This was also confirmed by monitoring growth curves in liquid culture (Fig. 2). Here, the 
phenotypes of rnpBC238 and rnpBC239 were very similar, thus deviating from the 
observation that the B. subtilis rnpBC258 allele was more deleterious than rnpBC259 (see 
above). The growth defect caused by the S. aureus rnpBC238/239 mutant alleles could be 
completely rescued by overexpression of B. subtilis rnpA (Table II). 
Table II. Heterologous complementation of B. subtilis RNase P mutant strain SSB318 by  
S. aureus (type B) and E. coli (type A) rnpB alleles 
rnpB variants in pHY300                                   + IPTG           - IPTG     aldose 
S. aureus PBs rnpB rnpBwt + + +  + + +       none 
S. aureus PBs rnpB rnpBC238 + + +  +       none 
S. aureus PBs rnpB rnpBC239 + + +  +       none 
 
S. aureus PBs rnpB rnpBwt + Pxyl rnpA + + +  + + +      xylose 
S. aureus PBs rnpB rnpBC238 + Pxyl rnpA + + +  + + +      xylose 
S. aureus PBs rnpB rnpBC239 + Pxyl rnpA + + +  + + +      xylose 
 
E. coli PEc rnpB rnpBwt + + +  + + +       none 
E. coli PEc rnpB rnpBC292 +  -       none 
E. coli PEc rnpB rnpBC293 +  -       none 
 
E. coli PEc rnpB rnpBwt + Pxyl rnpA n. d.     
E. coli PEc rnpB rnpBC292 + Pxyl rnpA +  -      xylose 
E. coli PEc rnpB rnpBC293 + Pxyl rnpA +  -      xylose 
 
Growth of mutant strain SSB318 transformed with wild-type S. aureus or E. coli rnpB 
(rnpBwt) and respective mutant alleles on plasmid pHY300; promoter types: PBs rnpB, 
native B. subtilis rnpB promoter; PEc rnpB, native E. coli rnpB promoter; Pxyl, inducible 
xylose promoter; B. subtilis rnpA was overexpressed in parallel from the same plasmid as 
indicated. Cell growth was analyzed on LB plates in the presence (1 mM) or absence of 
IPTG; the aldose xylose was added to 2% (w/v) for pHY300 derivatives encoding B. 
subtilis rnpA.  
+ + +: growth with equal numbers of colonies on +/- IPTG plates; 
+: retarded cell growth; 
-: no growth; 
n. d.: not determined 
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Fig. 2. Growth curves of SSB318 cells complemented with pHY300 derivatives, carrying S. aureus rnpBwt 
(squares) or rnpBC238 (triangles with apex at the top) or rnpBC239 (triangles with apex at the bottom) mutant 
alleles in the presence (+) or absence (-) of IPTG. 
Complementation with E. coli P RNA  
We have recently shown that E. coli P RNA (type A) can functionally replace B. subtilis P 
RNA (type B) in vivo, no matter if E. coli rnpBwt was expressed from its own native or from 
the B. subtilis rnpB promoter, and even a single copy of E. coli rnpBwt integrated into the 
amyE site of the B. subtilis chromosome was sufficient for cell viability (Wegscheid et al, 
2006). Since the S. aureus rnpBC238/C239 mutant alleles displayed a somewhat relaxed 
phenotype relative to B. subtilis rnpBC258/C259, we also tested function of the corresponding 
E. coli mutant alleles (rnpBC292/C293) in the B. subtilis background of strain SSB318. The 
E. coli mutant alleles were unable to restore growth under non-permissive conditions (without 
IPTG, Table II). Even when co-expressed with B. subtilis rnpB (in the presence of IPTG), the 
E. coli rnpBC292/C293 mutant alleles impaired cell growth; overexpression of B. subtilis 
rnpA did not rescue this growth defect (Table II). 
Overexpression of rnpA – effect on P RNA levels 
The complementation results shown in Tables I and II revealed a rescue of the B. subtilis 
rnpBC258/C259 and S. aureus rnpBC238/C239 mutant phenotypes when the B. subtilis P 
protein was overexpressed. One explanation may be that higher levels of P protein increase 
the steady-state level of RNase P holoenzyme, thereby alleviating the processing defects 
caused by the mutant alleles. To test this possibility, we used SSB318 bacteria expressing the 
S. aureus rnpB mutant alleles, because here the rescue by rnpA overexpression was complete, 
reducing the risk that spontaneous mutant bacteria might have dominated the liquid cultures. 
PCR reactions were limited to 12 cycles, because under these conditions product yields were 
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essentially linearly dependent on RNA template amounts (Fig. 3, lanes 25 to 30). The mRNA 
for ribosomal protein S18 served as the control to be able to assess experimental fluctuations. 
Overexpression of rnpA caused, on average, a 3 to 5-fold increase in the yields for the P 
RNA-specific product, independent of whether bacteria expressed the rnpBwt or one of the 
mutant alleles (Fig. 3, lanes 1 to 12). No increase in the S18-specific RT-PCR product was 
observed upon overexpression of rnpA (lanes 13 to 24). The results demonstrate that 
overexpression of the P protein results in an increase in the steady-state levels of P RNA, and 
thus RNase P holoenzyme, which explains the observed rescue effects (Tables I and II). The 
data of Fig. 3 further document indistinguishable cellular levels of wt and mutant P RNAs.   
 
 
Fig. 3. Radioactive reverse transcription PCR (RT-PCR) analysis of strain SSB318 complemented with S. aureus 
rnpBwt or rnpBC238/C239. PCR products were analyzed on a 10% polyacrylamide/8 M urea gel. Lanes 1–30: 
total RNA from SSB318 complemented with S. aureus rnpBwt (lanes 1-4 and 13-16), rnpBC238 (lanes 5-8, 17-
20 and 25-30) or rnpBC239 (lanes 9-12 and 21-24) grown at 37°C in the absence of IPTG and in the presence of 
2% xylose (w/v); amounts of total RNA were 200 ng in lanes 1 –24, 26 and 29, 100 ng in lanes 25 and 28, and 
400 ng in lanes 27 and 30. Pxyl rnpA: + or – indicates the presence (+) or absence (–) of an xylose-inducible, 
plasmid-encoded B. subtilis rnpA gene. Lanes 1-12 and 25-27: primers specific for S. aureus rnpB (rnpB); lanes 
13-24 and 28-30: primers specific for the mRNA encoding B. subtilis ribosomal protein S18 (S18). AMV: + or – 
indicates the presence (+) or absence (-) of reverse transcriptase. For details on RT-PCR, see Material and 
methods. Lanes 25-30 document that the amount of RT-PCR product was sensitive to RNA template 
concentration. 
In vitro processing of ptRNA by B. subtilis RNase P holoenzymes  
To shed light on the nature of the in vivo defect of the C258/C259 mutant P RNAs, we 
analyzed the kinetics of B. subtilis RNase P holoenzymes assembled in vitro. The rescue 
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effect observed when the B. subtilis P protein was overexpressed (Table I) pointed, among 
several possibilities, to a protein affinity defect of the mutant P RNAs. We thus tested the 
activity of B. subtilis wt and mutant holoenzymes as a function of P protein concentration. We 
applied a buffer system which has been used for B. subtilis holoenzyme kinetics, containing 
10 mM MgCl2, 50 mM Mes pH 6.0 and 100 mM KCl (referred to as buffer F10; adapted from 
Day-Storms et al, 2004). Surprisingly, activities were indistinguishable for the wt and mutant 
holoenzymes at all P protein concentrations (Fig. 4). We then decreased the Mg2+ 
concentration to 2 mM (buffer F2), assuming that this more closely mimics the intracellular 
free Mg2+-concentration (1 to 2 mM; Alatossava et al, 1985). Now the two mutant 
holoenzymes were more than 100-fold less active than wt RNase P (Table III) when acting on 
ptRNAGly with a canonical 3’-CCA terminus (termed ptRNAwt in the following). However, 
combining the C259 enzyme with the mutant substrate ptRNAG74 restoring base pairing to 
the C259 P RNA resulted in cleavage efficiencies as good as for the wt enzyme acting on 
ptRNAwt, whereas the wt and C258 enzymes cleaved ptRNAG74 at a more than 100-fold 
decreased rate. Likewise, the C258 mutant enzyme performed best with ptRNAG75 as the 
substrate, but the improvement in catalytic performance was only two- to sixfold (Table III). 
This indicated that nt 258 and 259 indeed form Watson-Crick base pairs with C75 and C74 of 
tRNA 3’-CCA. However, only the isosteric C259-G74 pair, but not the C258-G75 pair, in the 
E-S complex fully restored activity to that of wt complexes, illustrating the importance of 
G258 identity. A rescue of activity in the presence of the ptRNAG74 substrate was also 
observed for chimeric holoenzymes composed of the B. subtilis P protein and the S. aureus 
C239 mutant P RNA partially purified from SSB318 bacteria (data not shown).  
Fig. 4. Activity of in vitro reconstituted B. subtilis 
RNase P wt and mutant holoenzymes as a function of 
protein concentration; kobs is given as nmol substrate 
converted per nmol of RNase P RNA per min; assay 
conditions: 50 mM Mes pH 6.1, 100 mM KCl and 10 
mM MgCl2; P RNA concentration was 20 nM, protein 
concentration as indicated and ptRNAwt concentration 
was 200 nM, including trace amounts (< 1 nM) of 5’-
endlabeled substrate. 
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Table III. Cleavage activity of B. subtilis wt and mutant RNase P holoenzymes acting on 
ptRNAGly wt and G74 or G75 mutant substrates at 2 mM Mg2+ and two protein 
concentrations 
RNase P RNA ptRNAGly B. subtilis P protein [nM] kobs 
B. subtilis wt wt 37.5 0.18 ± 0.03 
B. subtilis wt wt 62.5 0.20 ± 0.04 
B. subtilis C258 wt 37.5 (4.0 ± 2.0)  x 10-4 
B. subtilis C258 wt 62.5 (1.3 ± 0.5) x 10-3 
B. subtilis C259 wt 37.5 (5.0 ± 1.0) x 10-4 
B. subtilis C259 wt 62.5 (1.6 ± 0.9) x 10-3 
    
B. subtilis wt G74 37.5 (7.0 ± 1.0) x 10-4 
B. subtilis wt G74 62.5 (1.3 ± 0.3) x 10-3 
B. subtilis C258 G74 37.5 (2.0 ± 1.0) x 10-4 
B. subtilis C258 G74 62.5 (3.0 ± 2.0) x 10-4 
B. subtilis C259 G74 37.5 0.15 ± 0.006 
B. subtilis C259 G74 62.5 0.30 ± 0.04 
    
B. subtilis wt G75 37.5 (3.0 ± 1.0) x 10-4 
B. subtilis wt G75 62.5 (4.0 ± 3.0) x 10-4 
B. subtilis C258 G75 37.5 (6.0 ± 4.0) x 10-4 
B. subtilis C258 G75 62.5 (1.8 ± 0.2) x 10-3 
B. subtilis C259 G75 37.5 (1.0 ± 1.0) x 10-4 
B. subtilis C259 G75 62.5 (5.0 ± 0.1) x 10-4 
Assay conditions: 50 mM Mes pH 6.1, 100 mM KCl, 2 mM MgCl2; RNase P RNA 
concentration was 20 nM, protein concentration as indicated and substrate concentration was 
200 nM. 5’-endlabelled substrate was added in trace amounts. (< 1 nM). 
kobs is given in nmol substrate converted per nmol of RNase P RNA per min; values are based 
on at least three independent experiments. 
 
In vitro processing of ptRNA by B. subtilis holoenzymes in a buffer assumed to closely 
mimic intracellular conditions 
We recently showed (Wegscheid & Hartmann, 2006) for E. coli P RNA that folding of the 
catalytic RNA may be incomplete in low Mg2+ buffers, such as buffer F2 (Table III). 
However, a buffer originally optimized for ribosome function (buffer KN, see Material and 
methods) and containing spermine and spermidine appears to favour formation of a native 
fold (Wegscheid & Hartmann, 2006). We therefore tested activity of the wt and mutant B. 
subtilis holoenzymes in buffer KN at two different Mg2+ concentrations (2 and 4.5 mM, KN2 
and KN4.5). At 4.5 mM Mg2+, the mutant enzymes cleaved ptRNAwt at almost identical 
(C259) or two-fold reduced (C258) rates. However, at 2 mM Mg2+, the rate dropped two-fold 
for the wt enzyme, but about six-fold for the mutant enzymes (Table IV). Thus, the minor 
shift from 4.5 to 2 mM Mg2+ exacerbated the defect of the mutant enzymes. To analyze if the 
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defect was on the level of substrate affinity or holoenzyme stability, we tested processing 
activity under the same conditions but at a fivefold higher holoenzyme concentration (Table 
IV). If substrate binding or holoenzyme stability were the major defect in reactions catalyzed 
by the C258/C259 mutant enzymes at 2 mM Mg2+, one would have expected that the ratio of 
cleavage rates for the mutant enzyme versus wt enzymes (krel, Table IV) improves at the 
higher enzyme concentration. However, krel values rather showed a tendency to further 
decrease (0.12 and 0.13 versus 0.17 and 0.30, Table IV).  
 We also analyzed cleavage of ptRNAG74 by the C259 mutant enzyme in buffer KN2 
(Table IV). This fully restored the cleavage rate to that of the wt enzyme, in line with the 
results of Table III.  
Table IV. Cleavage rates for B. subtilis holoenzymes and E. coli hybrid holoenzymes 
reconstituted in vitro at low Mg2+ concentrations. 
RNase P RNA  ptRNAGly enzyme concentration             [Mg2+]           kobs            krel 
B. subtilis wt     wt  10 nM P RNA/37 nM RnpA       4.5            9.7 ± 0.08        1.0 
B. subtilis C258     wt  10 nM P RNA/37 nM RnpA       4.5            4.4 ± 0.08        0.45 
B. subtilis C259     wt  10 nM P RNA/37 nM RnpA       4.5            8.4 ± 0.12        0.87 
 
B. subtilis wt      wt  10 nM P RNA/37 nM RnpA       2.0            4.6 ± 0.09        1.0 
B. subtilis C258     wt  10 nM P RNA/37 nM RnpA       2.0            0.8 ± 0.01        0.17 
B. subtilis C259     wt  10 nM P RNA/37 nM RnpA       2.0            1.4 ± 0.03        0.30 
 
B. subtilis C259     G74 10 nM P RNA/37 nM RnpA       2.0            6.5 ± 0.08 
 
B. subtilis wt     wt  50 nM P RNA/185 nM RnpA      2.0            47.7 ± 0.68      1.0 
B. subtilis C258     wt  50 nM P RNA/185 nM RnpA      2.0            5.9 ± 0.07        0.12 
B. subtilis C259     wt  50 nM P RNA/185 nM RnpA      2.0            6.2 ± 0.05        0.13 
 
E. coli wt     wt  10 nM P RNA/37 nM RnpA       4.5            6.3 ± 0.02        1.0 
E. coli C292     wt  10 nM P RNA/37 nM RnpA       4.5            2.3 ± 0.05        0.37 
E. coli C293     wt  10 nM P RNA/37 nM RnpA       4.5            7.3 ± 0.08        1.16 
 
E. coli wt      wt  10 nM P RNA/37 nM RnpA       2.0            7.3 ± 0.12        1.0 
E. coli C292     wt  10 nM P RNA/37 nM RnpA       2.0            0.5 ± 0.01        0.07 
E. coli C293     wt  10 nM P RNA/37 nM RnpA       2.0            1.9 ± 0.02        0.26  
 
E. coli wt      wt  50 nM P RNA/185 nM RnpA      2.0            26.8 ± 0.41      1.0 
E. coli C292     wt  50 nM P RNA/185 nM RnpA      2.0            1.5 ± 0.03        0.06 
E. coli C293     wt  50 nM P RNA/185 nM RnpA      2.0            3.5 ± 0.02        0.13 
Assay conditions: 20 mM Hepes pH 7.4 (37°C), 2 mM Mg(OAc)2, 150 mM NH4OAc,  2 
mM spermidine, 0.05 mM spermine, 4 mM ß-mercaptoethanol, and RNase P RNA (P 
RNA) and B. subtilis RNase P protein (RnpA) concentrations as indicated; the substrate 
concentration was 100 nM; 5’-endlabeled substrate was added in trace amounts (< 1 nM); 
kobs is given in nmol substrate converted per nmol of RNase P RNA per min; krel is defined 
as the ratio of kobs obtained with wt versus mutant holoenzymes under the respective 
conditions; values are based on at least four independent experiments. 
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Activity assays performed with chimeric holoenzymes consisting of E. coli P RNA (wt 
and the corresponding C292/C293 mutant variants) and the B. subtilis P protein (Table IV, 
lower part) resulted in essentially the same findings as with the B. subtilis holoenzymes.  
Analysis of B. subtilis P RNA folding equilibria 
Incomplete (Zarrinkar et al, 1996) or aberrant folding might have contributed to the in vivo 
and in vitro phenotypes of the C258/C259 mutant P RNAs. To address this possibility, we 
performed a native PAGE analysis using the same buffer systems as for the kinetic 
experiments. When 5’-endlabeled wt, C258 or C259 P RNAs were directly loaded (after gel 
purification and ethanol precipitation) onto the native gel without a preincubation step, two 
major bands appeared under all four tested conditions, which we termed I1 and I2 (Fig. 5, 
lanes 1 to 3). We are aware that I1 and I2 observed in the presence of 2 mM Mg2+ during 
electrophoresis may not necessarily identical to those seen at 10 mM Mg2+. Upon RNA 
preincubation at 37°C or 55°/37°C, a faster migrating conformer appeared, which we assign 
to the native fold (termed “N”), in line with a previous study (Buck et al, 2005). Remarkably, 
in buffer F2 (2 mM Mg2+) the N conformer was much less populated in the case of the two 
mutant relative to the wt P RNA (Fig. 5, lanes 4 to 12). This difference was largely reduced in 
buffer KN2. When preincubation was performed in buffers F10 and KN4.5 (10 and 4.5 mM 
Mg2+, respectively) and native PAGE at 10 mM Mg2+, differences between wt and mutant P 
RNAs were further mitigated (lanes 4 to 9) and essentially abolished after preincubation at 
55°/37°C (lanes 10 to 12). No substantial changes were seen when the P protein was added to 
the preincubation mix (lanes 4 to 6 versus 7 to 9). In summary, our native PAGE analysis 
indicates that (i) the KN2 buffer containing spermine and spermidine favours formation of the 
native fold relative to the F2 buffer and (ii) folding differences can be considered insignificant 
in buffer KN4.5 combined with our standard preincubation (5 min at 55°C, 50 min at 37°C). 
The data in Fig. 5 illustrate that the folding equilibria of wt and C258/C259 mutant RNase P 
RNAs are sensitive to the buffer conditions. As we do not know the exact ionic milieu in vivo, 
we cannot rule out a contribution from impaired folding of the mutant P RNAs to their growth 
defect in vivo. 
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Fig. 5. Analysis of folding equilibria for wt and C258/C259 mutant B. subtilis P RNAs by native PAGE. RNAs 
(50 fmol, 5’-endlabeled) were preincubated either in buffer F containing 2 mM (F2) or 10 mM (F10) Mg2+, or in 
buffer KN containing 2 mM (KN2) or 4.5 mM (KN4.5) Mg2+ in a volume of 4 to 5 µl (for buffer F and KN 
compositions, see Materials and methods). Lanes 1 to 3: no preincubation (kept at 4°C); lanes 4 to 6: 
preincubation of P RNAs for 70 min at 37°C; lanes 7 to 9: preincubation of P RNAs for 55 min at 37°C, addition 
of 1 µl B. subtilis C5 protein (final concentration 37 nM) and further incubation for 15 min at 37°C; lanes 10 to 
12: as in lanes 7 to 9, but preincubation of P RNAs for 5 min at 55°C and 50 min 37°C. Samples were run on 
11.25% polyacrylamide gels in 1 x THE buffer supplemented with 100 mM NH4OAc and either 2 mM (F2, 
KN2) or 10 mM (F10, KN4.5) MgCl2. 
Processing of CCA-less ptRNAs  
Since in B. subtilis only one-third of the tRNA genes encode 3’-CCA, the question arose 
whether tRNA transcripts not encoding 3’-CCA have to undergo 3’-end processing and CCA 
addition before 5’-end maturation by RNase P can occur. To address this question, we 
constructed ptRNAGly 3’-variants, either encoding 3’-U73CCAAUA, 3’-U73UAAAUA or 
lacking CCA (3’-U73 = ∆CCA); UAA instead of CCA downstream of the discriminator base 
is found in the native B. subtilis trnI-Thr precursor (Pellegrini et al, 2003). Processing of these 
substrates by wt RNase P was tested in buffer KN, either at 4.5 or 2 mM Mg2+, and for 2 mM 
Mg2+ also at a fivefold higher P RNA and P protein concentration (Table V). The obtained 
pattern of relative cleavage rates roughly mirror-imaged what we had seen with the 
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C258/C259 mutant enzymes in Table IV: (i) the cleavage rate was reduced for the UAA and 
∆CCA variant, and the ratio of rates for the canonical versus mutant substrates worsened 
when the Mg2+ concentration was reduced from 4.5 to 2 mM; (ii) a fivefold increase in P 
RNA and protein concentration did not improve performance of the mutant substrates relative 
to the canonical ptRNA (Table V), suggesting that substrate affinity is not the major cause of 
the defect.  
Table V. Cleavage rates for the B. subtilis wild-type RNase P holoenzyme acting on 
substrates with 3’-end variations at low magnesium concentrations  
ptRNAGly  enzyme concentration           [Mg2+]  kobs            krel 
U73  10 nM P RNA/37 nM RnpA     4.5        4.3 ± 0.08  0.36 
U73UAAAUA 10 nM P RNA/37 nM RnpA     4.5        3.3 ± 0.05  0.28 
U73CCAAUA  10 nM P RNA/37 nM RnpA     4.5        11.8 ± 0.15 1.0 
 
U73  10 nM P RNA/37 nM RnpA     2.0            1.5 ± 0.01 0.21 
U73UAAAUA  10 nM P RNA/37 nM RnpA     2.0            1.4 ± 0.01 0.2 
U73CCAAUA 10 nM P RNA/37 nM RnpA     2.0            7.0 ± 0.04 1.0 
 
U73  50 nM P RNA/185 nM RnpA    2.0            9.5 ± 0.08 0.19 
U73UAAAUA  50 nM P RNA/185 nM RnpA    2.0            6.8 ± 0.03 0.13 
U73CCAAUA 50 nM P RNA/185 nM RnpA    2.0            49.9 ± 0.43 1.0 
For assay conditions, see legend to Table IV; krel is defined as the ratio of kobs obtained 
with the wild-type (U73CCAAUA) versus mutant holoenzymes under the respective 
conditions; values are based on at least four independent experiments. 
5’-RACE experiment of trnSL-Ala1 and trnSL-Val2 
That processing of the CCA-less substrates was impaired but not abolished in vitro posed the 
question whether this residual activity would suffice for RNase P cleavage of CCA-less tRNA 
transcripts in vivo. This was addressed by 5’-RACE experiments. For this purpose, we used 
strain SSB320, in which the chromosomal rnz gene (encoding RNase Z) is put under control 
of the IPTG-inducible Pspac promoter. In B. subtilis, RNase Z is involved in the 3’-maturation 
of tRNAs lacking an encoded CCA motif. We chose two native tRNAs (trnSL-Ala1 and 
trnSL-Val2), which were shown to accumulate as 3’-precursors in strain SSB320 when rnz 
expression is decreased (Pellegrini et al, 2003). Both tRNAs are transcribed from 
monocistronic genes with 5’-precursor segments of 8 nt (trnSL-Ala1) and 38 nt (trnSL-Val2), 
and both are 3’-extended by their transcription terminator stem-loop (Pellegrini et al, 2003; 
Fig. 6 A). To ensure that only tRNAs with unprocessed 3’-ends were reverse transcribed 
during 5’-RACE, we designed a primer for reverse transcription whose 5’-proximal and 
central portion targeted the 3’-precursor sequences (Fig. 6 A). A control experiment 
performed with RNA from SSB320 cells grown in the presence of IPTG (normal RNase Z 
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expression) did not produce RT-PCR products (Fig. 6 B, lane 3) demonstrating that our 
primer was specific for the 3’-extended tRNA. Using total RNA isolated from SSB320 cells 
grown in the absence of IPTG we obtained a prominent 5’-RACE product, roughly 
corresponding to the size of 5’-matured 3’-precursor tRNA (ca. 110 nt). An additional TAP 
treatment (to permit RT-PCR of primary transcripts with 5’-triphosphates) did not give rise to 
an additional RT-PCR product. In the case of inefficient 5’-end processing we would have 
expected a product extended by 8 nt for tRNAAla1. To ensure that RT-PCR products 
corresponded to 5’-matured transcripts, we cloned the main band of Fig. 6 B (lanes 1 and 2) 
into the pCR2.1-TOPO vector (Invitrogen) and sequenced 5 clones (the same was done for 
trnSL-Val2; data not shown). Sequencing analysis confirmed mature 5’-ends for both tRNAs. 
This was surprising as we would have anticipated, based on our kinetic in vitro results (Table 
V), to detect at least some 3’-extended tRNA with immature 5’-ends. These results clearly 
demonstrated that RNase P processing can proceed in vivo in the absence of the CCA 
interaction. 
 
Fig. 6. 5’-RACE analysis of B. subtilis trnSL-Ala1 3’-precursors. (A) Secondary structure of tRNAAla1 primary 
transcripts with RNase P and Z cleavage sites indicated; the arrow aligning the transcription terminator and 
tRNA acceptor stem indicates the position of the primer (“180”) used for the 5’-RACE experiment; the boxed 
nucleotides (U74, A75) are replaced with the two C residues after RNase Z cleavage and CCA addition. (B) 
Analysis of 5’-RACE RT-PCR products on a native 10% PAA gel; M, 10 bp ladder as size marker; the arrow on 
the right indicates the main amplification product, its size was expected for a processing intermediate with a 
mature 5’-end but carrying the entire 3’-extension as in the primary tRNA transcripts; this type of product was 
only detected in total RNA isolated from SSB320 cells grown in the absence of IPTG (lanes 1 and 2), but not in 
the presence of IPTG (lane 3); before reverse transcription, total RNA preparations were treated (+ TAP) or not 
treated (- TAP) with Tobacco Acid Pyrophosphatase (TAP). 
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Discussion 
We have investigated the tRNA 3’-CCA interaction with type B RNase P under in vivo 
conditions, using B. subtilis mutant strain SSB318 which has the chromosomal rnpB gene 
under control of the IPTG-inducible Pspac promoter (Wegscheid et al, 2006). For this purpose, 
complementation efficiencies of B. subtilis rnpBwt relative to rnpBC258/C259 mutant alleles 
were analyzed in strain SSB318 under non-permissive conditions (- IPTG). The latter two 
rnpB alleles encode P RNAs with point mutations of the nucleotides thought to be involved in 
the CCA interaction. We also tested the functionality of S. aureus rnpBwt and its mutant 
rnpBC238/C239 alleles (as representatives of an heterologous type B P RNA) and that of the 
corresponding E. coli rnpBC292/C293 alleles representing type A RNase P RNA architecture. 
All rnpBwt alleles (B. subtilis, S. aureus, E. coli) were functional in SSB318 bacteria (Tables 
I and II). However, the mutant P RNA alleles resulted either in a severe growth defect (S. 
aureus rnpBC238/C239) or were even lethal (B. subtilis rnpBC258/C259 and E. coli 
rnpBC292/C293; Tables I and II). Until now, it was assumed that the CCA interaction is not 
critical in reactions catalyzed by type B RNase P holoenzymes (Oh & Pace, 1994). We could 
confirm this assumption when activity was tested at 10 mM Mg2+ (Fig. 4), which has been the 
“gold standard” magnesium concentration for the testing of bacterial holoenzymes. However, 
here we demonstrate, for the first time, that the CCA interaction is (i) essential for vitality of 
B. subtilis cells (Tables I and II), (ii) critical in vitro at low Mg2+ concentrations, such as 2 
mM, assumed to better mimic the cellular milieu than 10 mM Mg2+, and (iii) that tRNA 3’-
CCA ends form Watson-Crick base pairs with two guanosines in the L15 loop of type B 
RNase P RNAs. As found for E. coli (Wegscheid & Hartmann, 2006), an isosteric C259-G74 
base pair, but not a C258-G75 pair, fully restored catalytic performance of type B RNase P to 
that of the wt holoenzyme acting on ptRNA with a canonical 3’-CCA end (Tables III and IV). 
This indicates that the nucleotide identity of the 5’-proximal G residue (G258 in B. subtilis 
and G239 in S. aureus) is critical for catalytic performance, as observed for G292 of E. coli P 
RNA (Wegscheid & Hartmann, 2006).  
Overexpression of the B. subtilis P protein partially or fully (for S. aureus rnpB alleles) 
restored cell viability of bacteria expressing the mutant rnpB alleles (Tables I and II). This 
phenomenon was also observed for the E. coli C293 mutant RNA in its natural host 
(Wegscheid & Hartmann, 2006), but was not scrutinized there. Here we could attribute the 
rescue to a severalfold increase in  P RNA steady-state levels owing to P protein 
overexpression (Fig. 3). In a study on P RNA metabolism in E. coli (Kim et al, 2005) it was 
found that rnpB primary transcripts can undergo either 3’-end maturation or oligoadenylation 
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resulting in degradation. A knockout of poly(A) polymerase (pcnB) blocked the degradation 
pathway and consequently increased the level of 3’-precursor P RNA. Since these higher 
levels of 3’-precursor P RNA did not entail an increase in the level of mature P RNA, the 
authors proposed that mature RNase P RNA may only stably accumulate when complexed 
with its protein subunit (Kim et al, 2005). Our results in Fig. 3 are consistent with this model, 
suggesting similar mechanisms to regulate cellular RNase P levels in E. coli and B. subtilis 
despite fundamentally different P RNA maturation pathways in the two organisms. Whereas 
the mature 5’- and 3’-ends of B. subtilis P RNA appear to be generated by autolytic 
processing of precursor P RNA (Loria & Pan, 2000), E. coli P RNA primary transcripts are 
mainly intitiated at the mature 5’-end, and 3’-precursor sequences are removed by RNase E 
followed by exonucleolytic removal of 1 or 2 additional nucleotides (Lundberg & Altman, 
1995; Kim et al, 2005).  
 The defect of the B. subtilis C258/C259 mutant RNAs was exacerbated when the Mg2+ 
concentration was lowered from 4.5 to 2 mM (Table IV). This correlated with some reduction 
in the fraction of correctly folded P RNA molecules relative to the wt P RNA (Fig. 5). The 
latter result was surprising as the L15 loop is thought to be quite unstructured in free P RNA 
based on its low resolution in the X-ray structure of B. stearothermophilus P RNA (Kazantsev 
et al, 2005). Although the effect of the two point mutations in L15 on P RNA folding is not 
understood, this underscores the high sensitivity of P RNA folding to minimal structural 
changes at low Mg2+ concentrations.   
 In E. coli, the P15/L15/P16 region has been identified as a central Me2+ binding module in 
the active site of P RNA (Kufel & Kirsebom, 1998; Brännvall et al, 2003). There are sites of 
prominent Pb2+ hydrolysis at two locations in the internal L15 loop (sites III and V). Binding 
of tRNA 3’-CCA suppresses, in vitro and in vivo, Pb2+ hydrolysis at sites III and V and 
creates a new prominent Pb2+ hydrolysis site (IVb) nearby (Ciesiolka et al, 1994; Lindell et 
al, 2005). This indicates a structural rearrangement of the P15/L15/P16 region upon formation 
of the G292-C75 and G293-C74 intermolecular base pairs. For B. subtilis P RNA, four out of 
nine prominent Pb2+ hydrolysis sites could also be assigned to its apical L15 loop (Zito et al, 
1993). This combined with the phenotypic similarities of C258/C259 (C292/C293 in E. coli) 
mutations in the E. coli and B. subtilis systems supports the notion that the L15 loop is a 
central Me2+ binding module in the active site of type B RNAs as well. We thus attribute the 
deterioration in catalytic performance of the C258/C259 mutant RNAs upon a decrease of 
[Mg2+] from 4.5 to 2 mM primarily to a defect in binding of catalytically relevant Mg2+ to the 
L15 loop in E-S complexes. As in the E. coli system (Wegscheid & Hartmann, 2006), the 
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identity of G258 plays a key role in this process, as an isosteric C258-G75 base pair only 
marginally rescued the defect (Table III). One could argue here that the low activity of mutant 
holoenzymes at 2 mM Mg2+ may have its major cause in the folding defect (Fig. 5). However, 
the results of Table V argue against this view. When we deleted or mutated 3’-CCA in the 
substrate and assayed processing by wt RNase P, results were essentially a mirror image of 
what we had seen with the mutant enzymes acting on ptRNAwt (cf. Table IV and V): catalytic 
performance of the mutant substrates relative to ptRNAwt deteriorated upon a reduction of 
[Mg2+] from 4.5 to 2 mM, and the relative catalytic performance of the mutant substrates did 
not improve at a fivefold P RNA and protein concentration.  
 Despite the striking similarities in the CCA interaction of type A and B RNase P RNAs, 
some details are different. For E. coli RNase P, a fivefold increase in P RNA and protein 
concentrations did not increase the cleavage rate for the C293 and C292 mutant enzymes at 2 
mM Mg2+ (Wegscheid & Hartmann, 2006). In contrast, the B. subtilis C258 and C259 mutant 
enzymes cleaved ptRNAwt at a 4 to 7-fold higher rate when P RNA and protein 
concentrations were increased fivefold (Table IV). Activity of the chimeric holoenzymes 
consisting of E. coli P RNA and B. subtilis P protein also improved 2 to 3-fold at the higher 
RNase P subunit levels. This may point to a specific effect exerted by the B. subtilis P protein, 
which could be related to the finding that binding of P protein and substrate to P RNA are 
cooperative in the B. subtilis system (Day-Storms et al, 2004). 
 Also, the in vivo phenotype of the C258 (B. subtilis) and C238 (S. aureus) type B mutant P 
RNAs could be partially (B. subtilis; Table I) or fully (S. aureus; Table II) rescued by 
overexpression of B. subtilis rnpA. However, in the E. coli system essentially no rescue was 
observed for the corresponding E. coli C292 mutant P RNA upon overexpression of E. coli 
rnpA (Wegscheid & Hartmann, 2006). In this context, the better complementation efficiency 
of mutant S. aureus versus B. subtilis rnpB alleles was surprising. The S. aureus 
rnpBC238/C239 alleles even enabled some cell growth at normal P protein levels (Table II). 
This might be related to the general problem associated with studies of homologous genes 
especially in B. subtilis which is known to possess an efficient recombination machinery. The 
presence of homologous rnpB genes carrying point mutations may interfere with genetic 
repair systems, especially if the mutant genes cause stress to the cells. This may also explain 
our severe problems to transform SSB318 bacteria with the homologous B. subtilis 
rnpBC258/C259 alleles. Finally, the severeness of phenotypes for B. subtilis rnpBC258 and E. 
coli rnpBC292 exceeded that of B. subtilis rnpBC259 and E. coli rnpBC293, respectively 
(Tables I and II; Wegscheid & Hartmann, 2006). In contrast, the in vivo phenotypes of S. 
146  Results and Discussion 
aureus rnpBC238 and rnpBC239 were indistinguishable (Table II; Fig. 2), which we do not 
understand at present.   
 In vitro at 10 mM Mg2+ (buffer F10) and increasing P protein concentrations, the 
reconstituted B. subtilis C258 and C259 mutant holoenzymes had activities indistinguishable 
form the wt enzyme (Fig. 4). Likewise, in buffer KN supplemented with 4.5 mM Mg2+, 
activity reductions for the mutant holoenzymes were marginal. Only at 2 mM Mg2+, a 
substantial loss of activity was seen for the mutant enzymes, which correlated with the severe 
in vivo defects. Since the reduction from 4.5 to 2.0 mM Mg2+ causes only a very minor 
decrease in ionic strength and based on equal activities and P protein titration profiles (Fig. 4) 
of wt and mutant enzymes in buffer F10, we think it unlikely that the major defect of the 
mutant P RNAs is related to impaired P protein and/or substrate affinity. We rather infer that 
the L15 loop mutations lower the affinity for catalytically relevant Mg2+ ions that either 
directly contribute to the catalytic process or help to fold the L15-CCA interaction module as 
part of the active site in E-S complexes.  
Our 5’-RACE experiments performed in the RNase Z mutant strain revealed that RNase P 
cleaves CCA-less ptRNAs in vivo (Fig. 6). Since RNase Z, which acts on CCA-less tRNA 3’-
precursors, has largely impaired activity on ptRNAs with long 5’-leaders, RNase P cleavage 
was proposed to precede RNase Z cleavage on CCA-less ptRNAs carrying expanded 5’- in 
addition to 3’-extensions (Pellegrini et al, 2003). Our results verify this hypothesis. The 
finding that B. subtilis RNase P is able to process CCA-less ptRNAs then raises the question 
why the C258/C259 mutations caused a lethal phenotype in the presence of normal amounts 
of P protein (Table I). Most likely, the general deceleration in ptRNA maturation kinetics 
adds up to a collective collapse caused by the incapability of the tRNA biosynthesis 
machinery to meet the demands of the protein synthesis apparatus. This collapse is mitigated 
when the steady-state amounts of the RNase P holoenzyme increase severalfold as a result of  
P protein overproduction. It can also not be ruled out that disruption of the CCA interaction 
may block 5’-maturation of a subset of ptRNAs more severely than that of the bulk of 
ptRNAs. 
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Materials and Methods 
Bacteria 
B. subtilis strain SSB318 (Wegscheid et al, 2006) was used for complementation studies and 
SSB320 (Pellegrini et al, 2003) for 5’-RACE experiments. 
Complementation studies in strain SSB318 
Recombinant rnpB-coding pHY300 derivatives were introduced into SSB318 using the 
LS/HS-medium protocol as described (Wegscheid et al, 2006). Residual IPTG was removed 
by centrifugation (1 min, 6000 rpm, Eppendorf Minispin) and resuspension of the cells in LB 
medium. Cells were plated in parallel on LB agar plates with or without 1 mM IPTG and 
containing 0.5 µg/ml erythromycin, 12.5 µg/ml lincomycin and 30 µg/ml tetracycline (to 
select for the presence of pHY300). In cases of poor transformation efficiency, cells were first 
plated exclusively in the presence of IPTG. For plasmids encoding rnpB or rnpA genes under 
control of the Pxyl promoter, the medium was additionally supplemented with 2% (w/v) 
glucose or 2% (w/v) xylose. For the construction of complementation plasmids, see 
Supplementary data. 
Growth curve monitoring 
B. subtilis SSB318 cells were grown overnight at 37°C in the presence of the appropriate 
antibiotics and 1 mM IPTG. IPTG was then washed out by repeated centrifugation and 
resuspension of the cell pellet in LB without IPTG; the final cell pellet was resuspended in 
LB, adjusted to a starting OD578 of 0.05 - 0.1 in 50 mM LB supplemented with the respective 
antibiotics and grown at 37°C at 180 rpm under aeration (180 rpm in a GFL Shaking 
Incubator 3033). 
In vitro transcription and 5’-endlabeling 
T7 runoff transcription and 5’-endlabeling was performed as described (Busch et al, 2000). 
For transcription of ptRNAGly (and G74 and G75 variants thereof) as well as E. coli P RNAs, 
see Wegscheid & Hartmann (2006). For transcription of B. subtilis wt and mutant P RNAs, as 
well as other mutant substrates (see Table V), see Supplementary data.  
Preparation of recombinant RNase P protein 
B. subtilis RNase P protein carrying an N-terminal His-tag (His-tagged peptide leader: 
MRGSHHHHHHGS, encoded in plasmid pQE-30 in E. coli JM109) was prepared as 
described (Wegscheid & Hartmann, 2006). 
Processing assays 
RNase P holoenzyme kinetics were performed in buffer F (2 or 10 mM MgCl2, 50 mM Mes 
pH 6.1, 100 mM KCl) or buffer KN (20 mM Hepes-KOH, pH 7.4, 2 or 4.5 mM Mg(OAc)2, 
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150 mM NH4OAc, 2 mM spermidine, 0.05 mM spermine and 4 mM β-mercaptoethanol; 
Dinos et al, 2004). In vitro reconstitution of RNase P holoenzymes was performed as follows: 
RNase P RNAs were incubated in the respective buffer for 5 min at 55°C and 50 min at 37°C, 
after which RNase P protein was added, followed by another 5 min at 37°C before addition of 
substrate. Processing reactions were started by combining enzyme and substrate solutions 
(final volume 10 µl) and assayed at 37°C. 
Folding analysis by native PAGE 
Folding analyses were conducted exactly as described (Wegscheid & Hartmann, 2006).  
5’-RACE 
SSB320 cells were grown in parallel either in the presence or absence of IPTG to an OD578 of 
0.6. Total RNA was isolated using the TRIzol (Invitrogen) method. In order to include 
primary transcripts, one half of total RNA was treated with Tobacco Acid Pyrophosphatase 
(TAP, Epicentre). Afterwards, the adapter oligonucleotide A1 (5’- GTC AGC AAT CCC 
TAA GGA G; the three 3’-terminal residues were RNA, the remainder DNA) was ligated to 
the 5’-monophosphates of RNA molecules. Specific primers were designed to map 3’-
unprocessed transcripts of trnSL-Ala1 (primer 180, 5’- TCG AAT AAG GGT TTA AAG 
GTA TGG AG) and trnSL-Val2 (primer 178, 5’- CTG CGC AAG GGT TTA AGC TAT 
GAT T). These primers were used in cDNA synthesis and in combination with primer 5’- 
GTC AGC AAT CCC TAA GGA G (matches the sequence introduced by the adapter 
oligonucleotide) in the following PCR reaction. PCR products were identified by native 8% 
PAGE, gel-purified and cloned into pCR2.1-TOPO for sequencing. Five clones were 
sequenced for each tRNA. 
Overexpression of rnpA – effect on P RNA levels  
To determine rnpB expression levels in strain SSB318 complemented with S. aureus rnpBwt 
or rnpBC239/C239 as a function of B. subtilis rnpA overexpression, cells were grown 
overnight at 37°C in 3 ml LB medium supplemented with 1 mM IPTG, 12.5 µg/ml 
lincomycin, 0.5 µg/ml erythromycin and 30 µg/ml tetracycline. IPTG was then washed out by 
by repeated centrifugation/resuspension of the cell pellet in LB without IPTG; the final cell 
pellet was then resuspended in LB, and adjusted to a starting OD578 of 0.05 to 0.1 in 50 ml 
LB; antibiotics (see above) and 2% xylose (w/v) were added and cells were grown at 37°C 
under aeration to an OD578 of 0.5 to 0.6. Aliquots of the cell suspensions were then diluted 
and plated in parallel on four plates (+ xylose, + IPTG / + xylose, - IPTG / + glucose, + IPTG 
/ + glucose, - IPTG) supplemented with antibiotics to verify the original growth phenotype 
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(retarded growth with mutant rnpB alleles in the absence of Pxyl rnpA, Table II). Total RNA 
from the cultures was prepared using the RNeasy Mini/Midi Kit from Qiagen according to the 
protocol provided by the manufacturer, followed by DNase I treatment (Turbo DNase, 
Ambion). RT-PCR was performed with the Access RT-PCR System (Promega). PCR was 
stopped after 12 cycles within the exponential phase of amplification. Primers specific for S. 
aureus rnpB were 5’- ATT TGG ATT GCT CAC TCG AGG G (5’-endlabeled in Fig. 3) and 
5’- GGG TAA TCG CTA TAT TAT ATA GAG G; primers specific for B. subtilis ribosomal 
protein S18 were 5’-ACG TGC GCG TTT GAT CGC TGC A (5’-endlabeled in Fig. 3) and 
5’- GCA GAG GCG GTC GTG CGA AA. RT-PCR reactions contained the normal amounts 
of unlabeled primers, and, in addition, trace amounts of the respective 5’-endlabeled primer.  
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Construction of B. subtilis rnpB complementation plasmids 
For complementation, the B. subtilis rnpB wild-type gene (rnpBwt) under control of its native 
rnpB promoter and terminator was cloned into pHY300 as described (Wegscheid et al, 2006).  
B. subtilis complementation plasmids under control of the xylose repressor (xylR) and 
promoter (Pxyl) were constructed in two steps: first, the fragment encoding xylR and Pxyl was 
amplified from plasmid pX2 (Mogk et al, 1997) using phosphorylated primers “100”, 5’-CGC 
GGA TCC AGG TTT GCT AAC CTT TGC G (introducing a Bam HI site, underlined), and 
“105”, 5’-GGG ACA CAT GTT ATC TCA TCA TAT ACA AAA TAA ATG TTT 
(introducing a Psc I and a half Sma I site, underlined); the PCR product was cloned into 
pHY300 cut with Sma I and Bam HI, resulting in plasmid pHY300 xylRP. B. subtilis rnpBwt 
was amplified from genomic DNA of strain W168 with primer “102”, 5’-GAT GAG ATA 
ACA TGT TCT TAA CGT TCG GGT (introducing a region overlapping with the xylose 
promoter, underlined, at the 5’-end of B. subtilis rnpB), and primer “103”, 5’-CGT CCC GGG 
CTT CAT CGT ATC ACC CTG TC (introducing a Sma I site 3’-adjacent to rnpB, 
underlined); the PCR product was cloned into the unique Psc I and Sma I sites of pHY300 
xylRP. This plasmid is referred to as pHY300 B. subtilis Pxyl rnpBwt (Table I). Mutations 
C258 and C259 were introduced by the site-directed Dpn I method according to the manual 
provided with the QuikChange XL Site-Directed mutagenesis Kit (Stratagene), using the 
primer pair 5’-TCC GTT AAG AAG GTT CCC CTA CGA AAA TTT GGG TTT CTC GCT 
CGA G and 5’- CTC GAG CGA GAA ACC CAA ATT TTC GTA GGG GAA CCT TCT 
TAA CGG A for the C258 mutation, and 5’-TCC GTT AAG AAG GTT CCC CTA GCA 
AAA TTT GGG TTT CTC GCT CGA G and 5’-CTC GAG CGA GAA ACC CAA ATT 
TTG CTA GGG GAA CCT TCT TAA CGG A for the C259 mutation (introduced point 
mutations underlined). 
 For parallel overexpression of the B. subtilis RNase P protein, B. subtilis rnpA was 
amplified including the xylose promoter from strain sb (Gößringer et al, 2006), using primers 
“115”, 5’-CAG GAT CCG ATT TAG TAC ATA GCG AAT CTT ACC, and “116”, 5’-CAG 
GAT CCA ACC AGA AAG GAA GCG C (both introducing a Bam HI site, underlined); the 
PCR product was cloned into the Bam HI site of pHY300 B. subtilis Pxyl rnpB(wt, 258 or 
259). Constructs with the insert “Pxyl rnpA-stop” carried point mutations close to the 5’-end 
of the xylose-inducible rnpA gene, resulting in two stop codons; for this purpose, the xylose 
promoter region was amplified from genomic DNA of strain sb (Gößringer et al, 2006) with 
primer “114”, 5’- TTT CGC TTC TTC AAA TGA CTC AT, and primer “115” (see above). 
The rnpA gene with the two stop codons was amplified from plasmid p3dstop (Gößringer et 
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al, 2006) with primer “116” (see above) and primer “113”, 5’- ATG AGT CAT TTG AAG 
AAG CGA AA. Those two fragments were combined by overlap extension PCR using 
primers “115” and “116”, and the product was cloned into the Bam HI site of pHY300 B. 
subtilis Pxyl rnpB(wt, 258 or 259). 
Construction of S. aureus rnpB complementation plasmids 
The S. aureus rnpB gene was cloned under control of the natural B. subtilis rnpB promoter 
and terminator. For amplification of the B. subtilis promoter, we used primer “19”, 5’-GGC 
AGC AAG CTT TAT GAT TGA TCA C (including the naturally occurring Hind III site 
upstream of the B. subtilis rnpB promoter, underlined), and primer “44”, 5’-ATG AAT TAT 
TAT ATA ACA ACT GAT TAC (covering the 3’-part of the B. subtilis rnpB promoter). The 
B. subtilis terminator was amplified using primer “45”, 5’-ACA TTT AAA ATG ATG AAA 
ACA AGC, and primer “21”, 5’-CGC CCA AGC TTG TGT ATA CTT CTT C (introducing a 
Hind III site, underlined, at the 3’-end of the B. subtilis rnpB terminator). S. aureus rnpB was 
amplified from genomic DNA of Staphylococcus aureus subsp. aureus Rosenbach (ATCC 
12600) with primer “42”, 5’-GTA ATC AGT TGT TAT ATA ATA ATT CAT TGA TAT 
TTT GGG  TAA TCG C, and primer “47”, 5’-GCT TGT TTT CAT CAT TTT AAA TGT 
ACT AGT AGT GAT ATT TCT ATA AGC C (containing overlapping regions with B. 
subtilis rnpB promoter and terminator, respectively). Fragments encoding the B. subtilis rnpB 
promotor, S. aureus rnpB and the B. subtilis rnpB terminator were combined by overlap 
extension PCR. The resulting PCR product was cloned into the Hind III site of pHY300, 
yielding plasmid pHY300 S. aureus PBs rnpB rnpBwt. Point mutations at position G238 and 
G239 within the S. aureus rnpB gene were introduced by the site-directed Dpn I method as 
described above. For introduction of the C238 mutation, the following primers were used: 5’-
CGA GTG AGC AAT CCA AAT TTC GTA GGA GCA CTT GTT TAA CGG and 5’-CCG 
TTA AAC AAG TGC TCC TAC GAA ATT TGG ATT GCT CAC TCG; for the C239 
mutation: 5’-CGA GTG AGC AAT CCA AAT TTG CTA GGA GCA CTT GTT TAA CGG 
and 5’-CCG TTA AAC AAG TGC TCC TAG CAA ATT TGG ATT GCT CAC TCG 
(introduced point mutations are underlined). For the construction of pHY300 S. aureus PBs 
rnpB rnpB(wt, 238 or 239) + Pxyl rnpA, the B. subtilis rnpA under control of the xylose 
promoter was amplified from strain sb (Gößringer et al, 2006) using phosphorylated primers 
“108”, 5’-CCC GAT TTA GTA CAT AGC GAA TCT TAC C, and “107”, 5’-GGG CAA 
CCA GAA AGG AAG CGC; the PCR product was cloned into the Sma I site of pHY300 S. 
aureus PBs rnpB rnpB(wt, 238 or 239).  
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Construction of E. coli rnpB complementation plasmids 
Complementation plasmids encoding E. coli rnpBwt, rnpBC292 and rnpBC293 under control 
of its native promoter (PEc rnpB) were cloned as described previously (Wegscheid et al, 2006). 
B. subtilis rnpA under control of the xylose promoter was amplified from plasmid pHY300 S. 
aureus PBs rnpB rnpBwt + Pxyl rnpA using primers 115 and 116 (see above, both introducing 
Bam HI sites); PCR products were digested with Bam HI and cloned into the Bgl II site of 
pHY300 E. coli PEc rnpB rnpB(wt, 292 or 293).  
Construction of pHY300 + P xyl rnpA 
B. subtilis rnpA under the control of the xylose-inducible promoter was amplified from 
plasmid pHY300 B. subtilis Pxyl rnpB + Pxyl rnpA with phosphorylated primers 107 and 108 
(see above). The fragment was then cloned into the Sma I site of pHY300. The same was done 
for the xylose-inducible rnpA gene with two stop codons close to the 5’-end of rnpA (Pxyl 
rnpA-stop). 
Construction of templates for T7 transcription 
C258 and C259 mutations were introduced into B. subtilis rnpB by site-directed Dpn I 
mutagenesis (see above) using pDW66 (Smith et al, 1992) as the template; pDW66 
derivatives were linearized with Dra I for T7 runoff transcription; E. coli P RNAs were 
transcribed from plasmid pJA2’ linearized with Fok I (Vioque et al, 1988); ptRNAGlyU73, 
ptRNAGlyU73UAAAUA and ptRNAGlyU73CCAAUA were transcribed from PCR templates 
amplified with primer “167” (5’-ATT AAT ACG ACT CAC TAT AGG) as forward primer, 
and primer “169” (5’-AGC GGG AGA CGG GAC TTG), or primer “170” (5’- TAT TTA 
AGC GGG AGA CGG GAC TTG), or primer “171” (5’-TAT TGG AGC GGG AGA CGG 
GAC) as reverse primer, respectively; plasmid pSBpt3’HH (Busch et al, 1999) was used as 
the PCR template. 
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5 Summary 
The Ribonuclease P (RNase P) is a ribonucleoprotein enzyme, which catalyses the 5’-
maturation of precursor tRNAs. Bacterial RNase P consists of one RNA subunit (P RNA; 
encoded by rnpB; ~400 nt), and a protein subunit (P protein, encoded by rnpA; ~120 aa). In 
vitro under elevated salt concentrations the RNA subunit is catalytically active. However, 
under physiological conditions the protein subunit is essential for activity. 
 
Type A and B RNase P RNAs are interchangeable in vivo despite substantial biophysical 
differences 
It could be demonstrated that structural type A and type B bacterial RNase P RNAs can fully 
replace each other in vivo despite the many reported differences in their biogenesis, 
biochemical/biophysical properties and enzyme function in vitro. Even a single copy of E. 
coli rnpBwt integrated into the amyE site of the B. subtilis chromosome was sufficient for cell 
viability. The findings suggest that many of the reported idiosyncrasies of type A and B 
enzymes either do not reflect the in vivo situation or are not critical for RNase P function in 
vivo, at least under standard growth conditions.  
 
The precursor tRNA 3’-CCA interaction with Escherichia coli RNase P RNA is essential 
for catalysis by RNase P in vivo 
The L15 region of Escherichia coli RNase P RNA forms two Watson-Crick base pairs with 
precursor tRNA 3’-CCA termini (G292-C75 and G293-C74). Here, the phenotyes associated 
with disruption of the G292-C75 or G293-C74 pair in vivo was analyzed. Mutant RNase P 
RNA alleles (rnpBC292 and rnpBC293) caused severe growth defects in the E. coli rnpB 
mutant strain DW2 and abolished growth in the newly constructed mutant strain BW in which 
chromosomal rnpB expression strictly depended on the presence of arabinose. An isosteric 
C293-G74 base pair, but not a C292-G75 pair, fully restored catalytic performance in vivo, as 
shown for processing of precursor 4.5S RNA. This demonstrates that the base identity of 
G292, but not G293, contributes to the catalytic process in vivo. Activity assays with mutant 
RNase P holoenzymes assembled in vivo or in vitro revealed that the C292/293 mutations 
cause a severe functional defect at low Mg2+ concentrations (2 mM), which can be infered to 
be on the level of catalytically important Mg2+ recruitment. At 4.5 mM Mg2+, activity of 
mutant relative to the wild-type holoenzyme, was decreased only about 2-fold, but 13-24-fold 
at 2 mM Mg2+. Moreover, the findings make it unlikely that the C292/293 phenotypes include 
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significant contributions from defects in protein binding, substrate affinity or RNA 
degradation. However, native PAGE experiments revealed non-identical RNA folding 
equilibria for the wild-type versus mutant RNase P RNAs, in a buffer- and preincubation-
dependent manner. Thus, it cannot be excluded that altered folding of the mutant RNAs may 
have also contributed to their in vivo defect. 
 
In vivo role of bacterial type B RNase P interaction with tRNA 3’-CCA 
It has been unclear if catalysis by bacterial type B RNase P involves a specific interaction 
with  p(recursor)tRNA 3’-CCA termini. We show that point mutations at two guanosines in 
loop L15 result in growth inhibition, which correlates with an enzyme defect at low Mg2+. For 
Bacillus subtilis RNase P, an isosteric C259-G74 bp fully and a C258-G75 bp slightly rescued 
catalytic proficiency, demonstrating Watson-Crick base-pairing to tRNA 3’-CCA and 
emphasizing the importance of G258 identity. We infer the defect of the mutant enzymes to 
be primarily on the level of recruitment of catalytically relevant Mg2+, with a possible 
contribution from altered RNA folding. Cell viability of bacteria expressing mutant RNase P 
RNAs could be (partially) restored by RNase P protein overexpression, resulting in  increased 
cellular RNase P levels. Finally, we demonstrate that B. subtilis RNase P is able to cleave 
CCA-less ptRNAs in vivo. We conclude that the in vivo phenotype upon disruption of the 
CCA interaction is either due to a global deceleration in ptRNA maturation kinetics or severe 
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6 Zusammenfassung 
 
Die Ribonuclease P (RNase P) ist ein Ribonucleoproteinenzym, das die Reifung der Vorläufer 
tRNAs (ptRNAs) katalysiert. Die bakterielle RNase P besteht aus einer RNA- (P RNA, 
kodiert durch rnpB; ~ 400 nt) und einer Protein-Untereinheit (P Protein; kodiert durch rnpA; ~ 
120 aa). In vitro unter erhöhten Salzkonzentrationen ist die RNA-Untereinheit katalytisch 
aktiv. Unter physiologischen Bedingungen ist jedoch die Protein-Untereinheit essentiell für 
die katalytische Aktivität. 
Typ A und Typ B RNase P RNAs sind in vivo austauschbar trotz erheblicher 
biophysikalischer Unterschiede 
Es konnte gezeigt werden, dass die bakteriellen RNase P RNAs vom strukturellen Typ A und 
Typ B sich gegenseitig vollständig in vivo ersetzen können, trotz der vielen dokumentierten 
Unterschiede in der Biogenese, in den biochemischen und biophysikalischen Eigenschaften 
und in der Enzymfunktion in vitro. Selbst eine einzelne Kopie des E. coli rnpBwt-Gens, 
integriert in den AmyE-Locus des B. subtilis Chromosoms, war ausreichend für die 
Lebensfähigkeit der Zellen. Die Ergebnisse deuten an, dass viele der berichteten Eigenheiten 
der RNase P Enzyme vom Typ A und B entweder nicht die in vivo-Situation widerspiegeln 
oder für die Funktion in vivo nicht kritisch sind, zumindest unter 
Standardwachstumsbedingungen.  
Die Interaktion des 3’-CCA Endes von Vorläufer tRNAs mit Escherichia coli RNase P 
RNA ist essentiell in vivo 
Die L15-Region der Escherichia coli RNase P RNA bildet zwei Watson-Crick Basenpaare 
mit dem 3’-CCA Ende von Vorläufer tRNAs (G292-C75 und G293-C74). Im Rahmen dieser 
Arbeit wurde der in vivo-Phenotyp untersucht, der mit einer Zerstörung des G292-C75 oder 
G293-C74 Basenpaares assoziiert ist. Die mutanten RNase P RNA-Allele (rnpBC292 and 
rnpBC293) verursachten einen schweren Wachstumsdefekt in dem E. coli rnpB-
Mutantenstamm DW2 und vernichteten das Wachstum vollständig in dem neu konstruierten 
E. coli Mutantenstamm BW, in dem die Expression des chromosomalen rnpB-Gens strikt von 
der Anwesenheit von Arabinose abhängt. Am Beispiel der Prozessierung von Vorläufer-4.5S 
RNA konnte gezeigt werden, dass ein isosterisches C293-G74 Basenpaar, jedoch nicht ein 
C292-G75 Paar, die katalytische Funktion in vivo vollständig wiederherstellt. Dies 
demonstriert, dass die Identität der Base G292, jedoch nicht von G293, zum katalytischen 
Prozess in vivo beiträgt. Aktivitätsassays mit in vivo und in vitro assemblierten Holoenzymen 
zeigten, dass die C292/C293-Mutationen einen schweren funktionellen Defekt bei niedrigen 
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Mg2+-Konzentrationen (2 mM) verursachen, welcher auf Ebene der Rekrutierung von 
katalytisch aktivem Magnesium anzusiedeln ist. Bei 4.5 mM Mg2+ war die Aktivität der 
mutanten relativ zum Wildtyp-Holoenzym nur ca. 2-fach erniedrigt, jedoch 13-24-fach bei  
2 mM Mg2+. Darüber hinaus deuten unsere Ergebnisse darauf hin, dass es unwahrscheinlich 
ist, dass Defekte in der Proteinbinding, Substrataffinität oder RNA-Stabilität signifikant zum 
C292/C293-Phenotyp beitragen. In nativen PAGE-Experimenten wurden jedoch nicht-
identische Faltungsgleichgewichte für Wildtyp vs. mutanten RNase P RNAs aufgedeckt, 
welche sowohl puffer- als auch präinkubationsabhängig waren. Deshalb kann nicht 
ausgeschlossen werden, dass eine veränderte Faltung der mutanten RNAs zum in vivo Defekt 
partiell beiträgt. 
Die Rolle der Interaktion zwischen Typ B RNase P und dem tRNA 3’-CCA Ende in vivo 
Bisher war es unklar, ob RNase P vom (strukturellen) Typ B eine spezifische Interaktion mit 
dem 3’-CCA Ende von Vorläufer tRNAs (ptRNAs) eingeht und ob diese Wechselwirkung 
gegebenenfalls für den katalytischen Prozess eine Rolle spielt. Es konnte gezeigt werden, dass 
Punktmutationen der zwei Guanosine im L15-Loop, für welche eine Interaktion mit dem 3’-
CCA Ende vermutet wird, das Zellwachstum hemmen (S. aureus rnpB) oder unterdrücken (B. 
subtilis oder E. coli rnpB). Dies korreliert mit einem Enzymdefekt bei niedrigen Mg2+-
Konzentrationen. Für B. subtilis RNase P stellte ein isosterisches C259-G74 Basenpaar die 
katalytische Prozessivität vollständig wieder her, während ein C258-G75 Basenpaar nur einen 
schwachen Kurierungseffekt bewirkte. Dies weist auf eine Waston-Crick Basenpaarung der 
zwei Guanosine mit dem 3’-CCA Ende von tRNAs hin und unterstreicht zugleich die 
Wichtigkeit der Basenidentität an der Postition G258. Kinetische Untersuchungen lassen die 
Folgerung zu, dass der Defekt der mutanten Enzyme hauptsächlich auf Ebene der 
Rekrutierung von katalytisch aktivem Mg2+ anzusiedeln ist. Es kann jedoch nicht 
ausgeschlossen werden, dass Unterschiede in der RNA-Faltung einen Beitrag zum in vivo 
Defekt der Mutanten leisten. Die Lebensfähigkeit der Bakterien, welche mutierte RNase P 
RNA exprimierten, konnte (teilweise) durch parallele Überexpression des B. subtilis RNase P 
Proteins wiederhergestellt werden; dieser Effekt konnte auf erhöhte intrazelluläre RNase P-
Mengen zurückgeführt werden. Des weiteren konnte gezeigt werden, das B. subtilis RNase P 
3’-Vorläufer tRNAs ohne 3’-CCA Ende in vivo prozessieren kann. Wir folgern daraus, dass 
der in vivo-Phenotyp, der mit einer Unterbrechung der CCA-Interaktion assoziiert ist, 
entweder durch eine globale kinetische Verlangsamung der 5’-Reifung von tRNAs oder durch 
eine kritische Blockierung der 5’-Maturierung einer Subgruppe von tRNAs verursacht wird. 
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7 Outlook 
Within this study the E. coli rnpB mutant strain BW was constructed and the B. subtilis rnpB 
mutant strain SSB318 was established for in vivo complementation analyses. By introducing 
and utilizing such “clean” type A and B RNase P mutant strains, we have paved the way for 
sophisticated future studies that enable the parallel analysis of RNase P function in vivo and in 
vitro. Combined with previous RNase P mutant strains, the two strains of this work have the 
advantage that the chromosomal rnpB genes can be completely silenced, and that stresses 
such as heat shock are avoided during complementation analyses.  
The mutant strains permit systematic investigations of structurally different P RNAs in order 
to define the architectural constraints for type A and B RNase P function in the cellular 
milieu. Such investigations can be further extended by including archaeal P RNAs. Also, 
some cyanobacterial RNase P RNAs lack the two conserved G residues involved in the CCA 
interaction, raising the question how cyanobacterial RNase P enzymes accomplish efficient 
catalysis in vivo. The function of cyanobacterial P RNAs could be tested in the E. coli BW 
and B. subtilis SSB318 RNase P mutant strains. Concomitant expression of cyanobacterial P 
proteins will answer the question if features of the cyanobacterial P proteins may compensate 
for the absence of the CCA interaction.  
The rnpB mutant strains provide a useful tool for in vivo folding studies of RNase P. For 
example, in vitro experiments have revealed that S- and C-domain of bacterial P RNA fold 
independently of each other. However, nothing is known on the physiological relevance of 
this finding. With the rnpB mutant strains, assembly and function of independently expressed 
S- and C-domains can be examined in vivo. 
The rnpB mutant strains could also be exploited to isolate in vivo assembled holoenzymes e.g. 
for structural analyses. For this purpose, one could express a P RNA carrying one or two 
affinity tags for enzyme purification (e.g. a small hairpin binding to a phage coat protein 
combined with a tobramycin aptamer). As the native rnpB can be tighly down-regulated in 
strain BW and SSB318, titration effects resulting from competition of native P RNA and 
tagged P RNA for binding to the native P protein can be avoided. Possible interference of 
purification tags with holoenzyme functionality can be eliminated by initial complementation 
analyses. Double-tagged P RNAs expressed in the rnpB mutant strains also provide a means 
to isolate cellular components associated with RNase P. Previous studies have suggested 
interactions between bacterial RNase P with ribosomes as well as other RNases (RNase E, 
RNase III). Archaeal RNase P has a more complex architecture (1 RNA, 4 protein subunits) 
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than the bacterial enzyme, cellular levels of the enzyme are low, and in vitro reconstitution of 
active archaeal RNase P is still an unsolved problem. Tagged archaeal P RNAs may be 
overexpressed in strains BW and SSB318 together with the archaeal P proteins, and the 
archaeal holoenzyme assembled in the bacterial host may be isolated in large quantities for 
structural and biochemical studies. 
The mutant strains are also a helpful tool to identify new substrates of RNase P. In microarray 
analyses potential candidates might be identified which accumulate upon repression of rnpB. 
Such candidate substrates could be characterized within the framework of combined in vitro 
investigations (kinetics and RNA folding studies at low Mg2+) and in vivo analyses 
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8 Appendix 
8.1 Chemicals 
Acrylamide M-Bis (50 % stock solution 24:1)  Gerbu 
Agar Agar       Serva 
Agarose       Roth 
Ampicillin       Gerbu 
Ammonium acetate      Fluka 
Ammoniumperoxodisulfate     Roth 
BlueSlick       Serva 
Boric acid       Roth 
Bromophenol blue (BPB)     Merck 
Chloramphenicol     Sigma 
Chloroform      Merck 
Crystal violet      Fluka 
Deoxynucleosidtriphosphates (dNTPs)  Boehringer 
Disodiumhydrogenphosphate    Merck 
Dithiothreitol (DTT)      Gerbu 
Erythromycin      Merck 
Ethanol p.a. 99.8 %     Roth 
Ethidiumbromide      Roth 
Glycerol       Gerbu 
Glycogen       Roche 
Urea        Gerbu 
Yeast extract       Gerbu 
Isopropanol       Roth 
Lincomycin      Sigma 
β-Mercaptoethanol     Serva 
Potassiumdihydrogenphosphate    Fluka 
Sodiumacetate      Merck 
Nucleosidtriphosphates (NTPs)    Roche 
Peptone      Roth 
Phenol       Roth 
Bovine serum albumin (BSA)    Sigma 
Skim milk powder (blotting grade)   Roth 
N,N,N‘,N‘-Tetraethylmethylenediamin (TEMED)  Serva 
Tetracyclin      Sigma 
Tris-(hydroxymethyl)aminomethane   Gerbu 
Trizol      Invitrogen 
Xylenecyanol blue (XCB)     Serva 
All other chemicals (not listed above) were purchased from Sigma, Gerbu or Life 
Technologies and had a purity grade “pro analysis”. 
8.2 Radioisotopes 
[γ-32P] ATP       Hartmann Analytic ICN Radiochemicals 
[5’-32P] pCp      Hartmann Analytic ICN Radiochemicals 
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8.3 Size markers 
1 kb DNA ladder      New England Biolabs 
10 bp DNA ladder      Invitrogen 
2 Log DNA ladder      New England Biolabs 
PageRuler™ Prestained Protein Ladder  MBI Fermentas 
PageRuler™ Prestained Protein Ladder Plus MBI Fermentas 
8.4 Enzymes 
Alkaline Phosphatase   MBI Fermentas 
DNase I    Promega, Ambion 
Klenow Fragment   MBI Fermentas 
Nuclease P1    Biomol 
Pfu-Polymerase    Promega and our lab 
Pyrophosphatase    Roche 
Restriction endonucleases   MBI Fermentas and New England Biolabs 
Taq polymerase   MBI Fermentas and our lab 
Thermoscript    Invitrogen 
T4 DNA ligase    Gibco BRL and MBI Fermentas 
T4 Polynucleotide kinase   New England Biolabs 
T4 RNA-ligase    MBI Fermentas 
T7 RNA polymerase    MBI Fermentas;  
T7 RNA polymerase (Y639F) our lab 
Turbo DNase    Ambion 
8.5 Equipment 
Agarose gel chamber   Biorad, Mini Sub Cell 
Autoclave   Systec V95 
Blotting device  Schleicher & Schuell, SammyDry 
Electroporator   Biorad, Gene Pulser Xcell, PC- and CE- module 
FPLC    Amersham, ÄktaBasic 
Gel documentation system  Cybertech, CS1 with Mitsubishi Video Copy 
Processor; Biostep, GelSystem MINI 
Gel dryer    Biorad, Model 483 SLAB Dryer 
Hand-monitor   Berthold, LB 1210 B 
Heating blocks   Techne, Dri-Block DB-3D; Biometra, TB1 
Incubator   Memmert BE400 
Imager cassettes   Fuji Film, Bas cassette 4043, Rego, 35,6x43,2cm 
Magnetic stirrers   Heidolph, MR 2002 
Power supply    Pharmacia, EPS 3500; Bio Rad, Power Supply160/1.6 
(Power Pac 3000); Apelex, PS 9009T 
PAA-gel chamber   Custom-made, University of Lübeck 
PCR cycler    Biometra, TGradient Thermocycler 
pH-Meter    WTW, pH Level 1 
Phosphoimager   Raytest, Bio-Imaging Analyser BAS 1000 (Fujifilm);  
FLA 3000, (Fujifilm) 
Pipettes    Gilson-Pipetman, P20, P200, P1000 
Abimed 0.1-2µl 
Protein Gel chamber  Mini Protean 3 cell, Biorad 
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Quartz cuvette   Hellma 104-QS, 105.202, 115B-QS, 105 
Mixer    IKA, Vibrax-VXR; Eppendorf, Thermomixer 
5436, Thermomixer comfort 
Shaking incubator  GFL 3033 
Spectrophotometer   Hewlett Packard, Photometer 8453; Varian, Cary 
50 Conc; Thermo Spectronic, Biomate 3 
Software    PCBas/Aida Image Analyser v.3.45, 
Corel Graphics Suite; GraFit 3.0; 
Microsoft Office; 
Pymol, Delano, W.L. 2002 
Vector NTI®, Invitrogen 
Speedvac   Heto vacuum centrifuge 
Scintillation counters  Perkin Elmer, Wallac WINSPECTRAL a/b 1414 
Liquid Scintillation Counter; Packard, Tricarb 2000CA 
Centrifuges    Heraeus, Biofuge pico, biofuge fresco; Sigma, Typ 112;  
    Eppendorf, centrifuge 5810R, minispin plus Stratagene,  




Anti-B. subtilis RnpA-Antiserum from rabbits (P.ab syra 6)  C. A. Fierke, University of  
Michigan, U.S.A.  
Anti-E. coli RnpA-Antiserum from rabbits  A. Vioque, University of  
Sevilla, Spain (Pascual and  
Vioque, 1996)  
Secondary antibodies 
Anti-Rabbit IgG made in goat (affinity purified), Roche Diagnostics  
conjugated with alakaline phosphatase  
8.7 Synthetic DNA Oligonucleotides 
DNA oligonucleotides were obtained from Invitrogen or Metabion. The sequence of DNA 
oligonucleotides is given in the 5' to 3' direction. Nt in bold letters indicate introduced 
mutations. Underlined sequences indicate either restriction enzyme recognition sites, 
overlapping regions or the T7 promoter sequence. 
Primer 
No 
Name Used for 5’→ 3’ sequence 
1 E. coli M1 G292C 
sense 
E. coli C292 
mutagenesis 
GTA CTG AAC CCG CGT 
AGG CTG CTT GAG C 
2 E. coli M1 G293C 
sense 
E. coli C293 
mutagenesis 
GTA CTG AAC CCG GCT 
AGG CTG CTT GAG C 
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3 E. coli M1 G293C 
antisense 
E. coli C293 
mutagenesis 
GCT CAA GCA GCC TAG 
CCG GGT TCA GTA C 
4 E. coli M1 G292C 
antisense 
E. coli C292 
mutagenesis 
GCT CAA GCA GCC TAC 
GCG GGT TCA GTAC 
12 rnpB (–96) pSP64 seq B. subtilis rnpB EP; 
sequencing 
CAT ATT GTC GTT AGA 
ACG CG 
15 S. aur. M1 G238C 
sense  
S. aureus C238 
mutagenesis 
CGA GTG AGC AAT CCA 
AAT TTC GTA GGA GCA 
CTT GTT TAA CGG 
16 S. aur. M1 G238C 
antisense 
S. aureus C238 
mutagenesis 
CCG TTA AAC AAG TGC 
TCC TAC GAA ATT TGG ATT 
GCT CAC TCG 
17 S. aur. M1 G239C 
sense 
S. aureus C239 
mutagenesis 
GAG TGA GCA ATC CAA 
ATT TGC TAG GAG CAC 
TTG TTT AAC GG 
18  S. aur. M1 G239C 
antisense 
S. aureus C239 
mutagenesis 
CCG TTA AAC AAG TGC 
TCC TAG CAA ATT TGG ATT 
GCT CAC TC 
19 5’ B. sub. rnpB – 
HindIII 
B. subtilis rnpB 
promoter 
GGC AGC AAG CTT TAT 
GAT TGA TCA C 
21 3’ B. sub. rnpB HindIII B. subtilis rnpB 
terminator 
CGC CCA AGC TTG TGT 
ATA CTT CTT C 
34 pACYC177 Seq sequencing CTA TTA ATT TCC CCT CGT 
C 
41 5’ E. coli M1+B. sub. 
promoter 
E. coli rnpB BPT GTA ATC AGT TGT TAT ATA 
ATA ATT CAT GAA GCT 
GAC CAG ACA GTC 
42 5’ S. aur. M1 + B. sub. 
terminator 
S. aureus rnpB BPT GTA ATC AGT TGT TAT ATA 
ATA ATT CAT TGA TAT TTT 
GGG  TAA TCG C 
44 3’ B. sub. promoter B. subtilis rnpB 
promoter 
ATG AAT TAT TAT ATA 
ACA ACT GAT TAC 
45 5’ B. sub. terminator B. subtilis rnpB 
terminator 
ACA TTT AAA ATG ATG 
AAA ACA AGC 
46 3’ E. coli M1+B. sub. 
terminator 
E. coli rnpB BPT GCT TGT TTT CAT CAT TTT 
AAA TGT AGG TGA AAC 
TGA CCG ATA AG 
47 3’ S. aur M1 +B. sub 
terminator 
S. aureus rnpB BPT GCT TGT TTT CAT CAT TTT 
AAA TGT ACT AGT AGT 
GAT ATT TCT ATA AGC C 
49 E. c. RevT 3 Primer extension E. coli 
rnpB, RT-PCR 
CTC ACT GGC TCA AGC 
AGC CT 
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52 pHY300 Seq (PLS) sequencing CTA AAT CGT TAA GGG 
ATC AAC 
53 S. a. RevT 3 Primer extension  
S. aureus rnpB 
GAA TTC CGT TAA ACA 
AGT GCT CCT 
66 pHY300 Seq rev MCS sequencing CCT GTC GGG TTT CGC C 
82’ 3’ B. sub M1 C258 B. subtilis C258 
mutagenesis 
TCC GTT AAG AAG GTT 
CCC CTA CGA AAA TTT 
GGG TTT CTC GCT CGA G 
83’  3’ B. sub M1 C259 B. subtilis C259 
mutagenesis 
TCC GTT AAG AAG GTT 
CCC CTA GCA AAA TTT 
GGG TTT CTC GCT CGA G 
84 3’ ptgly G74 ptgly G74 mutagenesis GCA CAT CCG GTG ACT 
GCA GCG GGA GAC GG 
85 3’ ptgly G75 ptgly G75 mutagenesis GCA CAT CCG GTG ACT 
CGA GCG GGA GAC GG 
86’ 5’ B. sub M1 C258 B. subtilis C258 
mutagenesis 
CTC GAG CGA GAA ACC 
CAA ATT TTC GTA GGG 
GAA CCT TCT TAA CGG A 
87’  5’ B. sub M1 C259 B. subtilis C259 
mutagenesis 
CTC GAG CGA GAA ACC 
CAA ATT TTG CTA GGG 
GAA CCT TCT TAA CGG A 
88  5’ ptgly G74 ptgly G74 mutagenesis CCG TCT CCC GCT GCA GTC 
ACC GGA TGT GC 
89 5’ ptgly G75 ptgly G75 mutagenesis CCG TCT CCC GCT CGA GTC 
ACC GGA TGT GC 
92 B. sub. P4_5’ Primer extension 
B. subtilis/S. aureus 
rnpB 
GAG CAT GGA CTT TCC TCT
93 B. sub RevT 1 Primer extension 
B. subtilis rnpB,  
RT-PCR 
TTC CGT TAA GAA GGT TCC 
CCT 
96 4.5S RevT 1 Primer extension 4.5S 
RNA 
GGA GAA CCA ACA GAG 
CCC 
100 5’ xylR BamHI xyl B.subtilis rnpB CGC GGA TCC AGG TTT 
GCT AAC CTT TGC G 
102 5’ B. sub M1 mit xyl xyl B.subtilis rnpB GAT GAG ATA ACA TGT 
TCT TAA CGT TCG GGT 
103 3’ B. sub M1 SmaI xyl B.subtilis rnpB CGT CCC GGG CTT CAT CGT 
ATC ACC CTG TC 
105 3’ xylR 
PscI(XceI)/SmaI 
xyl B.subtilis rnpB GGG ACA CAT GTT ATC 
TCA TCA TAT ACA AAA 
TAA ATG TTT 
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107 3’ xyl rnpA xyl B. subtilis 
rnpA/rnpA-stop 
GGG CAA CCA GAA AGG 
AAG CGC 
108 5’ xyl rnpA xyl B. subtilis 
rnpA/rnpA-stop 
CCC GAT TTA GTA CAT 
AGC GAA TCT TAC C 
113 5’ rnpA direct xyl B. subtilis rnpA-stop ATG AGT CAT TTG AAG 
AAG CGA AA 
114 5’ antisense rnpA direct xyl B. subtilis rnpA-stop TTT CGC TTC TTC AAA TGA 
CTC AT 
115 5’ xyl rnpA BamHI xyl B. subtilis rnpA  CAG GAT CCG ATT TAG 
TAC ATA GCG AAT CTT 
ACC 
116 3’ xyl rnpA BamHI xyl B. subtilis rnpA  CAG GAT CCA ACC AGA 
AAG GAA GCG C 
134 3’ rnpB +1start 
RExBAD 
BW GTC TCC CCC GAA GAG 
GAC GAC GAC GAA GCG 
GCG ACT GTC TGG TCA 
GCT TCT ATG GAG AAA 
CAG TAG AGA GTT GC 
135 5’ rnpB upstr RExBAD BW CTT CAG CGT ATT GAC 
CAG CAT AGG TAC GTT 
GGA CGA AGC ATT CCG 
CGG GCT TGC ATA ATG 
TGC CTG TC 
136 5’RExBADveri  BW CGG CGT CAC ACT TTG CTA 
TGC C 
137 5’-rnpB ext BW CGA TTG GTG TCG CAA 
ACG TGG 
138 3’ catRExBAD veri BW CGC AAG GCG ACA AGG 
TGC TG 
149 5’B. sub M1  RT-PCR CTT AAC GTT CGG GTA ATC 
GC 
150 5’ E. coli M1  RT-PCR; 
BW 
GAA GCT GAC CAG ACA 
GTC GC 
156 3’ E. c. prom + B. sub. 
M1 
B. subtilis rnpB EP CAG CGA TTA CCC GAA 
CGT TAA GAA CGG CGC 
GCA GTA TAG AGG G 
157 5’ ext veri rnpB B. subtilis rnpB EP; 
BW 
TGC AGG AGC TGC GGG 
TGG 
158 3’ext veri rnpB BW GTG AAA CTG ACC GAT 
AAG CCG C 
163 3’ E. coli rnpB BW AGG TGA AAC TGA CCG 
ATA AGC C 
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167 T7 ptRNA 3’-variants ATT AAT ACG ACT CAC TAT 
AGG 
169 U73 ptgly 3’ ptRNA 3’-variants AGC GGG AGA CGG GAC 
TTG 
170 U73UAAAUA ptgly3’ ptRNA 3’-variants TAT TTA AGC GGG AGA 
CGG GAC TTG 
171 U73CCAAUA ptgly 3’ ptRNA 3’-variants TAT TGG AGC GGG AGA 
CGG GAC 
177 trnSL-Val2 RT1 5’-RACE GCG CAA GGG TTT AAG 
CTA TGA TTC CG 
178 trnSL-Val2 RT2 5’-RACE CTG CGC AAG GGT TTA 
AGC TAT GAT T 
179 trnSL-Ala1 RT1 5’-RACE CGA ATA AGG GTT TAA 
AGG TAT GGA GCC A 
180 trnSL-Ala1 RT2 5’-RACE TCG AAT AAG GGT TTA 
AAG GTA TGG AG 
183 3’ E. c. M1 +350  BW CGC CGG AAC GGT TTA 
TTA CGT AC 
186 E. c. M1 up +350 BW CAT TCG CGT CGC TTG TGA 
TGT C 
193 5’ E. coli rnpB 
promoter -58 
BW CAC GTA ATA TCG CCG 
CGA CAC TGG 
194 5’ AraC BW GCG ACT CGT TAA TCG CTT 
CCA TGC 
195 3’ AraC BW GCA TGG AAG CGA TTA 
ACG AGT CGC 
196 5’ E. c. rnpA NcoI pTrc E. coli rnpA AGA CCA TGG TTA AGC 
TCG CAT TTC C 
197 3’ E. c. rnpA XbaI pTrc E. coli rnpA ATC TCT AGA GTC AGG 
ACC CGC GAG CCA 
203 t1t2 NsiI pTrc E. coli rnpA CAC ATG CAT GCA AAA 
AGG CCA TCC GTC AGG 
206 pTrc MfeI/ClaI pTrc E. coli rnpA ACA ATC GAT TCA ATT 
GCG CCG ACA TCA TAA 
CGG 
207 5’ 4.5S prom + EcoRI mutated 4.5S RNA ACA GAA TTC AGC ATA 
ATC TGG AAA AAC GCC C 
208 3’ 4.5S prec + mod 
stem 
mutated 4.5S RNA CCA ACA GAC GGG CCA 
TTG AGA GCG TTG AGA 
ACC 
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209 5’ 4.5S + mod stem mutated 4.5S RNA CTC AAT GGC CCG TCT GTT 
GGT TCT CCC GCA AC 
210 3’ 4.5S + mod stem mutated 4.5S RNA TGG CCC GCC TGC CAG 
CTA CAT CCC GG 
211 5’wt CCC mutated 4.5S RNA GCT GGC AGG CGG GCC 
ACC CAT TTC TGC CTC CCA 
CCG TTT C 
212 5’ G74 GCC mutated 4.5S RNA GCT GGC AGG CGG GCC 
AGC CAT TTC TGC CTC CCA 
CCG TTT C 
213 5’ G75 CGC mutated 4.5S RNA GCT GGC AGG CGG GCC 
ACG CAT TTC TGC CTC CCA 
CCG TTT C 
214 3’ ybaA PstI mutated 4.5S RNA CAC CTG CAG CAA GGC 
ATT ACC GAA AGA AG 
215 4.5S RT mod Primer extension mod. 
4.5S RNA 
GGA GAA CCA ACA GAC 
GGG 
216 3’ MluI + PstI 4.5S 
RNA 
mutated 4.5S RNA TCT CTG CAG TAA CGC GTC 
ATC TGC CTT GGC 
223 E. c. prom + NheI B. subtilis rnpB EP GCA TGC TAG CGA TTG 
GTG TCG CAA ACG TGG C 
224 3’ S. aur. rnpB -GG RT-PCR S. aureus rnpB ATT TGG ATT GCT CAC TCG 
AGG G 
225 5’ S. aur. rnpB RT-PCR S. aureus rnpB GGG TAA TCG CTA TAT TAT 
ATA GAG G 
X1 5’- p4.5S RNA + T7 4.5S RNA marker CCA GAA TTC GAA ATT 
AAT ACG ACT CAC TAT A 
X2 3’- p4.5S RNA  4.5S RNA marker TAT GGG TGG GGG CCC 
TGC CAG CTA 
X3 Primer (Adapter): 5’-RACE experiments GTC AGC AAT CCC TAA 
GGA G 
HP499 B. sub rnpB HindIII SSB318 construction ACC AAA GCT TGT TCT TAA 
CGT TCG GGT AAT CGC TG 
HP500 B. sub rnpB BamHI SSB318 construction TCC AGG ATC CGT TTA CCG 
CGT TCC ACT CTC ACC ATT 
TC 
M1 rpsR-R RT-PCR B. subtilis S18 ACG TGC GCG TTT GAT 
CGC TGC A 
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8.8 DNA/RNA-Oligonucleotides 
Underlined nt are ribonucleotides, all others are deoxyribonucleotides. 
Primer 
No 
Name Used for 5’→ 3’ sequence 
A1 Adapter 5’-RACE experiments, 
adapter ligation 
GTC AGC AAT CCC TAA 
GGA G 
 
8.9 Bacterial strains 
Strain Relevant Genotype Reference 
E. coli BW pBAD::rnpB, Camr Wegscheid and 
Hartmann, 2006 
E. coli DH5α supE44 deltalacU169 (phi80 lacZ deltaM15) 
hsdR17 recA1 endA1 gyrA96 thi-1 relA1 
 
Sambrook et al., 1989
E. coli K12 MG1655 F- lambda- ilvG- rfb-50 rph-1 Guyer et al., 1981 
E. coli DW2/pDW160 ∆rnpB, pDW160 ts rnpB KanR Waugh and Pace, 
1990 
E. coli TG1cat-araC TG1, cat gene inserted downstream of the 
araC gene, Camr 
Roux et al., 2005 
E. coli XL-2 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIqZ.M15 Tn10 (Tetr) 
Amy Camr] 
Stratagene 
B. subtilis W168 wildtype Bacillus genetic stock 
center 
B. subtilis SB Pxyl B. subtilis rnpA Gößringer et al., 2006
B. subtilis SSB318 Pspac::rnpB mls
r (ery) Wegscheid et al., 
2006 
B. subtilis SSB320 Pspac::rnz mls
r (ery) Pellegrini et al., 2003 
B. subtilis SSB321 Pspac::rnz mls
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8.10  Plasmid vectors 
Vector Relevant Genotype Reference 
pMAP65 pUB110 lacI++ Kanr Petit et al., 1998 
pSP64 ori pMB1 Ampr Promega 
pDG364 Ampr Camr Cutting et al. 1990 
pACYC177 p15A Ampr Kanr Chang et al., 1978 
pBR322 pMB1 rop Ampr Tetr Bolviar et al. 1977 
pHY300 PLK Tetr Ampr pAMα1 p15A Ishiwa et Shibahara-Sone, 1986 
pTrc99A pMB1 lacIq Ampr pTrc Amann et al. 1988 
pKD46 pBAD γ β exo repA101ts Ampr Datsenko et Wanner, 2000 
p3dstop Pspac B. subtilis rnpA-stop Gößringer, 2004; Gößringer et al., 2006 
8.11  Plasmid vectors for T7 transcriptions 
Vector Genotype Reference Linearised with 
pDW66 B. subtilis P RNA Smith et al., 1992 Dra I 
pSBpt3’HH ptRNAGly from Thermus 
thermophilus with 14mer flank 
Busch et al., 2000 Bam HI 
pJA2’ E. coli P RNA, (wt or 
C292/C23 variants) 
Vioque et al., 1988 Fok I 
For plasmid vectors constructed within this study see chapters 3.7.2 and 3.7.4. 
Those plasmids were used as template, to introduce point mutations by site-directed Dpn I 
mutagenesis (chapter 3.3.9). 
8.12  PCR Mutagenesis performed within this study 
Point mutations were introduced by site-directed Dpn I mutagenesis (chapter 3.3.9). 
Gene/target Introduced mutation Primers plasmid 
E. coli rnpB C292 1, 3 1) 
E. coli rnpB C293 2, 4 1) 
S. aureus rnpB C238 15, 16 2) 
S. aureus rnpB C239 17, 18 2) 
B. subtilis rnpB C258 86’, 82’ 3) 
B. subtilis rnpB C259 87’, 83’ 3) 
ptRNAGly T. thermophilus G74 84, 88 pSBpt3’HH 
ptRNAGly T. thermophilus G75 85, 89 pSBpt3’HH 
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1) all plasmids encoding E. coli rnpB (see chapter 3.7.2 and 3.7.4) 
2) all plasmids encoding S. aureus rnpB (see chapter 3.7.2 and 3.7.4) 
3) all plasmids encoding B. subtilis rnpB (see chapter 3.7.2 and 3.7.4) and plasmid pDW66 
 
8.13  Abbreviations and Units 
A260  absorption at 260 nm  
A  Adenosine 
aa  amino acid(s) 
Amp  Ampicillin 
AP  Alkaline Phosphatase 
APS  Ammonium peroxodisulfat 
BCIP  5-Brom-4-Chlor-3-Indolylphosphat 
Bp  base pair(s) 
BPB  Bromophenol blue 
BPT  native B. subtilis rnpB promoter and terminator 
BSA  Bovine serum albumine 
C  cytosine 
C5  protein subunit of E. coli RNase P 
cam  Chloramphenicol 
cEnd  end concentration  
cStock  stock concentration 
cpm  counts per minute  
Da  dalton 
DNA  deoxyribonucleic acid 
DNase  deoxyribonuclease 
dNTP  deoxynucleoside triphosphates 
DTT  dithiothreitol 
E  extinction 
ε  molar extinction coefficient 
EDTA  Ethylenediamine tetraacedic acid 
EP  native E. coli rnpB promoter 
Fig.  Figure 
g  gram 
G  guanosine 
h  hour(s) 
HEPES  N-2-Hydroxyethylpiperazin-N’-2-ethane sulfonic acid 
IPTG  Isopropyl-β-D-thiogalactopyranosid 
kan  Kanamycin 
kb  kilo bases 
l  liter 
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LB  Luria-Bertani  
M  molar [mol/l] 
mA  milliampere 
MBq  Megabecquerel 
min  Minute 
MW  Molecular weight 
NBT  p-Nitroblue-tetrazolium chloride 
nt(s)  Nucleotide(s) 
NTP   Ribonucleosidtriphosphate 
OD578  optical density at 578 nm 
p.a.  pro analysis  
PAA  Polyacrylamide 
PAGE  Polyacrylamid gel elektrophoresis 
PB.s. rnpB  native B. subtilis rnpB promoter 
PCR  Polymerase chain reaction 
PE.c. rnpB  native E. coli rnpB promoter 
pmol  Picomol 
P Protein  Protein subunit of RNase P 
P RNA  RNA subunit of RNase P 
RACE  rapid amplification of cDNA ends 
RNA  ribonucleic acid 
RNase  ribonuclease 
rpm  rounds per minute  
RT  reverse transcriptase 
SDS  natriumdodecylsulfat 
s  second 
T  thymine 
TBE  Tris-Borat-EDTA Buffer 
Tet  tetracycline 
Tm  melting temperature 
Tris  Tris-hydroxymethylaminomethan 
(p)tRNA  (precursor) transfer RNA 
U  Unit(s) (unit for enzyme activity) 
U  Uridine 
wt  wild-type 
XCB  Xylene cyanol blue 
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8.14  Index of Buffers and Solutions 
5 x Anode buffer (Schägger) 63 
Arg/His-Mix 27 
Blocking Buffer (Western blot)  66 
Buffer A (FPLC) 60 
Buffer F 2/10 60 
Buffer KN 2/4.5  60 
Buffers used for preparative plasmid preparation 42 
5 x Cathode buffer (Schägger) 63 
denaturing sample buffer 32 
denaturing sample buffer/EDTA 70 
5 x DNA sample buffer 31 
Elution buffer 1 39 
Elution buffer 2 39 
3 x Gel buffer (Schägger) 63 
5 x Gel running buffer (Laemmli) 64 
Gel staining solution (Coomassie) 65 
Growth Medium (electrocompetent cells B. subtilis) 26 
HS Medium 26 
LB (Luria Bertani) Medium 23 
LS Medium 27 
2 x native loading buffer 34 
Outgrowth Medium (electrocompetent cells B. subtilis) 30 
PAA gel solution (nativ, THE)  35 
PAA gel solution (TBE)  33 
PUV Buffer 62 
5 x RT Annealing Buffer 55 
10 x S-Base 27 
4 x SDS-PAGE sample buffer (Schägger) 63 
4 x Separation gel buffer (Laemmli) 64 
SOC Medium 29 
SpC Medium 28 
SpII Medium 28 
8 x Stacking gel buffer (Laemmli) 64 
Substrate Buffer (Western blot)  66 
T-Base 28 
5 x TBE buffer 31 
5 x TBS Buffer 66 
TFB1-Solution 25 
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TFB3-Solution 25 
10 x THE buffer 34 
Transfer buffer (Western blot)  65 
Washing Buffer (Western blot)  66 
Washing solution (electrocompetent cells B. subtilis) 26 









































chloramphenicol resistance cassette 
E. coli rnpB gene 
transcription start of pBAD 
araC 
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